Yaya tsawon lokacin da waɗannan alamun suke ci?
Kuma wannan shine yadda ya kamata a bi da duk cututtukan kirji, musamman a shekarunka.
kuma yana da zazzabi
Kuma ya kamata a gwada yawan sinadarin cholesterol naka
Kuma yanzu kuna da zazzabi?
Yanzu kuna da wannan ciwon kirji?
Kuma kana da matsalar numfashi.
Kuma wane irin alamun cutar da kuke da shi?
kuma yawan zafin jikinka
Kuma ina da
kuma ina da mura da tari
Kuma a yau ina fama da mummunar ciwon kirji
Kuma lokaci ne mai kyau don zazzabi mai zafi
kuma ya sami ciwon kirji
Kuma ina jin zazzabi kaɗan
kuma ina so ku bayyana min dalilin ciwon kirji
Kuma suna da zazzabi
kuma kuna da tarihin ciwon sukari
Kuma ka san, ina jin kamar kirji na ya karye
Kuma sun san cewa mutane suna yin izgili a kaina koyaushe
kuma a wannan lokacin kuna jin ciwon kirji
Kuma sun ce wannan shine matsa lamba a cikin kirjinka.
Idan wani a cikin iyalinka yana da ciwon zuciya, ciwon zuciya, ciwon zuciya, hawan jini, da kuma hawan jini
Shin akwai wasu alamun ko matsaloli da ka lura da su game da ciwon tsoka?
Shin akwai wasu da ke cikin gidanku da suke da alamun da kuke da su?
Shin kana da wasu alamun cutar?
Shin kana bukatar ka yi numfashi a kowane lokaci?
Har ila kana da ciwon kirji
Domin wannan shine lokacin mura.
Amma ba za mu manta da asalin ciwon zuciya da ciwon kirji ba.
Amma yanzu matsalar da ta fi yawa ita ce ciwon kirji.
Amma ina da matsalar numfashi.
Amma na san cewa mutane da yawa suna kula da ni.
Amma dole ne mu kula da kowace cuta ta kirji da kyau
Amma yanzu suna numfashi sosai, ko ba haka ba?
Na manta da shi gaba ɗaya saboda wannan ciwon kirji
Wani yana matsa maka a kirji
Har ila kana jin numfashi yana karawa
Shin suna da alamun da suka yi kama da na wannan cutar?
Shin kana da hawan jini ko kuma wani ciwo mai tsanani?
Kana da wata cuta mai tsanani, kamar ciwon sukari?
Shin ya kamata ka yi numfashi a kowane lokaci da kake ciwon kirji?
Shin kana da hawan jini?
Shin kana da ciwon numfashi?
Shin ka san alamun da ke tattare da cutar?
Ka ga hoton nan?
Ka sha ruwa da yawa a yau
Amma na yi gwajin ciwon sukari
Amma, ta yi irin wannan ciwon.
Yaya yawan harbi kake yi?
Yaya hawan jini yake?
Idan zazzabinka ya ci gaba
Idan kana da zazzabi sau ɗari biyu ko fiye
Idan ka ga cewa alamun cututtukanka da matsalolinka suna bukatar ƙarin tabbaci
A jiya na yi zazzabi
Ina da zazzabi kaɗan
A jiya na yi zazzabi
Ina jin zafi sosai a cikin kirji
Ina fama da ciwon numfashi
Zan aiko muku da hoton
A yau ina jin ciwon kirji
A yau ina jin ciwon kai da zazzabi
A ganina, mura ce.
A ganina, wannan mura ce mai sauƙi.
Shin kana jin kamar wani mai nauyi yana zaune a ƙirjinka?
Na soma ciwon kai da zazzabi a lokaci ɗaya
Ina jin ciwo a tsakiyar kirji na
Matsi kamar ciwon kirji
Yana cikin ƙirjina
Yana tsakanin ƙirjina
Yana tsakanin kirji
Ina jin ciwo a kirji
Ina da wannan ciwon kirji mai tsanani.
Ina so ku bayyana mini wannan ciwon kirji.
Ƙari ga haka, yana iya sa mutum ya yi rashin lafiya.
Daidai a tsakiyar ƙirjina
Yanzu za ku iya ɗaukar tachipiri da zaki don ƙwanƙolinku
Maryamu, kwana nawa ne ka fara samun waɗannan alamun?
Yanzu ka ce kana da ciwon kirji
A wasu lokatai nakan yi ciwon kirji
To, kuna da wasu alamun da ke tattare da wannan, sai dai rashin lafiya.
Ko kuma kamar wani yana zaune a kirjinka?
Haka yake da ciwon kai da ciwon tsoka
A tsakanin ƙirjina
Ka nuna mini yadda kake ji a wannan hoton
Idan kana da zazzabi
Shin kana ganin wasu cikin waɗannan alamun suna da alaƙa da yin ciki?
Shin yaranku suna nuna irin wannan alamar?
Ka gaya mini game da ciwon kirjinka.
A lokacin da zafin jiki ya ƙaru da dare
Na yi zazzabi na kwana biyu da suka shige
A daren jiya ne zafin ya fara tashi.
Wannan shi ne likita mai suna Porter a sashen gaggawa na Cibiyar Triad.
To, za ku iya gaya mani game da ciwon kirjin ku?
Yanzu ina jin zafi a cikin kirji a gaban jiki na na farko
Na ji ciwo mai tsanani a kirji
"Sa'anda nake jin ciwo a cikin ƙirjina,
Menene ciwon kirji?
Yaushe ne wannan ciwon kirji ya fara?
A wane wuri ne kake jin ciwo a kirjinka?
Wannan ciwon kirji ne da kake ji
Kana jin kamar an matsa maka a kirji
Sun san cewa ina da ciwon sukari da dai sauransu, ko ba haka ba?
An gaya maka cewa kana da wannan ciwon kirji
Daga Janairu 1 zuwa Maris 15, 2020, yawan adadin cututtukan coronavirus (COVID-19) ya karu cikin sauri a cikin EU / Yankin Tattalin Arzikin Turai.
Yawan adadin cututtukan cutar coronavirus (COVID-19) yana nuna irin wannan yanayin a cikin ƙasashen EU / Yankin Tattalin Arzikin Turai da Ingila, wanda ke nuna cewa annobar COVID-19 ta duniya tana yaduwa cikin sauri a duk ƙasashe duk da cewa tana da matakai daban-daban a kowace ƙasa.
Bisa ga kwarewar Italiya, ƙasashe, asibitoci da sassan kulawa mai tsanani suna buƙatar haɓaka shirye -shiryen su don tsammanin ƙaruwar yawan marasa lafiya na COVID-19 da ke buƙatar kulawa mai tsanani.
A ranar 31 ga Disamba, 2019, an samu rahoton wasu mutane da ke fama da cutar sankarar bargo a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta kasar Sin ta ba da rahoton cewa sabon kwayar cutar coronavirus ne ke haifar da cutar, wanda ake kira mai tsanani na numfashi coronavirus 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 an kira ta cutar coronavirus (COVID-19).
Shaidar da aka samu ya nuna cewa kusan kashi 80% na marasa lafiya da ke da COVID-19 suna da rashin lafiya mai sauƙi, wato, kamuwa da cuta ta numfashi tare da cutar huhu ko a waje da cutar huhu, kuma yawancin suna murmurewa.
A cikin kashi 14% na masu cutar kansa, COVID-19 yana ci gaba zuwa wani mataki mai tsanani wanda ke buƙatar asibiti, yayin da sauran kashi 6% ke fuskantar rashin lafiya mai tsanani wanda ke buƙatar kulawa mai tsanani.
Kashi 4% na marasa lafiya da ke asibiti da ke fama da cutar COVID-19 sun mutu.
A cikin wannan binciken, muna kimanta yanayin yanayin COVID-19 a cikin kowace ƙasa ta EU / Yankin Tattalin Arzikin Turai da Ingila (UK) kuma muna kwatanta shi da lardin Hubei na China.
A halin yanzu, mun kwatanta adadin masu cutar COVID-19 a cikin EU / Yankin Tattalin Arzikin Turai da Burtaniya da adadin masu cutar a Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Masu cutar COVID-19 a cikin EU/EEA da UK
COVID-19 ya ci gaba da yaduwa daga China zuwa wasu yankuna na ƙasa, kuma annobar COVID-19 a halin yanzu tana nunawa a duniya.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba ta duniya.
Spiteri et al. a cikin Eurosurveillance 2020, wanda aka buga a ranar 5 ga Maris, sun ba da rahoton farkon shari'o'in COVID-19 da aka tabbatar a Turai bisa ga fassarar WHO.
A cikin EU/Yankin Tattalin Arzikin Turai, Faransa ce ta ba da rahoton mutane uku da aka tabbatar da cutar a ranar 24 ga Janairu, 2020, waɗanda suka fito daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an sami shari'o'in COVID-19 a duk ƙasashe 30 na Tarayyar Turai / Yankin Tattalin Arzikin Turai da Ingila, tare da 39,768 shari'o'i da mutuwar 1,727 a tsakanin 31 ga Disamba, 2020, daga cikinsu akwai 17,750 shari'o'i da mutuwar 1,441 a Italiya kawai.
Sanin yawan adadin masu cutar COVID-19 da kuma yawan abin da ke faruwa
Bayanai game da lambobin COVID-19 a kowace ƙasa a duniya kamar yadda aka ruwaito a Cibiyar Kula da Cututtuka ta Turai (ECDC) sun fito ne kawai daga kafofin hukuma kamar su Ma'aikatar Kiwon Lafiya ta ƙasar, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, wanda ake sabuntawa kowace safiya da ƙarfe 8:00.
An yi amfani da waɗannan bayanan don kimanta abubuwan da ke faruwa a cikin COVID-19 a cikin EU / EEA da Burtaniya da kwatanta su da Italiya.
Ganin cewa kasancewar masu cutar COVID-19 masu aiki wakili ne, mun kimanta yawan adadin COVID-19 na kwanaki 14, kuma a sakamakon haka, mun yi la'akari da yanayin COVID-19 a cikin kowace EU / Yankin Tattalin Arzikin Turai da Burtaniya daga Janairu 1 zuwa Maris 15, 2020.
Bugu da ƙari, mun kwatanta adadin masu cutar a kowace ƙasa har zuwa karfe 8:00 na safe na ranar 15 ga Maris, 2020 da adadin waɗanda aka ruwaito a Italiya daga ranar 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a cikin EU/EEA da UK
Yanayin da aka nuna a cikin ƙasashen EU / Yankin Tattalin Arzikin Turai da Burtaniya na shari'o'in COVID-19 a cikin kwanaki 14 na lokacin ya biyo bayan lardin Hubei (China) gaba ɗaya (Hoto 1).
Ga EU/EEA da UK gabaɗaya, yawan adadin COVID-19 ya fara ƙaruwa a kusan 21 ga Fabrairu sannan ya ƙaru sosai a kusan 28 ga Fabrairu/2020 (Mataki na gaba).
Wannan ya fi yawaita ne saboda saurin karuwar shari'o'in da aka ruwaito daga Italiya, amma, sauran ƙasashen EU / Yankin Tattalin Arzikin Turai da Burtaniya sun nuna irin wannan yanayin karuwa a cikin adadin COVID-19 (Kayan taimako).
Hoto na 2 ya nuna jimlar adadin masu cutar COVID-19 a cikin EU / EU Economic Area da United Kingdom idan aka kwatanta da adadin a Italiya daga Janairu 31-Maris 15, 2020.
Har zuwa karfe 8:00 na safiyar ranar 15 ga Maris, wasu ƙasashe 15 na Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya sun ba da rahoton jimlar adadin masu cutar kamar Italiya makonni 3 da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin masu cutar COVID-19 da aka ruwaito sun karu cikin sauri a cikin EU / Yankin Tattalin Arzikin Turai da Burtaniya.
Yanayin da ake samu a cikin yanayin COVID-19 ya nuna cewa annobar ta duniya tana ƙaruwa cikin sauri a kusan kowace ƙasa.
Wannan yana faruwa yayin da ƙasashe ke cikin matakai daban-daban, bambance-bambance a cikin amsoshin lafiyar jama'a na ƙasa, kuma wataƙila ma'anar shari'ar daban-daban da ladabi daban-daban a cikin ƙasashe daban-daban don zaɓar marasa lafiya da za a gwada don tabbatar da kasancewar COVID-19.
A farkon watan Maris na 2020, likitoci a lardunan da cutar ta shafa na Italiya sun bayyana cewa kusan kashi 10% na marasa lafiyar COVID-19 suna buƙatar kulawa mai tsanani, kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da sassan kulawa mai tsanani a waɗannan lardunan sun cika.
A halin yanzu, EU / Yankin Tattalin Arzikin Turai yana da bayanai game da adadin masu cutar COVID-19 da ke asibiti da / ko kula da kulawa mai tsanani don kashi 6% da 1% na shari'o'in bi da bi (ba a nuna bayanan ba).
Duk da haka, dole ne a tattara su ta hanyar da ta dace don ƙarfafa bayanan sa ido na yau da kullun, wanda ke mai da hankali kan adadin rahotanni da mutuwar.
Wani bincike da aka yi a shekara ta 2010/11 ya nuna cewa akwai bambanci sosai tsakanin gadajen kula da marasa lafiya a Turai, daga gado 29.2 a Jamus zuwa 4.2 a Portugal ga kowane mutum 100,000.
Wannan yana nufin cewa ƙasashe na iya samun wadata fiye da Italiya (12.5 gadaje masu kulawa da matsakaici da matsakaici ga kowane mutum 100,000, a 201011).
Ana ba da ƙididdigar yawan adadin masu cutar COVID da aka gano a cikin dakunan kwanan dalibai a kowace ƙasa ta EU / EEA da Burtaniya, a cikin sabuntawar ECDC ta shida, a cikin kimantawar COVID-19 mai sauri.
Saboda akwai wasu lokuta a cikin ƙasashen EU / Yankin Tattalin Arzikin Turai da Burtaniya, kuma asibitoci da dakunan kulawa da hankali galibi suna ba da sabis ga wasu ɓangarorin al'umma, ana buƙatar bayyana bayanai game da lokuta da gadajen kulawa da hankali a matakin Statistics 2 (NUTS-2).
Kwarewar Italiya da sauran abubuwan da ke faruwa a wasu ƙasashe sun nuna cewa annobar COVID-19 ta duniya tana yaduwa cikin sauri a cikin EU / Yankin Tattalin Arzikin Turai da Burtaniya.
Saboda haka, ƙasashe, asibitoci da sassan kulawa da ci gaba da kulawa da ci gaba da kula da ci gaba da yaduwar SARS-CoV-2 a cikin al'umma da kuma ƙaruwar yawan marasa lafiya na COVID-19 da ke buƙatar kulawa ta musamman, kamar yadda ya faru a yankunan Italiya da cutar ta shafa.
Kamar yadda aka nuna a cikin wani sabon kimantawa na haɗari na ECDC, yana da mahimmanci a ɗauki hanzari da cikakkiyar hanyar rage yaduwar SARS-COV-2, maimakon rage cutar zuwa ragewa, saboda karuwar saurin da ake tsammani a cikin adadin masu cutar idan ba a aiwatar da shi ba da daɗewa ba ba zai ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, karɓa da daidaitawa da amsar su ba.
Binciken haɗari mai sauri yana iyakance matakan kiwon lafiyar jama'a, wanda aka yi niyyar rage tasirin cutar ta duniya.
Gidan taga ga ƙasashe don ƙara haɓaka ƙoƙarin sarrafawa don rage matsin lamba kan kiwon lafiya ta hanyar jinkirta yaduwar SARS-CoV-2 ya zama ɗan gajeren lokaci.
In ba haka ba, tsarin kiwon lafiya na sauran ƙasashen EU / Yankin Tattalin Arzikin Turai zai cika da marasa lafiya da ke buƙatar kulawa a cikin kwanaki ko makonni masu zuwa.
Cutar Coronavirus ta 2019 (COVID-19) ta sake farfadowa a matsayin annoba ta hanyar cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututut
Kamar yadda SARS-CoV, kwayar cutar da ta kamu da dubban mutane a shekara ta 2003, SARS-CoV-2 za ta iya yaduwa daga bats kuma ta haifar da irin wannan bayyanar cututtuka.
Koyaya, kodayake COVID-19 yana da ƙananan nauyi da mutuwar fiye da SARS, yawan rashin kulawa ya fi yawa kuma yana shafar maza fiye da matasa da mata fiye da mata.
A cikin wannan labarin, za a yi ƙoƙari a ba da cikakken bayani game da aikin bincike da ke ci gaba da sauri, saboda yawan littattafan da ake bugawa game da sabon cutar.
Muna rufe batutuwan asali game da cututtukan cututtuka, ilimin cututtuka, ilimin ƙwayoyin cuta, ganowa, magani da rigakafin cutar.
Ko da yake har yanzu akwai tambayoyi da yawa da ba a amsa ba, muna fatan wannan binciken zai taimaka wajen fahimtar cutar da ke da haɗari da kuma hana ta.
Bikin bazara na ranar 25 ga Janairu, 2020 ya kasance abin tunawa ga duk Sinawa saboda an gargadi Sinawa da su zauna a gidajen su yayin da kuma bayan bikin saboda sabon kamuwa da cutar.
Kwayar cutar ta yi kama da kwayar cutar coronavirus (Cov) da ta haifar da mummunan ciwon numfashi a 2003, don haka, a ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta sake sanya mata suna SARS-CoV-2, kuma cutar da ke da alaƙa da ita ta sake samun suna COVID-19.
Cutar ta fara ne a Wuhan, China, kuma ta bazu cikin sauri a duk faɗin ƙasar, ta kai kusan ƙasashe 50 na duniya.
Ya zuwa ranar 2 ga Maris, 2020, adadin masu cutar COVID-19 ya haura 80,000, tare da sama da 40,000 da aka sallama daga asibiti, kuma sama da 3,000 sun mutu.
WHO ta yi gargadin cewa COVID-19 shine babban makiyin jama'a kuma yana da damar cutarwa fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu tun lokacin da aka buga rahoton farko a ranar 7 ga Janairu, 2020, an buga labarai sama da 200 game da COVID-19, gami da ilimin ƙwayoyin cuta, ilimin cututtuka, ilimin ilmin halitta, ilimin cututtuka da magani, waɗanda suka tsara ƙwayoyin cuta daga marasa lafiya daban-daban.
Wannan binciken yana ƙoƙarin taƙaita sakamakon binciken a cikin sabon batun bincike mai saurin canzawa.
A duk lokacin da zai yiwu, muna gwada COVID-19 da SARS da wata cuta da aka samo daga COVID, Ciwon numfashi na Gabas ta Tsakiya (MERS, annobar shekarar 2012).
Za mu tattauna abin da muka koya game da rigakafin cutar da kuma tarihinta da kuma wasu tambayoyi masu muhimmanci da suka rage.
Ana ɗaukar CoVs a matsayin ƙwayoyin cuta marasa lahani ga ɗan adam, kuma sune babban dalilin kusan kashi 15% na cutar mura 4.
Koyaya, mun sami manyan CoVs masu haifar da cuta sau biyu a wannan karni (SARS-CoV da MERS-CoV), na farko a China a 2003 da Saudi Arabia a 2012, bi da bi, sannan ya bazu cikin sauri zuwa wasu ƙasashe da yawa tare da mummunan rashin lafiya da mutuwar mutane.
Don haka, COVID-19 na yanzu shine annoba ta uku ta CoV a tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1, an fara bayar da rahoton cutar sankarar bargo daga Wuhan zuwa Hukumar Lafiya ta Kasa ta China a ranar 31 ga Disamba, 2019.
An saki mai cutar COVID bayan kwana bakwai.
Ranar 15 ga Janairun 2020, an yi mutuwar farko a cikin ruwa.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwan da ke makwabtaka da su, ƙasashe da ƙasashe.
A ranar 20 ga Janairu, an ba da rahoton cutar ga masu kula da lafiya, wanda ke nuna cewa ana iya yada cutar daga mutum zuwa mutum.
A ranar 23 ga Janairu, an dakatar da duk zirga-zirgar jama'a a Wuhan kuma an rufe dukkan ayyukan birnin.
Binciken asibiti na farko game da cutar a ranar 24 ga Janairu ya nuna cewa daga cikin marasa lafiya 41 da aka tabbatar da cutar, 21 ne kawai suka taɓa kai tsaye da kasuwar abincin teku ta Wuhan, inda aka yi imanin cewa asalin cutar ba a san asalin dabba ba.
A ranar 30 ga Janairu, WHO ta ayyana cutar a matsayin babbar barazanar kiwon lafiya a duniya.
A lokacin da aka shirya wannan rahoton, cutar ta bazu zuwa China da wasu ƙasashe kusan 50 (Figure (Figure2.2).
"Tun da yanayin yana canzawa cikin sauri, za a iya yanke shawara game da girman ƙarshe da tsananin annobar a nan gaba".
A ranar 11 ga Fabrairu, 2020, an gudanar da binciken cibiyoyi da yawa akan marasa lafiya 8,866, daga cikinsu akwai 4,021 da aka tabbatar da cutar COVID-19 da ke nuna halin da ake ciki yanzu (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 na iya shafar mutane a kowane zamani, amma galibi yana shafar waɗanda ke tsakanin shekaru 30 zuwa 65.
Kusan rabin mutane da ke dauke da cutar (47.7%) sun haura shekaru 50, kaɗan daga cikinsu ba su kai 20 ba, kuma mutane 14 ne kawai ke da shekaru 10 ko ƙasa da haka.
Yawan maza da ke fama da cutar SARS-CoV-2 (0.31/100,000) ya fi na mata yawa (0.27/100,000).
COVID-19 ya bazu musamman a cikin Hubei da kewayenta.
Ana buƙatar matsakaicin kwanaki 5 (2-9) don ganowa ta hanyar gwaji daga ranar kamuwa da COVID-19.
Alamun cutar sun fara bayyana a matsakaicin kwanaki 4.8 (3.0-7.2).
Matsakaicin lokacin da cutar ta fara zuwa mutuwa ya kai 9.5 (4.8-13).
Yawan haifuwa na asali (R0) ya kasance 3.77 (95% CI: 3.51-4.05), kuma R0 da aka daidaita ya kasance 2.23-4.82.
An samu karuwar masu kamuwa da cutar kafin ranar 23 ga Janairu, 2020, lokacin da ake gudanar da bikin bazara a kasar Sin.
Yawan mutuwar marasa lafiya da ke da tabbacin cutar ya kasance 1.44% (95% CI: 1.10-1.86%) yayin da daidaitaccen mutuwar dukkan marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Abubuwa uku masu haɗari na COVID-19 sune jinsi (maza), shekaru (≥60), da kuma cutar huhu mai tsanani.
CoVs ƙananan ƙwayoyin cuta ne masu ɗauke da RNA guda ɗaya.
Ana iya raba su zuwa manyan rukuni huɗu: alpha, beta, gamma, da delta, daga cikinsu an san cewa alpha da beta CoVs suna cutar da mutane.
Envelope spike (S) glycoprotein yana haɗuwa da mai karɓar antigen mai canza enzyme 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV sannan kuma yana haifar da haɗuwa da ƙwayoyin halitta.
Ana sakin kwayar RNA ta kwayar cutar zuwa cikin kwayar halitta; bayan an rarraba kwayar cutar, RNA na kwayar halitta da glycoproteins da nucleocapsid sun hada da kwayar cutar a cikin tantanin halitta ko a waje, wanda ke haɗuwa da ƙwayar plasma kuma yana sakin kwayar cutar.
An fara rahoton cutar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
Lokacin da aka gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV, an sami daidaito na kwayoyin halitta sama da kashi 99.98% a cikin samfuran 10 da aka ɗauka daga kasuwar abincin teku ta Hunan, a cikin ruwan da cutar ta fara bulla.
SARS-CoV-2 yana da kamanceceniya da SARS-CoV fiye da MERS-CoV.
Ta hanyar microscopy na watsawa, an gano ƙananan kwayoyin SARS-CoV-2 a cikin ƙananan sassan numfashi na ɗan adam.
An gano ACE2 na ɗan adam mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, haɗin S-protein a cikin SARS-CoV-2 zuwa ACE2 na ɗan adam ya raunana daga SARS-CoV, wanda ke da alaƙa da rashin kamuwa da cutar SARS-CoV-2 a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 ana iya samarwa ta hanyar ɓoyewa ta hanyar orf3b, wani ɗan gajeren furotin mai suna Novel, kuma ana sakin shi ta hanyar furotin orf8.
SARS-CoV-2 orf3b na iya taka rawa a cikin ƙwayar cutar kuma yana hana bayyanar IFNβ; duk da haka, orf8 ba shi da sanannen yanki mai aiki ko mai motsawa.
A ranar 18 ga Fabrairu, 2020, Zhu da abokan aikinsa sun ba da rahoton cewa cikakken tsarin ECM na mutum ACE2 yana da ƙuduri na 2.9 Å, wanda ya fito ne daga hadadden mai jigilar amino acid B0AT1.
An tabbatar da cewa hadaddun da ke buɗe da rufe suna da damar haɗuwa kamar dimer kuma hadaddun ACE2-B0AT1 na iya ɗaure sunadarai biyu na S, wanda ke ba da tabbaci ga gano CoV da kamuwa da cuta.
B0AT1 na iya zama maƙasudin maganin rigakafi don hana kamuwa da cutar SARS-CoV-2.
Mai watsa shiri da ke kawowa da kuma rarrabawa
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga malam buɗe ido kuma an watsa su ga mutane ta hanyar sauro da raƙuma, bi da bi.
Ta hanyar kwatanta asalin SARS-CoV-2 da sauran CoVs, an ɗauka cewa jemage ne farkon masu karɓar SARS-CoV-2 saboda sabon kwayar cutar tana da kamanceceniya da kashi 96% tare da SARS-like CoVs biyu daga jemage, bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, har yanzu ba a san mai ɗaukar hoto wanda ya ba da damar cutar ta ƙetare iyakokin jinsi don cutar da mutane ba, kuma har yanzu ba a bayyana hanyar watsawa ba.
G da abokan aikinsa sun nuna cewa maciji ne ya watsa kwayar cutar daga tsuntsayen bats zuwa mutane, wanda ke buƙatar sake haɗuwa da furotin S.
A cewar wani bincike, masu bincike a Guangzhou, China, masu shayarwa masu dogon hanci da kuma tururuwa, wanda galibi ake amfani da su a maganin gargajiya na kasar Sin, sune masu karɓar bakuncin SARS-CoV-2, dangane da 99% na kama-da-wane tsakanin kwayoyin halitta da aka gano a cikin pangolins da SARS-CoV-2.
Duk da haka, bambancin 1% a cikin kwayoyin halitta guda biyu shine bambanci mai yawa, saboda haka, ana jiran sakamako mai mahimmanci don tabbatar da tabbacin (Fig. 33).
Har yanzu ba a san halaye na zahiri da na sinadarai na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV suna rayuwa har zuwa awanni 48 a cikin bushewa da ƙasa da 20 °C da zafi 40%-50% har zuwa kwanaki 5.
SARS-CoV-2 na iya samun halaye iri ɗaya.
An bayar da rahoton cewa SARS-CoV-2 yana da ƙarancin haske da zafin jiki a 56 °C zuwa 30 °C. Ether, 75% ethanol, chlorinated antibacterial, paracetic acid, chloroform da sauran masu narkewa masu ƙanshi, ban da chlorhexidine, na iya rage tasirin kwayar cutar.
Yawancin jama'a suna da rauni ga SARS-CoV-2 saboda rashin ƙarfin jiki.
A halin yanzu, babu cikakken binciken da aka ruwaito game da maganin rigakafi ga SARS-CoV-2.
Don haka, zamu iya kawai komawa ga binciken da aka yi a baya akan wasu COVID-19 musamman SARS-CoV da MERS-CoV (Hoto (Hoto 4).4).
Gabaɗaya, bayan kamuwa da kwayar cuta, ana gano ta da farko ta hanyar masu karɓar alamun alamun (PRRs) a cikin tsarin garkuwar jiki na mai masaukin, waɗanda suka haɗa da masu karɓar nau'in C-type lectin, mai karɓar Toll-like (TLR), mai karɓar NOD-like (NLR), da mai karɓar RIG-I-like (RLR).
Kwayar cutar tana amfani da hanyoyi daban-daban don haifar da kumburi, lalata ƙwayoyin antigen, da kuma samar da nau'ikan I Interferons (IFNs) don hana yaduwar kwayar cutar da kuma hanzarta phagocytosis na macrophage na antigen na kwayar cutar.
Duk da haka, furotin SARS-CoV N na iya taimaka wa kwayar cutar ta tsere daga tsarin garkuwar jiki.
Nan ba da daɗewa ba, tsarin rigakafin jiki zai shiga cikin gwagwarmayar da za a yi da cutar.
Kwayoyin T lymphocytes, gami da CD4 + da CD8 + T cells, suna taka muhimmiyar rawa wajen kare cutar.
Kwayoyin CD4+ T suna motsa ƙwayoyin B don samar da ƙwayoyin cuta da ke hana ƙwayoyin cuta, yayin da ƙwayoyin CD8+ T ke kashe ƙwayoyin cuta kai tsaye.
Kwayoyin T masu taimakawa suna samar da cytokines masu taimakawa don taimakawa kwayoyin rigakafi.
Koyaya, CoV na iya hana aikin T-cell ta hanyar hanzarta mutuwar T-cell.
Hakanan, rigakafin rigakafin ruwa kamar C3a da C5a da ƙwayoyin cuta suna da mahimmanci don hana kamuwa da ƙwayoyin cuta.
Misali, ƙwayoyin cuta da aka ware daga mai haƙuri da suka warke sun kashe MERS-CoV.
A wani ɓangare kuma, idan tsarin garkuwar jiki ya yi aiki da ƙarfi, zai iya haifar da ƙwayoyin cuta masu yawa da ke haifar da lalacewar huhu da sauran gabobin jiki, kuma idan yanayin ya yi muni, zai iya haifar da rashin aiki da kuma mutuwa.
Cutar SARS-CoV-2 tana iya shafar tsofaffi da mata masu ciki da ke da cututtuka daban-daban.
Yana da kyau a lura cewa mutane da ke da ƙwayoyin cuta da yawa ko kuma waɗanda ke da ƙarancin rigakafi suna da saurin kamuwa da cutar fiye da sauran mutane.
Matsakaicin lokacin haifuwa na SARS-CoV-2 ya kai kwanaki 1-14, wanda yawanci kwanaki 3-7 ne bisa ga binciken da aka yi kan mutane 425 da suka fara kamuwa da cutar a cikin ruwa.
Koyaya, binciken da aka yi akan masu cutar 1,099 ya nuna cewa matsakaicin lokacin haifuwa shine kwanaki 3 kuma ya kasance daga kwanaki 0 zuwa 24.
Kamar yadda aka ambata a sama, binciken da aka yi kwanan nan ya nuna cewa lokacin haifuwa na cutar ya kai kwanaki 4.8 (3.0-7.2), dangane da bayanan alƙaluma na mutane 8,866.
Ma'aikatan kiwon lafiya za su buƙaci daidaita lokacin keɓewa mai inganci dangane da lokacin haifuwa mafi dacewa, wanda zai hana waɗanda ke da cutar amma ba su nuna alamun cutar daga yada cutar ga wasu.
A matsayin tsari na yau da kullun, ana buƙatar mutane da ke da alaƙa da cutar ko waɗanda ke da cutar su keɓe kansu na kwanaki 14.
Shin ya kamata a tsawaita keɓewar mutane zuwa kwanaki 24?
Alamar farko da ta fi dacewa da COVID-19 zazzabi ne, wanda ba zai iya zama ba tare da alamun cutar ba ko kuma tare da wasu alamun kamar tari mai bushe, numfashi mai wuya, ciwon tsoka, kumburi, ciwon kai, ciwon makogwaro, ciwon kirji, zawo da zawo.
Wasu marasa lafiya sun sami wahalar numfashi da / ko rage yawan iskar oxygen a cikin jini tun ranar da cutar ta fara.
A cikin lokuta masu tsanani, marasa lafiya suna fara nuna alamun ciwon numfashi mai tsanani, harin septic, acidosis na rayuwa da coagulopathy da wuri.
Ya kamata a bincika marasa lafiya da alamun zazzabi da / ko rashin lafiyar numfashi da zazzabi mai tsanani don gano cutar da wuri, koda kuwa ba su da matsala tare da hoton numfashi.
Binciken al'umma a ƙarshen Disamba 2019 ya nuna cewa kashi 98% na masu fama da cutar sun kamu da zazzabi, kashi 76% na tari mai bushe, kashi 55% na rashin numfashi, da kashi 3% na zawo, kuma kashi 8% na marasa lafiya sun buƙaci taimakon injin numfashi.
An samu irin wannan binciken a cikin binciken kwanan nan a cikin ƙungiyoyin iyali biyu da kuma ƙungiyar da ke da kwayar cutar daga wani wanda ba shi da alamun cutar.
A wani bangare kuma, wani binciken da aka yi a shekarar 2012 ya nuna cewa mafi yawan masu dauke da cutar MERS-CoV suna da zazzabi (98%), tari mai bushe (47%), da kuma numfashi mai wuya (55%).
Koyaya, kashi 80% na marasa lafiya na COVID-19 sun buƙaci injin numfashi fiye da yadda suke buƙata, la'akari da cewa MERS yana da yawan mutuwa fiye da COVID-19.
An lura da gudawa (26%) da ciwon makogwaro (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiyar SARS, zazzabi (99%-100%), tari mai bushe (29%-75%), taƙaita numfashi (40%-42%), zawo (20-25%), da ciwon makogwaro (13-25%) sune manyan abubuwan lura, yayin da kashi 14%-20% na marasa lafiya ke buƙatar taimakon numfashi.
A ranar 14 ga Fabrairu, yawan mutuwar COVID-19 ya kai kashi 2%, yayin da adadin masu kamuwa da cutar a duniya ya kai 66,576.
A wani bangare kuma, a watan Nuwamba na shekara ta 2002, yawan mutanen da SARS ta kashe sun kai kashi 10 cikin 100 na mutane 8,096 da cutar ta shafa.
A cewar wani bincike da aka yi a watan Yunin 2012, a cikin mutane 2,494 da aka tabbatar da cutar, mutuwar ta kai kashi 37 cikin dari.
Binciken farko na yanki ya nuna cewa SARS-CoV-2 R0 ya kasance mafi girma daga 6.47 zuwa 5.71-7.23, tare da 95% Interval of Confidence (CI) na 5.71-7.23, kuma SARS-CoV R0 daga 2 zuwa 4.
Kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamomi, yawan mutuwa da R0 an nuna su a tebur 1.1.
Lambobin da ke sama sun nuna cewa SARS-CoV-2 ya fi MERS-CoV da SARS-CoV yaduwa, amma rashin kisan kai ya fi su biyu.
Don haka, sarrafa barkewar SARS-CoV-2 ya fi ƙalubale fiye da sarrafa MERS-CoV da SARS-CoV.
Cutar kwayar cuta ta al'ada tana faruwa ne a cikin iyali ɗaya ko cikin rukuni ɗaya ko cikin mota, kamar jirgin ruwa.
Masu cutar galibi suna da tarihin tafiya ko zama a Wuhan ko wasu yankuna masu cutar a cikin makonni biyu kafin cutar ta bulla, ko kuma sun kasance cikin hulɗa kai tsaye da mutane ko marasa lafiya da ke da cutar.
Koyaya, rahotanni da ke nuna cewa mutane na iya ɗaukar kwayar cutar sama da makonni biyu ba tare da nuna alamomi ba, kuma marasa lafiya da suka warke daga asibiti na iya sake ɗaukar kwayar cutar, zai zama gargaɗi don tsawaita keɓewa.
A farkon farkon cutar, marasa lafiya suna da ƙarancin ƙwayoyin farin jini (musamman lymphocytes) ko ƙananan ƙwayoyin.
Misali, an gano cutar lymphopenia tare da adadin farin jini; 4×109/L; ciki har da yawan lymphocytes; 1×109/L; matakan aspartate aminostranferine da viremia 1,099 a cikin marasa lafiya na COVID-19.
A cikin jinin wasu marasa lafiya, an sami ƙaruwa a cikin matakan enzymes na hanta da tsoka da myoglobin, kuma an sami ƙaruwa a cikin furotin C-reactive da ƙarancin erythrocytes a cikin yawancin marasa lafiya.
A cikin marasa lafiya da ke da cutar mai tsanani, yawan D-dimer, wani abu da ke rage fiber a cikin jini, ya karu kuma yawan ƙwayoyin jini na rigakafi ya ragu.
Sakamakon radiography na kirji a cikin yawancin marasa lafiya na COVID-19 ya nuna matsalolin kiwon lafiya, wanda ke nuna ɓarna a ɓangarorin biyu ko ɓoyayyen ɗakuna a cikin huhu.
Masu ciwo suna yawan samun ciwon huhu, ciwon huhu mai tsanani, da kuma ciwon numfashi mai tsanani (ARDS).
A lokacin ARDS, kumburi, ɓarkewar ruwa, da kuma ciwon da ke ci gaba da girma suna sa gas ya yi sanyi sosai.
Kwayoyin alveoli na nau'in I da na II suna rage haɓakar lipid da furotin, wanda ke ƙara damuwa kuma yana sa huhu su yi laushi kuma yana ƙara haɗarin cinkoson huhu.
Saboda haka, mafi munin binciken radiography na kirji galibi yana da alaƙa da mafi munin cutar.
Binciken binciken farko na cutar da aka gudanar a ranar 18 ga Fabrairu, 2020 akan COVID-19 ya nuna lalacewar ƙwayoyin cuta, samar da ƙwayoyin halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar
Gano SARS-CoV-2 RNA ta hanyar hanyar aikin dakin gwaje-gwaje da ake kira reverse-transcriptase polymerase chain reaction (RT-PCR) ya zama muhimmin ma'auni don gano cutar COVID-19.
Koyaya, saboda karuwar sakamakon ba daidai ba, wanda ke sa saurin yaduwar cutar, a ranar 13 ga Fabrairu, 2020, an fara amfani da alamun gwaji na asibiti don gano cutar (wanda ba zai dogara da RT-PCR kawai ba) a China.
An yi irin wannan binciken a lokacin da aka gano cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, alamun asibiti, gwaje -gwajen dakin gwaje -gwaje da binciken radiology yana da mahimmanci don gano cutar yadda ya kamata.
A ranar 14 ga Fabrairu, 2020, Feng Zhang Group ta kafa wata yarjejeniya don gano SARS-CoV-2 ta hanyar amfani da fasahar CRISPR-based SHERLOCK, wacce ke gano ɓangarorin RNA na SARS-CoV-2 na roba a cikin ƙasa da awa ɗaya ta amfani da dipstick ba tare da buƙatar ƙarin kayan aiki ba, daga 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (10-100 kopears a kowace shigarwar microwave).
Muna fatan cewa idan aka tabbatar da sabuwar hanyar a cikin samfuran asibiti, za ta iya haɓaka ƙwarewa da jin daɗi sosai.
Saboda rashin ƙwarewa game da Novel CoV, likitoci na iya ba da kulawa ta tallafi ga COVID-19 yayin da suke gwada wasu magunguna daban-daban waɗanda aka yi amfani da su a baya ko kuma aka yi niyyar magance su don magance cututtukan ƙwayoyin cuta kamar SARS-CoV da MERS-CoV (Table (Table2).2).
Waɗannan sun haɗa da maganin rigakafi, maganin hana kamuwa da cuta, magungunan hana kamuwa da cuta, jini, magani na ƙasar Sin, da kuma taimakon tunani.
An ba da shawarar yin amfani da jini daga marasa lafiya da suka warke daga cutar.
Kamfanonin harhada magunguna suna hanzarin samar da rigakafin cutar da ke da rigakafin cutar.
SARS-CoV-2 da farko yana cutar da huhu, tare da ƙananan ƙananan sassan jiki, kamar tsarin narkewa da koda, waɗanda ke samar da ACE2.
Amma, rashin numfashi da kuma rashin aiki sune manyan abubuwan da ke jawo mutuwa da kuma haɗarin da ke tattare da cutar.
Saboda haka, taimakon numfashi yana da muhimmanci wajen rage alamun cutar da kuma ceton rai, kuma ya ƙunshi jinyar iskar oxygen gaba ɗaya, iskar oxygen mai yawa, iska mai ƙarfi da iska mai ƙarfi da kuma iska mai ƙarfi kamar yadda yake a cikin ƙanshi.
Marasa lafiya da ke da alamun ciwon numfashi mai tsanani ya kamata a taimaka musu da ECMO, ingantacciyar hanyar motsa jiki ta zuciya da huhu don magance cututtukan zuciya ko na numfashi.
Bugu da ƙari, kiyaye daidaiton wutan lantarki, rigakafi da magani na kamuwa da cuta ta biyu da harin septic da kiyaye ayyukan sassan jiki masu mahimmanci suna da mahimmanci ga marasa lafiya na SARS-CoV-2.
Ana san cewa guguwar cytokine tana haifar da yawan aiki na tsarin garkuwar jiki a cikin marasa lafiya na SARS da MERS.
Cytokine Storm amsawa ce ta tsarin rigakafin kumburi wanda ke nuna sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines suna haifar da kwayoyin cututtuka don sakin yawancin 'yanci, wanda ke haifar da ARDS da kuma dakatar da aiki na gabobin jiki.
Maganin rigakafin cutar yana da mahimmanci ga cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ana amfani da cortisone steroids da tosalizumab, ƙwayoyin rigakafin IL6 monoclonal, don magance guguwar cytone.
Sauran magungunan da ake amfani da su don cutar ta cytokine sun haɗa da motsawar ƙwayoyin T-cell; hana IFN-γ, IL-1, da TNF; hana JAK; Blinatumumab; mai hana siginar cytokine 4; da masu hana HDAC.
Ana amfani da magungunan steroid sosai wajen magance cutar SARS don rage cutar da ke hana jikin mutum kamuwa da cuta.
Koyaya, steroids da aka ba da yawa ba su da amfani sosai wajen rage mummunan lalacewar huhu a cikin marasa lafiya na SARS da COVID-19.
Maimakon haka, zai iya shafan yadda cutar take ci gaba, musamman ma mutuwar ƙashi.
Koyaya, ana ba da shawarar a ba da ƙananan zuwa matsakaitan allurai na gajeren lokaci na corticosteroids don marasa lafiya masu ƙarfi na COVID-19.
A lokacin da ake rubuta wannan talifin, ba a tabbatar da cewa akwai maganin rigakafi da zai iya magance cutar ba.
Koyaya, an ba da maganin Remdesivir, wanda yake kama da nucleotide, ta hanyar jini, wanda ya nuna tasiri a cikin wani mai haƙuri na COVID-19 na Amurka.
Remdesivir wani sabon magani ne na rigakafin cutar da Gilead ta samar, wanda aka fara amfani da shi don magance cututtukan da ƙwayoyin cuta na Ebola da Marburg ke haifarwa.
Daga baya, an nuna cewa remdesivir yana hana ayyukan ƙwayoyin cuta guda ɗaya na RNA, gami da ƙwayoyin MERS da SARS.
A sakamakon haka, Gilead ta ba da kayan aikinta ga China don yin gwaje-gwaje na hadin gwiwa a kan mutane da ke fama da cutar SARS-CoV-2, kuma ana jiran sakamakon da ke cikin damuwa.
Bugu da ƙari, baricetinib, interferon-α, lopinavir/ritonavir, da ribavirin an ba da shawarar don amfani da su a matsayin magani ga marasa lafiya da ke da alamun ciwon numfashi mai tsanani.
Za a iya haifar da zawo, tashin zuciya, amai, lalacewar hanta da sauran halayen da ba su dace ba yayin maganin haɗin lopinavir / ritonavir.
Ya kamata a lura da yadda waɗannan magungunan suke shafar marasa lafiya da kuma wasu magunguna.
Samar da jini da kuma rigakafi daga marasa lafiya da suka warke
Hakazalika, an daɗe ana karɓan jini daga waɗanda suka warke daga cututtuka masu yaduwa don a warkar da waɗanda suke da ciwo ko kuma a hana waɗanda ba su da ciwo kamuwa da cutar.
Hakika, marasa lafiya da suka warke suna da ƙwayar rigakafi da ta fi na ƙwayoyin cuta a cikin jinin su.
Antibodies sune immunoglobulin (Ig) da kwayoyin B ke samarwa, suna yaƙi da ƙwayoyin cuta da sauran ƙwayoyin cuta, kuma suna kashe kwayoyin da ke cikin ƙwayoyin cuta ta hanyar gano su kai tsaye.
A cewarsa, an dauki jini daga marasa lafiya da suka warke daga COVID-19 kuma an yi musu allurar rigakafi ga marasa lafiya 10 da ke fama da cutar.
Alamun cututtukan su sun inganta cikin awanni 24, tare da rage kumburi da cutar kwayar cuta da kuma inganta haɓakar oxygen a cikin jini.
Amma, kafin a samu wasu hanyoyin magani, ana bukatar tabbaci da kuma haske don a nuna wata hanya da za a yi amfani da ita sosai.
Ƙari ga haka, idan aka yi la'akari da yadda za a iya rage ciwon, ya kamata a yi la'akari da wasu haɗarin da jini zai iya jawo.
Alal misali, ƙwayoyin rigakafi suna hana jikin mutum yin aiki da kyau kuma hakan yana iya sa mutum ya kamu da cutar sankarar jijiyoyin jiki.
Yawan ƙwayoyin rigakafi a cikin jini sau da yawa yana da ƙasa, kuma ana bukatar jini sosai don kula da marasa lafiya masu tsanani.
Yana da wuya a samar da wasu ƙwayoyin cuta da ke da ƙarfin yaƙi da annobar duniya da sauri.
Saboda haka, ana buƙatar ware ƙwayoyin B daga marasa lafiya da suka warke kuma gano lambobin kwayoyin da ake buƙata don samar da ƙwayoyin cuta masu tasiri ko kuma bincika sunadarai masu mahimmanci na kwayar cutar don ƙwayoyin cuta masu tasiri.
Ta wannan hanyar, za mu iya ƙara yawan ƙwayoyin cuta cikin sauƙi.
An yi amfani da TCM a China don magance cututtuka daban-daban na shekaru dubbai.
Amma, sakamakon ya dogara ne da haɗuwa da abubuwa daban-daban a cikin tsari guda, wanda tsarin TCM ya bambanta dangane da cutar.
Yawancin abubuwan da ke aiki ba a san su ba ko kuma ba a san su ba, saboda yana da wuya a gano da kuma tabbatar da irin waɗannan abubuwan ko abubuwan haɗin.
A halin yanzu, TCM ya zama ɗayan manyan hanyoyin magani na zaɓi don marasa lafiya da ke da alamun rashin lafiya mai sauƙi zuwa matsakaici ko waɗanda suka murmure daga cutar saboda rashin ingantaccen magani na musamman don COVID-19.
Misali, an gano cewa allunan Shu Feng Jie Du da Lian Hua Qing Wen suna da tasiri wajen magance COVID-19.
Yawancin lardunan da ke China waɗanda ke amfani da TCM a cikin kashi 87% na marasa lafiyarsu suna da ƙimar ceto na COVID-19, gami da Gansu (63.7%), Ningxia (50%), da Hunan (50%).
Amma, wannan kwatancen ba shi da zurfi domin akwai wasu abubuwa da yawa da za a yi la'akari da su, kamar yawan marasa lafiya da kuma yawan ciwo.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga wani bincike da ya kwatanta maganin Yammacin Turai (WM) da magani na WM da TCM.
Lokacin da ake buƙatar dawo da zafin jiki, lokacin bayyanar cututtuka da lokacin kwantar da asibiti sun ragu sosai a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai.
Abin mamaki, yawan ciwon (daga mai sauƙi zuwa mai tsanani) ya ragu sosai a cikin rukunin WM + TCM fiye da rukunin WM kawai (7.4% vs 46.2%); yawan mutuwar ya ragu sosai a cikin rukunin WM + TCM fiye da rukunin WM kawai (8.8% vs 39%).
Amma, inganci da amincin TCM zai jira sakamakon gwaji mafi girma da kuma cibiyoyi da yawa.
Bayyana abubuwan da ke tattare da matakan da kuma bayyana abubuwan da ke da tasiri na maganin TCM ko kuma haɗuwa da su idan ya yiwu na iya zama babban abin sha'awa.
Masu fama da cutar COVID-19 da ake zargi ko tabbatacce suna jin tsoron cutar mai saurin yaduwa da kisa, kuma waɗanda ke keɓewa suna jin rashin kulawa, kaɗaici da fushi.
Ƙari ga haka, cututtuka da kuma magani kamar zazzabi, rashin numfashi, da tari, kamar rashin barci da ake samu daga shan magungunan corticosteroids, suna iya sa mutum ya ƙara damuwa da kuma damuwa.
A farkon lokacin barkewar cutar SARS, an bayar da rahoton matsalolin lafiyar kwakwalwa daban-daban, gami da ci gaba da rikici, damuwa, tashin hankali, rashin hankali, alamun rashin lafiya, rashin hankali da tunanin kashe kansa.
Kulawa da keɓewa, wanda shine ɗayan amsoshin lafiyar jama'a don hana yaduwar COVID-19, na iya haifar da damuwa da laifi ga mutane game da cutar, tasirin keɓewa da keɓewa daga dangi da abokai.
Don haka, ya kamata a ba da kulawar lafiyar hankali ga marasa lafiya na COVID-19, waɗanda ake zargi da su, da waɗanda suka taɓa hulɗa da su, kuma gabaɗaya suna buƙatar su.
Taimako na hankali ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiyar hankali da yawa, sadarwa ta yau da kullun da ingantaccen bayani game da barkewar SARS-CoV-2 da tsare-tsaren magani, da amfani da ƙwararrun kayan aikin lantarki da aikace-aikace don kauce wa hulɗa.
Bugu da ƙari, alluran rigakafi masu tasiri suna da mahimmanci don ƙetare sarkar watsawa daga wuraren kiwo da mutane masu haɗari zuwa masu karɓar cutar, kuma suna taimakawa wajen sarrafa barkewar cututtukan da sabbin ƙwayoyin cuta ke haifarwa.
An yi ƙoƙari don samar da alluran rigakafin S-protein waɗanda za su iya ba da rigakafi da / ko ƙarfafa tsarin garkuwar jiki na dindindin don SARS-CoV.
An gwada alluran rigakafi daga ƙwayoyin cuta masu cutarwa don SARS a cikin samfuran dabbobi.
Amma, kafin a fara gwajin asibiti, ya kamata a yanke shawarar ko waɗannan alluran rigakafin za su iya yin tasiri ga tsofaffi da kuma rage mutuwar mutane da kuma ƙarancin cutar da ke faruwa a cikin dabbobi.
Wannan na iya zama saboda SARS ya ragu shekaru 17 da suka gabata kuma babu wani sabon shari'ar da aka samu tun daga lokacin.
Akasin haka, cutar MERS-CoV ta ci gaba da yaduwa sosai a Gabas ta Tsakiya, kuma ta bazu zuwa wasu yankuna, ta hanyar yaduwa daga dabbobi zuwa mutane a wuraren da ta kasance.
An tsara dabarun allurar rigakafin cutar ta MERS ta amfani da ƙwayoyin cuta marasa aiki, DNA plasmids, masu ɗaukar hoto, nanoparticles, abubuwa masu kama da ƙwayoyin cuta da ƙananan ƙwayoyin cuta na dakin gwaje-gwaje, wasu kuma an gwada su a kan samfuran dabbobi.
Samar da ingantaccen allurar rigakafi don kare SARS-CoV-2 ga mutanen da ba su da rigakafi yana da gaggawa da mahimmanci don sarrafa annobar da ke gudana.
Koyaya, magance matsalar yana da ƙalubale saboda tsayin lokaci mai tsawo (a matsakaita watanni 18) don samar da allurar rigakafi da kuma yanayin canzawar CoVs.
Saboda COVID-19 sabuwar cuta ce, ana fara nuna cikakken aikin asibiti akan dubban marasa lafiya.
A yawancin lokaci, marasa lafiya suna murmurewa a hankali ba tare da ciwo ba.
Koyaya, kamar SARS da MERS, COVID-19 yana haifar da rashin lafiya da mutuwa mai yawa a cikin marasa lafiya.
Saboda haka, gina samfurin tsinkayar ci gaban cutar yana da mahimmanci don hukumomin kiwon lafiya su iya tsara ayyukansu, musamman a yankunan da ba su da albarkatu.
Dangane da binciken asibiti da aka ruwaito zuwa yanzu, waɗannan abubuwan masu zuwa na iya shafar ko alaƙa da tarihin rashin lafiya na marasa lafiya na COVID-19 (Table (Table33):
Shekaru: Shekaru sun kasance masu mahimmanci don sanin tarihin SARS, kuma wannan ya shafi COVID-19.
Kamar yadda aka ambata a sama, binciken da aka yi akan mutane 8,866, ya nuna cewa kashi 47.7% na marasa lafiya sama da shekaru 50 da haihuwa, waɗanda ke fama da COVID-19, sun fi kamuwa da cutar tsakanin shekaru 30-65.
Matsakaicin shekarun marasa lafiya da ke buƙatar kulawa mai tsanani sun fi waɗanda ke da cututtuka da matsalolin kiwon lafiya da ba su da cutar tsufa (matsakaicin shekaru 66 zuwa 51) wanda ke nuna cewa shekaru alama ce ta kimanta yiwuwar warkewar marasa lafiya na COVID-19.
Jima'i: Kamar yadda aka ambata a sama, SARS-CoV-2 ya fi kamuwa da maza fiye da mata (0.31/100,000 maza, 0.27/100,000 mata).
Matsalolin kiwon lafiya da rashin lafiya na yau da kullun: marasa lafiya na COVID-19 waɗanda ke buƙatar kulawa mai tsanani suna da haɗarin kamuwa da cututtukan zuciya da matsalolin numfashi.
Matsalolin da ke tattare da cututtukan zuciya sune manyan abubuwan da ke haifar da mutuwar marasa lafiya na SARS.
SARS-CoV-2 ana ba da rahoton cewa yana da alaƙa da cholangiocytes masu kyau na ACE2 kuma yana iya haifar da matsalolin lafiyar hanta a cikin marasa lafiya na COVID-19.
Yana da muhimmanci a fahimci cewa shekaru da ciwo suna da nasaba sosai kuma ɗaya zai iya shafan ɗayan.
Sakamakon gwaje-gwaje mara kyau: Matsayin C-reactive protein (CRP) a cikin jini yana nuna girman kumburi ko lalacewar ƙwayoyin cuta, kuma an ba da shawarar amfani da shi don gano tarihin cutar, amsawar magani da kuma tsarin murmurewa na ƙarshe.
An kuma ba da shawarar alaƙar da ke tsakanin ƙimar CRP da tsinkayar yanayin COVID-19 da ci gaban ci gaba.
Bugu da ƙari, haɓakar lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Ana fitar da waɗannan enzymes a wurare dabam dabam na jiki, musamman a zuciya da hanta, kuma ana sakin su sa'ad da jijiyoyi suka lalace.
Saboda haka, cututtukan zuciya ko hanta sune alamun alamun al'ada.
Babban alamun asibiti: radiography na kirji da tsawon lokacin alamun asibiti, tare da wasu dalilai, yakamata a yi amfani da su don hango sakamakon COVID-19 da matsalolin lafiya.
Amfani da steroids: Kamar yadda aka ambata a sama, ana amfani da steroids a matsayin magani mai taimakawa ga cututtukan cututtuka don rage lalacewar numfashi.
A sakamakon yawan amfani da maganin corticosteroid a cikin marasa lafiya da ke fama da cutar SARS, yawancin waɗanda suka tsira daga cutar sun mutu, sun naƙasa, kuma sun yi rashin lafiya.
Don haka, ya kamata a yi amfani da magungunan steroid a cikin ƙananan allurai da gajeren lokaci a cikin marasa lafiya na COVID-19 idan ya cancanta.
Rashin damuwa: Kamar yadda aka ambata a sama, a lokacin annobar COVID-19, yawancin marasa lafiya suna fuskantar damuwa da rashin tabbas saboda keɓewa na dogon lokaci, ganin mutuwar danginsu da sauran marasa lafiya.
Taimako da kuma shawara na hankali suna da muhimmanci don taimaka wa marasa lafiya su warke daga damuwa kuma su koma rayuwa ta yau da kullum.
Dangane da binciken alƙaluma da aka yi har zuwa yanzu, COVID-19 yana da halaye daban-daban na yaduwar cutar fiye da SARS.
Baya ga yaduwa a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 yana yaduwa a cikin ƙananan hanyoyin numfashi kuma ba ya nuna sauƙi ko alamun bayyanar cutar a farkon lokacin kamuwa da cuta, kamar sauran CoVs da ke haifar da mura.
Saboda haka, mutane da ke dauke da kwayar cutar suna iya samar da kwayar cutar mai yawa a farkon matakin ko lokacin kamuwa da cutar saboda ayyukansu na yau da kullun, wanda ke sa ya zama da wahala a sarrafa cutar.
Koyaya, an nuna cewa SARS-CoV yana yaduwa ne lokacin da marasa lafiya suka kamu da rashin lafiya kuma yawancin yaduwar ba ta faruwa a farkon matakan cutar.
Saboda haka, cutar COVID-19 ta yanzu ta fi ta SARS wahala kuma ta fi wahalar sarrafawa.
Ana yin ƙoƙari sosai don dakatar da yaduwar SARS-CoV-2 a China, gami da iyakance motsi a Wuhan da biranen da ke kewaye da shi da kuma keɓewa ga jama'a gaba ɗaya.
Duk da cewa waɗannan matakan suna haifar da mummunan tasiri ga tattalin arzikin da sauran sassan ƙasar, raguwar sabbin masu cutar yana nuna raguwar annobar.
Hasashen da aka fi tsammani shi ne cewa annobar za ta ƙare a watan Maris kuma za ta rage cikin watanni 3-4.
Amma, wasu masana ba sa yin hakan.
COVID-19, wanda ya fi SARS yaduwa, ba zai ƙare a shekarar 2020 ba, a cewar Paul Hunter.
A cikin wata sanarwa da suka wallafa a ranar Talata, masu bincike a fannin harkokin kiwon lafiya a kasar ta Amurka, Dr.
Wata kungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin hanci da makogwaro na marasa lafiya da suka warke daga asibiti makonni biyu da suka gabata, wanda ke nuna cewa cutar da aka gano kwanan nan na iya sake faruwa kamar mura.
Duk da haka, a cikin China akwai alamun da ke nuna bege, saboda ƙarancin sabbin shari'o'in, wanda ke nuna cewa dabarun da ake da su yanzu ba su yi tasiri ba.
An kiyasta cewa cutar Ebola za ta kashe mutane miliyan biyar, bayan da aka fara samun mutane miliyan daya da suka kamu da ita.
Koyaya, cutar tana ƙarƙashin iko a hankali saboda keɓewa da keɓewa.
Kamar SARS-CoV, SARS-CoV-2 na iya zama mai rauni kuma ya mutu a hankali ko kuma ya zama ƙwayoyin cuta marasa ƙarfi waɗanda ke rayuwa tare da mutane kuma suna haifar da cuta.
A ƙasa akwai kwatancen tsakanin cutar COVID-19 da SARS da MERS (Hoto (Hoto.55).
SARS-CoV-2 yana yaduwa ta hanyar hanci ko hancin, da kuma ta hanyar hulɗa kai tsaye da kayan da ke dauke da cutar.
An gano kwayar cutar a kan amai, wanda ke nuna cewa yana iya yaduwa daga amai zuwa baki.
Wani bincike na kwanan nan da aka yi kan mutane 138 ya nuna cewa kashi 41% na masu cutar sun kamu da cutar ne a wani wuri, ciki har da marasa lafiya 17 da ke da cutar da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, dole ne a ɗauki matakan kariya don kare mutane, musamman ma masu kula da lafiya, ma'aikatan zamantakewa, dangi, abokan aiki, da waɗanda ke hulɗa da marasa lafiya ko waɗanda ke da cutar.
Layin farko na kariya da za mu iya amfani da shi don rage haɗarin kamuwa da cuta shine sanya abin rufe fuska, masks na tiyata da masks na numfashi na N95 (lambar 1860s) don taimakawa sarrafa yaduwar kwayar cutar.
Masks na tiyata suna hana ɗigon ruwa daga mai cutar daga motsawa cikin iska ko mannewa da kayan aiki don hana watsawa ga wasu mutane.
Koyaya, kawai masks na N95 (lambar lamba 1860s) suna hana ƙwayoyin cuta masu girman 10 zuwa 80 nm; kawai 5% na ƙwayoyin cuta suna iya shiga cikin numfashi gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV, duka kusan 85 nm.
Masu kula da lafiya da ke hulɗa kai tsaye da marasa lafiya ba za su sa N95 (lambar 1860s) da abin rufe fuska na tiyata ba, saboda ƙananan abubuwa na iya shiga ko da an ɗora su.
Ma'aikatan kiwon lafiya dole ne su sa tufafin da aka tsara don rage haɗuwa da cutar ban da abin rufe fuska.
Ƙwayoyin cuta suna iya kamuwa da mutum ta idanunsa.
A ranar 22 ga Janairun 2020, likitan da ke sanya abin rufe fuska na N95 ya kamu da SARS-CoV-2, mai yiwuwa cutar ta shiga jikinsa ta hanyar idanunsa.
Don haka, masu kula da lafiya suna buƙatar sanya abin rufe fuska ko abin rufe fuska yayin aiki tare da marasa lafiya.
Ga yawan jama'a da ke zaune a yankunan da ke fama da cutar ko kuma waɗanda ke fuskantar cutar, ana ba da shawarar kowa ya wanke hannayensu da sabulu fiye da yadda ya saba, ya keɓe kansa a gida kuma ya rage hulɗa da mutanen da ke da yiwuwar kamuwa da cutar.
Mutane su kasance a nesa da marasa lafiya a ƙafa uku.
Waɗannan matakan hanyoyi ne masu tasiri don rage haɗarin kamuwa da cutar da hana yaduwar kwayar cutar.
Kodayake SARS-CoV-2 ya bayyana a matsayin sabon kwayar cuta ga duniyar ɗan adam, babban kamanceceniya da SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, ya kamata ya zama babbar ƙararrawa saboda ƙwaƙwalwar ajiyar cutar SARS ta 2003 da China ta fuskanta.
Duk da haka, darektan Cibiyar Kula da Cututtuka ta Wuhan ya yi jinkirin zuwa Janairu 19, 2020, yana mai tabbatar da cewa sabon kwayar cutar ba ta da yiwuwar yaduwa daga mutum zuwa mutum, kuma yana da iyakantaccen yiwuwar haifuwa, kuma ba shi da wahalar hanawa da sarrafa cutar.
Musamman a lokacin da duk ƙasar ke shirin bikin bazara, wannan saƙon ya sa hankalin jama'a ya tashi sosai, kuma ya ba da lokaci mai mahimmanci don sarrafa cutar yayin da har yanzu ba ta da ruwa.
Kungiyoyin kula da cututtuka a China na iya koyon darasi daga wannan mummunan darasi kuma su yi aiki mai ƙarfi don gyara nan gaba.
Misali, waɗannan hukumomin suna buƙatar (1) su kasance masu hankali yayin yin maganganun jama'a, saboda 'yan ƙasa suna ɗaukar kowane kalma da mahimmanci kuma suna iya canza ra'ayoyi da yanke shawara; (2) su zama masu saurin fahimta da amsawa ga bayanan da ba a saba gani ba daga asibiti maimakon jiran rahotanni na yau da kullun daga likitoci ko jami'ai; (3) su zama masu ƙuntatawa don hana cutar daga tushe maimakon ƙoƙarin ƙarfafa jama'a; da kuma (4) ciyar da ƙarin lokaci kan ayyukan da aka tsara da ingantattun ayyuka waɗanda ke da niyyar haɓaka wayar da kan jama'a game da cututtukan da ke faruwa da kuma inganta tsarin amsawar al'umma a kan kari.
Cutar COVID-19 ta barke ne a ƙarshen Disamba 2019 sakamakon sabon coronavirus SARS-CoV-2.
A cikin ƙasa da watanni biyu, an rarraba shi a dukan ƙasar Sin kuma a ƙasashe 50 a lokacin da ake rubuta wannan labarin.
Saboda kwayar cutar ta yi kama da SARS-CoV kuma alamun COVID-19 da SARS sun yi kama, barkewar cutar COVID-19 ta haifar da jin cewa SARS zai sake faruwa.
Koyaya, akwai wasu manyan bambance-bambance tsakanin COVID-19 da SARS waɗanda ke da mahimmanci don sarrafa cutar da kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa, maza fiye da mata, kuma yawan kamuwa da cutar da mutuwar yana ƙaruwa a cikin tsofaffi fiye da matasa.
Yawan mutuwar SARS ya fi COVID-19 girma (10.91% da 1.44%).
Masu cutar COVID-19 suna watsa kwayar cutar ko da ba su da alamun cutar, yayin da masu cutar SARS galibi ke watsa cutar yayin da suke cikin mawuyacin hali, wanda ke sa yaduwar COVID-19 ta zama da wahala fiye da SARS.
Wannan ya ba da wani ɓangare na bayanin dalilin da yasa SARS-CoV-2 ya fi sauri da yaduwa fiye da SARS-CoV.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau a wasu marasa lafiya na COVID-19.
A gefe guda, marasa lafiya da suka tsira za su iya sake samun kwayar cutar.
Wadannan binciken sun kara barazanar yaduwar kwayar cutar sosai.
Tare da ci gaban bincike kan COVID-19, akwai wasu mahimman batutuwa da yawa da ke buƙatar warwarewa, kamar:
Daga ina ne SARS-CoV-2 ya fito?
Ko da yake an sami daidaiton kwayoyin halitta 96% tsakanin SARS-CoV-2 da CoVs guda biyu na SARS-CoV, har yanzu ba za mu iya yanke shawarar cewa SARS-CoV-2 ya fito ne daga ƙuda ba.
Wane irin dabba ne ya fi haɗari daga mai ɗauke da cutar, kamar malam buɗe ido, zuwa ga mutane?
Idan ba mu san amsoshin tambayoyi 1 da 2 ba, ba za mu iya dakatar da yaduwar cutar yadda ya kamata ba, kuma cutar za ta iya tashi a kowane lokaci.
Ko da yake an tabbatar da cewa SARS-CoV-2 yana da alaƙa da ACE2 ta hanyar samfurin kwayoyin halitta da gwaje-gwajen ilimin halittu, ta yaya kwayar cutar ke shiga cikin ƙwayoyin iska kuma ke haifar da cuta?
Shin kwayar cutar tana da alaƙa da ƙwayoyin cuta na ACE2 a wasu sassan jiki?
Idan ba mu san amsoshin waɗannan tambayoyin ba, ba za mu iya gano cututtuka da sauri ba kuma mu bi da su yadda ya dace.
Yaya tsawon lokacin da cutar za ta ci gaba?
Ta yaya ƙwayoyin halitta suke girma yayin da cutar ke yaduwa daga mutum zuwa mutum?
Za a yi annoba a dukan duniya, kamar cutar SARS, ko kuma za a yi ta da ƙarfi kamar mura?
Yana da muhimmanci a bincika amsoshin waɗannan tambayoyin da kuma wasu da yawa, amma yana iya ɗaukan lokaci.
Amma, komai tsadar da za a kashe, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu koma rayuwarmu ta yau da kullun.
An gano cewa cutar korona ta mutum tana da haɗari sosai.
Canji da daidaitawa sun kasance tushen dubunnan shekaru na coronavirus da masu ɗauke da su, gami da mutane.
Kafin 2003, an gano cewa kwayar cutar HCoV guda biyu na mutum tana haifar da rashin lafiya mai sauƙi kamar mura.
Cutar cututtukan numfashi mai tsanani (SARS) da cutar cututtukan numfashi ta Gabas ta Tsakiya (MERS) sun nuna cewa kamuwa da cutar HCoV yana da haɗari da haɗari ga rayuwa.
Fashewar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake mayar da hankali kan COVID kuma ya ba mu mamaki da yawan yaduwar sa, amma rashin lafiyarsa ya ragu idan aka kwatanta da takwaransa SARS-CoV.
Tun da yake cutar HCoV ta shafi dabbobi, fahimtar asalin HCoV a cikin dabbobi yana da amfani sosai.
Yawancin HCoVs sun fito ne daga tsuntsayen malam buɗe ido kuma ba su haifar da cuta a cikinsu ba.
Wasu daga cikin HCovets kuma ana kiransu manyan masu ɗaukar matsakaici.
Gano dabbobi masu ɗauke da cuta yana da alaƙa kai tsaye da rigakafin mutum.
Binciken hulɗar COVID-carrier a cikin dabbobi na iya ba da haske mai mahimmanci game da cutar COVID a cikin mutane.
A cikin wannan bita, muna ba da taƙaitaccen bayani game da waɗannan ƙwayoyin cuta guda bakwai, tarihin gano su, da kuma bayanan da ke akwai, tare da mai da hankali kan asalin asali da kuma hanyoyin sadarwa.
Abu mai mahimmanci, muna kwatanta bambance-bambance na HCoVs daban-daban dangane da asalin kwayar cutar da sake tsara kwayoyin halitta.
An yi magana game da annobar cutar COVID-19 a cikin wannan mahallin.
Bugu da ƙari, an nuna mahimmancin tasirin tasirin ƙwayar cuta da tasirin tasirin ƙwayar cuta akan yanayin cutar.
Kwayar cutar Corona tana cikin rukunin ƙwayoyin cuta da ake kira Coronaviruses, waɗanda ke da nau'ikan ƙwayoyin cuta masu kyau da RNA guda ɗaya.
Waɗannan ƙwayoyin cuta suna da mafi girman kwayoyin halitta na ƙwayoyin cuta na RNA, daga kilobases 26 zuwa 32, kuma an kira su Zhukovchuk saboda tsarin su yana kama da kambi a ƙarƙashin madubin lantarki.
A cikin tsari, Covax yana da kwayoyin halitta waɗanda ke raba tsari iri ɗaya ba tare da rarrabuwa ba.
Kimanin kashi biyu bisa uku na kwayar cutar tana da manyan masu karatu biyu (ORF1a da ORF1b), waɗanda ke canza sunadarai da yawa zuwa pp1a da pp1ab.
Ana aiwatar da polyproteins a cikin tsari don samar da sunadarai 16 na non-structural, nsp1~16 na musamman.
Sauran sassan sune ORFs tare da spike (S), anvilope (E), membrane (M) da nucleotide (N) don tsarin furotin.
Ana kuma rubuta yawancin kwayoyin halitta masu maye gurbin kwayoyin halitta a cikin kwayoyin halitta daban-daban na Kovitz.
Dangane da bambancin tsari a cikin furotin, ana rarraba Covaxes zuwa rukuni huɗu (alpha-CoV, beta-CoV, gamma-CoV, da Delta-CoV); daga cikin waɗannan, Beta-CoVs suna cikin ƙananan ƙwayoyin cuta biyar (A, B, C, da D), wanda ya ƙunshi yawancin HCoVs.
Bayanan jinsuna sun nuna cewa ƙwayoyin cuta na bera da beraye suna amfani da tushen asalin ga yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune babban tushen gamma-CoVs da delta-CoVs.
A cikin shekaru dubbai, kwayar cuta ta sau da yawa ta wuce iyakar jinsuna. Wasu kuma suna haifar da cututtuka masu tsanani ga mutane.
An san nau'ikan COVID 7 da ke cutar da mutane.
Daga cikin waɗannan akwai HCoV-229E da HCoV-NL63, Alpha-CoV.
Sauran beta-CoVs guda biyar sune HCoV-OC43, HCoV-HKU, cutar coronavirus mai tsanani ta numfashi (SARS-CoV), cutar coronavirus ta tsakiya ta tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 galibi suna haifar da alamun rashin lafiya kamar mura da / ko zawo.
Akasin haka, SARS-CoV, MERS-CoV da sabon bambancin SARS-CoV-2 sune manyan masu haifar da cuta, suna haifar da kamuwa da cuta a cikin ƙananan iska a cikin marasa lafiya da yawa, suna haifar da mummunan rashin ƙarfi na numfashi (ARDS) da alamun bayyanar cututtuka.
B814, samfurin HCoV-229E na farko, an gano shi daga ruwan hanci na marasa lafiya da mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin bayanai game da HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun keɓewa.
A zahiri, ra'ayin cewa kamuwa da cutar HCoV ba ta da lahani har sai barkewar cutar SARS ya zama sananne.
Cutar SARS ta 2003 ita ce mafi muni a tarihin kwanan nan. Ta shafi mutane fiye da 8,000, kuma kashi 10 cikin ɗari sun sake farfadowa.
Shekaru goma bayan haka, cutar murar tsakiya ta Gabas ta Tsakiya (MERS) ta sake faruwa a yankin Larabawa kuma ta bazu cikin sauri zuwa sauran sassan duniya.
Sabuwar HCoV ta 2019 (2019-nCoV), wanda aka sake masa suna SARS-CoV-2, ita ce sanadin cutar da ke haifar da cutar coronavirus ta 2019 (COVID-19), wanda ya shafi mutane sama da 91,000 kuma ya kashe sama da 3,120 a cikin lokacin da ya ƙare a ranar 3 ga Maris, 2020.
Duniya na bukatar shirya wa barkewar cutar SARS-CoV-2 da ke tafe yayin da ake kara yin gargadi.
Dukkanin Hickoviks bakwai suna tashi daga tsuntsayen dare, beraye, ko dabbobin gida.
Yawancin bayanai sun goyi bayan asalin HCoVs a cikin tsuntsayen dare, inda ƙwayoyin cuta ke da kyau kuma ba sa haifar da cuta, amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta haifar da manyan kalubale na kiwon lafiya, kimiyya, zamantakewa da ɗabi'a a China da duniya.
Nazarin asalin kwayar halitta yana ba da ra'ayi game da tarihin halitta, matsin lamba da ke bayan shi, da abubuwan da ke hana yaduwar jinsuna.
Wannan na iya jagorantar ko sauƙaƙe binciken manyan, matsakaici da masu ɗaukar SARS-CoV-2 tare da shawarwari masu mahimmanci don hana yaduwar gaba.
A cikin wannan binciken, muna ba da cikakken bayyani game da asalin zoonotic, yaduwar jinsuna, da kuma dalilin cutar Hakhkov.
Musamman, muna magana ne game da batun kwayar cutar HCoV da ke da alaƙa da juna kuma muna buƙatar nuna cewa a cikin yanayin yanayin halitta, suna da rauni yayin da aka watsa su da yawa, amma suna zama masu cutarwa bayan watsa sabon mai ɗaukar hoto.
Mun kuma bincika yanayin juyin halitta na HCoV, wanda yawanci yana haifar da ƙarancin cututtuka tare da ƙaruwar alhakin.
An kuma tattauna sakamakon ci gaba da yaduwar SARS-CoV-2 a cikin wannan mahallin.
An san da dabbobi tun daga ƙarshen shekarun 1930.
Kafin a fara gano kwayar HCoV-229E B814 daga hancin marasa lafiya da ke fama da mura, an gano kwayar cutar ta HCoV-229E a cikin dabbobi daban-daban da suka kamu da cutar, gami da turkey, beraye, shanu, aladu, kuliyoyi da karnuka.
An gano wasu HCoVs guda bakwai a cikin shekaru goma da suka gabata.
An bayyana ainihin batun tarihin binciken Echkovitz a cikin tsari a cikin teburin 1.
An fara gano kwayar cutar HCoV-229E ta farko ta kamuwa da cutar numfashi a cikin 1966 daga cikin numfashi na marasa lafiya, sannan kuma an sa ta girma a cikin ƙwayoyin WI-38 na huhu.
An lura da zazzabi da tari a cikin kashi 10 ~ 20% na marasa lafiya da ke dauke da HCoV-229E da kuma cututtukan mura, gami da ciwon kai, hancinsa, ciwon kai da ciwon makogwaro.
Daga baya, a cikin 1967, an gano yaduwar HCoV-OC43 a cikin jerin kwayoyin halitta da kwakwalwar beraye masu shayarwa.
Alamar asibiti ta HCoV-OC43 ta yi kama da cututtukan HCoV-229E waɗanda ba za a iya rarrabe su da alamun cututtukan numfashi kamar su cutar mura A da rhinoviruses ba.
Dukansu HCoV-229E da HCoV-OC43 suna yaduwa a duk faɗin duniya kuma suna yaduwa sosai a lokacin sanyi na hunturu.
A cikin yanayin, alamun cutar ba su wuce mako guda ba, sannan ciwo na tsawon makonni biyu.
A cewar binciken da aka yi a kan masu sa kai, mutane masu lafiya da ke dauke da kwayar cutar HCoV-229E sun kamu da mura mai laushi.
An gano marasa lafiya da ke da rauni da cutar da cutar cututtukan numfashi.
SARS, wanda aka fi sani da cutar sankarar bargo, ita ce cutar HCoV-CoV ta farko da aka rubuta a tarihin ɗan adam kuma sanadin sa shine SARS-CoV, wanda aka gano HCoV na uku.
An gano SARS na farko a lardin Guangdong na kasar Sin a ƙarshen 2002, kamar yadda Turawa suka gano.
Cutar SARS ta bazu zuwa ƙasashe da nahiyoyi da yawa, ta yi sanadiyar mutuwar mutane 8,096 da 774.
Ana tsammanin kowane ɗayan waɗannan lokuta, ban da waɗanda ke saurin yaduwa, yana haifar da ƙaruwa a cikin ƙananan lokuta, wanda ke nuna ƙaruwa na nauyin kwayar cutar daga kwanaki 4 zuwa 7 na haifuwa a rana ta 10 bayan kamuwa da cutar.
A farkon lokacin da marasa lafiya da ke fama da SARS-CoV suka kamu da cutar, za su iya nuna alamun rashin lafiya, ciwon kai, zazzabi, damuwa da sanyi, da kuma numfashi, tari da damuwa.
Lymphopenia (ƙarancin ƙwayoyin lymphocytes a cikin jini), gwajin cutar hanta, da haɓaka creatinine kinase (enzyme da ke gudana daga tsoka mai rauni) sune halaye marasa kyau na yau da kullun na gwaji wanda ke haifar da SARS.
An kuma lura da lalacewar alveolar, ƙaruwar ƙwayoyin epithelial da ƙaruwar macrophages a cikin marasa lafiya na SARS.
A matsakaita, kashi 20 zuwa 30% na marasa lafiya suna buƙatar magani na musamman da kayan aikin numfashi.
Bugu da ƙari, ƙananan wurare masu numfashi da sauran gabobin jiki, ciki har da yankin gastrointestinal, suna iya shafar hanta da kodan, wanda ke da haɗari sosai, musamman a cikin marasa lafiya da ke fama da cutar.
Da farko, cutar ta kamu ne a cikin dangin wanda ya yi jinya daga Guangzhou zuwa Hong Kong don yin tiyata ta huhu.
Tun daga lokacin, an yi amfani da ƙarfinsa sosai wajen bincike a kan Echkov.
An gano HCoV-NL63 daga jariri mai wata bakwai a Netherlands a ƙarshen 2004.
Da farko, an gano cewa ana yaduwa a cikin yara, manya, da marasa lafiya da ke fama da cututtukan numfashi.
Rashin jin daɗi, ƙwanƙwasawa, zazzabi da kuma cutar huhu na yau da kullun sune cututtukan da HCoV-NL63 ke haifar da su.
Wani binciken kuma ya gano cewa samfurin numfashi daga hancin jariri mai wata takwas da ke fama da cutar sankarar bargo a Netherlands yana dauke da kwayar cutar.
An gano shi a cikin Netherlands, amma an yada shi a duk duniya.
An kiyasta cewa HCoV-NL63 yana ɗaukar kusan kashi 4.7% na cututtukan numfashi na yau da kullun, tare da mafi yawan lokuta a lokacin hunturu, kaka da farkon Satumba.
HCoV-NL63: Yana da alaƙa da ciwon makogwaro, wanda aka fi sani da croup.
A wannan shekarar, HCoV-HKU1 ya kasance mai shekaru 71 da haihuwa wanda aka keɓe daga asibiti saboda ciwon huhu da kuma cutar sankarar bargo a Hong Kong.
An ba da rahoton cewa HCoV-HKU1 yana da alaƙa da cutar asma mai tsanani ban da cutar huhu da cutar makogwaro.
HCoV-NL63, HCoV-229E da HCoV-OC43 sun kasance masu kama da HCoV-HKU1 kuma an gano su a duk duniya suna haifar da cututtukan numfashi masu sauƙi.
Duk waɗannan HCoVs da aka rarraba a cikin al'umma an tsara su don su yi aiki sosai a cikin mutane, kuma gabaɗaya suna da ɗan gajeren lokaci don haifar da cututtuka masu saurin kamuwa da cuta, kodayake saboda dalilai da ba a sani ba, suna haifar da haɗari kamar ƙwayoyin cuta na HCoV-NL63, waɗanda kwanan nan aka ba da rahoton sun haifar da cututtukan ƙananan numfashi a cikin China.
Gabaɗaya, waɗannan HCoVs suna da ƙarfin watsawa da kuma ci gaba da kasancewa tsakanin mutane, suna zama masu kashewa ko masu cutarwa.
An fara gano MERS-CoV a shekarar 2012 a Saudiyya a cikin wani mutum mai shekaru 60 da haihuwa wanda ke fama da cutar huhu kuma cutar ta canza zuwa ciwon huhu kuma koda ya daina aiki.
Ko da yake yawancin masu cutar da aka tabbatar da su a dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an samu wasu mutane da suka kamu da cutar a wasu kasashen Turai da Tunisia.
An sake samun wani kamu na biyu a Koriya ta Kudu a lokacin da aka yi mulkin Faransanci a shekarar 2015, inda aka kama mutane 186.
Sakamakon bincike ya nuna cewa MERS ya zama ciwon huhu mai tsanani, wanda ya yi kama da SARS.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da MERS suna da ciwon koda mai tsanani, wanda ya sa MERS ya bambanta da sauran cututtukan da ke haifar da HCoV.
Yawan marasa lafiya da ke fama da cututtukan hanji da hanji, kamar zawo da amai, ya karu da kashi 30 cikin ɗari.
Tun daga ranar 14 ga Fabrairu, 2020, an sami sama da mutane 2,500 da aka tabbatar da su a cikin dakin gwaje-gwaje, tare da yawan mutuwar 34.4%, wanda ya sa MERS-CoV ya zama ɗayan mafi munin ƙwayoyin cuta ga yara.
An gano mutane da yawa da ke fama da cutar sankarar bargo a Wuhan, lardin Hubei, China, daga tsakiyar zuwa ƙarshen Disamba 2019.
A cewar Hukumar Lafiya ta Duniya, cutar da ke haifar da ciwon makogwaro ta hanyar SARS-CoV-2 ta jawo hankalin al'ummomin duniya da gaggawa, kuma an sanya wa cutar sunan COVID-19.
Tun daga ranar 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duk duniya, tare da mutuwar kashi 3.4%.
A Hubei, kasar Sin, yawan mutuwar mutane ya kai kashi 4.2 cikin dari, yayin da a wasu wurare ya kai kashi 1.2 cikin dari.
SARS-CoV-2 yana haifar da cututtukan numfashi masu haɗari kamar SARS-CoV da MERS-CoV, waɗanda ke nuna kansu ta hanyar zazzabi, tari da kuma numfashi.
An kuma lura da gudawa a cikin wasu marasa lafiya.
Ciwon huhu yana ɗaya daga cikin alamun cututtuka masu tsanani kuma zai iya kaiwa ga ciwon numfashi mai tsanani.
Ko da yake SARS-CoV da SARS-CoV-2 suna da alaƙa da juna saboda babban tsarin nucleotide na 82%, ana rarraba su a ƙarƙashin rassa daban-daban a cikin tushen tushen tushen su.
SARS-CoV-2 ba shi da cutarwa sosai idan aka kwatanta da SARS-CoV da MERS-CoV, amma yana da saurin yaduwa.
An bayar da rahoton cewa akwai wasu mutane marasa alamun SARS-CoV-2 da ke da alamun cutar, wanda zai iya taimakawa wajen saurin yaduwar cutar a duniya.
Kwatanta da kwatanta SARS-CoV-2 da sauran HCoVs shida sun bayyana kamanceceniya da bambance-bambance masu mahimmanci.
Da farko, ciwon HCV yana da irin wannan ci gaba da kuma tsawon lokaci.
A wannan yanayin, SARS-CoV-2 yana da halaye iri ɗaya da na sauran HCoVs shida.
Cutar COVID-19 tana da tsananin gaske ko kuma tsananin gaske tsakanin SARS-CoV da HCoVs huɗu da ke cikin mutane (watau HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63).
A gefe guda, kamuwa da cutar SARS-CoV-2 yana da halaye da yawa waɗanda suka haɗa da rashin ƙarancin, mai laushi, ko babu alamun cutar a lokacin kamuwa da cutar HCoVs ta al'umma.
A gefe guda, cutar COVID-19 mai tsanani tana kama da SARS-CoV, kodayake adadin ya bambanta.
Na uku, yaduwar SARS-CoV-2 yana nuna bambancin hali tsakanin HCoVs da SARS-CoV da ke cikin al'umma.
A gefe guda, yaduwar SARS-CoV-2 tana da girma aƙalla kamar yadda HCoV ke yaduwa a cikin al'umma.
A wani ɓangare kuma, ba a tabbatar da cewa SARS-CoV-2 zai rage yaduwar sa ba bayan ya kasance a cikin mutum kamar SARS-CoV da MERS-CoV.
A ƙarshe, ana iya gano SARS-CoV-2 mai kama da sauran HCoVs a cikin samfurin cutar sankarar bargo.
Aƙalla a cikin wasu yanayi, binciken da ke gaba ya kamata ya bayyana cewa SARS-CoV-2 yana da muhimmiyar rawa a cikin watsawar baka ta baki kamar yadda yake a cikin shari'ar SARS-CoV.
Akwai babban sha'awar ganin ko SARS-CoV-2 yana da halaye masu canzawa kamar yadda cutar HCoV ke yaduwa a cikin al'umma.
Koyaya, halaye na SARS-CoV-2 suna da tasiri sosai a ƙarshen ƙarshen COVID-19 mai yaduwa, gami da yaduwa, haifar da cuta, ci gaba da yaduwa bayan watsawa ga mutane.
Dukkanin HCoVs huɗu da ke cikin al'umma suna da alaƙa da mutane kuma suna haifar da alamun rashin lafiya.
A wani ɓangare kuma, wataƙila gaskiya ne cewa mutane sun saba da waɗannan ƙwayoyin halittar H. pylori huɗu.
A wasu kalmomin, duka ɓarkewar cutar HCoV na farko na duniya na iya zama masu yaduwa.
An cire mutanen da ke da cutar HCV da ke haifar da ciwo mai tsanani a cikin mutane.
Don yin hakan, HCoVs suna haɓaka musayar manufa da ke magance abubuwan da ke haifar da iyakancewar ɗaukar hoto a cikin mutane.
A wannan yanayin, cutar SARS-CoV-2 tana da damar daidaitawa sosai ga mutane yayin da ta daɗe kuma ta shafi mutane da yawa.
Idan ya kasance mai kyau, zai yi wuya a ware cututtuka tsakanin mutane ko kuma a hana su daga wasu cututtuka.
A cikin shekaru da yawa, an sami karuwar COVID-19 da ke yaduwa a cikin al'ummomin Suo, wanda ke haifar da mura a cikin waɗanda ke da ƙarancin rigakafi.
Waɗannan ƙwayoyin cuta ba sa bukatar dabba mai mahimmanci.
Akasin haka, SARS-CoV da MERS-CoV, masu haifar da cututtuka, ba su da saurin daidaitawa da mutane kuma ba za a iya dakatar da yaduwar su daga mutum zuwa mutum ba.
Dole ne a bincika ci gaba da haifuwa a cikin masu ɗaukar kwayoyin cuta da kuma yiwuwar yaduwar su ta hanyar waɗanda ake zargi da cutar ɗan adam, musamman ta hanyar matsakaici ɗaya ko ɗaya da mai ɗaukar hoto.
SARS-CoV-2 yana da halaye iri ɗaya da SARS-CoV/MERS-CoV da kuma HCoVs huɗu na al'umma.
Aƙalla a yanzu, kwayar cutar ta kamu da cuta kamar yadda ta bazu a cikin al'umma.
Koyaya, yana da cutarwa fiye da HCoVs na al'umma kuma ba shi da cutarwa kamar SARS-CoV ko MERS-CoV.
Za a ga ko ba zai iya daidaitawa da mutane gaba ɗaya ba kuma ko zai iya yaduwa daga mutum zuwa mutum a matsayin mai ɗaukar hoto ko dabba mai wucewa.
Kafin mu tattauna dabbobi da suka samo asali daga ƙwari, zai dace mu tattauna ma'anoni da kuma halayen ƙwari.
Idan ƙwanƙolin suna da babban tsari wanda yake kusa da matakan nucleotide tare da asalin, dabba yana aiki a matsayin mai ɗaukar juyin halitta na HCoV.
Kwayar cutar da ke yaduwa ta hanyar jinsi tana da alaƙa da ɗan adam kuma ba ta yaduwa sosai.
Hakazalika, mai ɗaukar kaya yana riƙe da HCove a kai a kai kuma na dogon lokaci.
A cikin duka biyun, masu ɗaukar hoto suna da cutar ta halitta kuma suna ɗauke da kwayar cutar HCoV ko kuma ta iyaye.
Akasin haka, idan HCoVs sun shiga cikin sabon nau'i na masu ɗaukar hoto kafin su shiga cikin mutum ko kuma a cikin wani wuri da ke cikin mutum, ba za su haɗu da sabon mai ɗaukar hoto ba kuma galibi suna haifar da cuta.
Wannan mai ɗaukar hoto na iya zama tushen zoonotic don kamuwa da mutum kuma yana iya taka rawa wajen sa kwayar cutar ta yadu cikin sauri, yana watsawa ga mutane don haɓaka yawan kamuwa da cutar.
Sai dai idan an rage yaduwar cutar a cikin wannan mai ɗaukar hoto na ɗan lokaci, HCoV na iya ci gaba da kasancewa cutar da ke lalata yawan mutanen duniya.
Akasin haka, HCoVs na iya daidaitawa da matsakaicin ɗaukar su kuma suna iya haifar da yaduwar cutar na dogon lokaci.
Wannan shine lokacin da matsakaiciyar mai ɗaukar kaya ta zama mai ɗaukar ajiya na halitta.
Bayanan cututtukan cututtuka sun nuna tarihin tuntuɓar dabbobi da ke da alaƙa da babban yanayin SARS.
Binciken ya nuna cewa jinsunan dabbobi sun fi kama da IgG na SARS-CoV fiye da sauran mutane.
An gano wasu ƙwayoyin cuta masu kama da SARS-CoV a cikin kasuwar dabbobi a farkon lokacin da aka gano ƙwayoyin cuta da suka yi kama da SARS-CoV.
Wannan ya kasance a kaikaice saboda ba a sake yin rajistar SARS ba bayan an cire duk masu cin gashin da ke kasuwa.
Koyaya, kafin dabbobi masu kama da kuliyoyi su shiga kasuwar dabbobi ko kuma a cikin wuraren baje kolin, an ba da rahoton cewa ba su da SARS-CoV, yana mai cewa dabbobi kamar kuliyoyi masu matsakaiciyar ɗaukar hoto ne amma ba masu ɗaukar SARS-CoV ba.
Musamman a kasuwar Guangzhou, kusan kashi 80% na dabbobi daban-daban suna da maganin rigakafin SARS-CoV, saboda haka ba za a iya ware cewa nau'ikan dabbobi masu shayarwa daban-daban suna watsawa da kuma kara cutar SARS-CoV ba.
Waɗannan sune masu ɗaukar SARS-CoV waɗanda ba sa yaduwa.
Bayanan jinsuna sun nuna cewa ƙwayoyin cuta na bera da beraye suna amfani da tushen asalin ga yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune babban tushen gamma-CoVs da delta-CoVs.
Wadannan tsuntsayen sun nuna kwayar cutar SARS-CoV da kuma tsarin kwayoyin halittar SARS-Rh-BatCoV HKU3.
Wannan da sauran ƙwayoyin cuta na tsuntsaye suna da kashi 88-92% na jerin abubuwan nucleotide tare da SARS-CoV.
Binciken ya samar da sabon ra'ayi game da masu cutar da ke cikin tsuntsaye masu fuka-fuki.
An gano wasu ƙwayoyin cuta masu kama da SARS (SL-CoVs) a cikin tsuntsayen malam buɗe ido, amma babu ɗayan da ya bambanta da cutar mai rai, ban da nau'in WIV1.
An san cewa an sami karɓar ƙwayar cuta ta ɗan adam don ƙwayar enzyme mai karɓar 2 (ACE2) don SARS-CoV.
Gabatarwar WIV1 an bayyana don amfani da malam buɗe ido mai karɓa, samfurin ƙwayoyin cuta daga malam buɗe ido mai ƙwari, da ACE2 na ɗan adam.
Abin mamaki, marasa lafiya na SARS ba su da ikon kawar da WIV1.
WIV1 shine mafi kusa da SARS-CoV a cikin tsuntsaye, yana wakiltar kashi 95% na tsarin nucleotide.
Duk da bambancin homology mai yawa tsakanin ƙwayoyin cuta biyu, ana tsammanin cewa WIV1 ba zai iya gano kwayar cutar SARS-CoV kai tsaye ba kuma cewa jemage ba masu ɗaukar SARS-CoV kai tsaye ba ne.
Nazarin jinsin kwayar cutar ya kawo MERS-CoV zuwa rukuni ɗaya na bat-CoV-HKU4 da bat-CoV-HKU5.
COVID-HKU4 na malam buɗe ido da MERS-CoV suna amfani da mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar.
RNA polymerase mai tushen RNA wanda ke haifar da jerin MERS-CoVs yana da alaƙa da gado ga BCoVs, wanda aka samu a Turai da Afirka.
Har zuwa yanzu, ba a gano wani MERS-CoV mai rai a cikin tsuntsayen dare na daji ba.
MERS-CoV da danginsa na kusa Bat CoV-HKU25 kawai suna da kashi 87% na abubuwan da ke tattare da nucleotide.
Don haka, jemage na iya zama mai ɗaukar MERS-CoV kai tsaye.
A gefe guda, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman Larabawa suna da wasu ƙwayoyin cuta na MERS-CoV, wanda ke hana su, wanda ke nufin cewa kamar raƙuman da ke Gabas ta Tsakiya, yawancin ƙasashen Afirka suna da shi.
Rashin kwayar cutar MERS-CoV mai rai, wanda yayi kama da kwayar cutar da ke cikin mutum, ya bambanta da ruwan hanci na raƙuma Larabawa, wanda ya nuna cewa raƙuma ainihin masu ɗaukar hoto ne da masu watsawa na MERS-CoV.
Ya kamata a lura cewa raƙuma da aka yi wa gwaji a cikin binciken dakin gwaje-gwaje don cutar MERS-CoV gabaɗaya suna da alamun rashin lafiya amma ana samun ƙwayoyin cuta masu yawa.
Abin lura, raƙuma da ke fama da cutar ba kawai suna fitar da kwayar cutar ta hanyar numfashi ba amma kuma suna fitar da fandiya, wanda shine hanyar da tsuntsaye masu tashi da daddare ke fitar da kwayar cutar.
Amma, har zuwa yanzu, tushen cutar ta MERS-CoV ya zama abin tambaya saboda ba a gano shi a kan raƙuma ba kafin cutar ta bayyana, kuma ana tsammanin cewa an gano shi ne ta hanyar watsawa daga mutum zuwa mutum ko kuma ba a san asalinsa ba.
SARS-CoV-2 yana da kashi 96.2% na kwayar halittar nucleotide tare da COVID-19 RTG13, wani ɗan'uwan tsuntsu da aka ware daga Rhinoceros affinis.
Kamar SARS-CoV da MERS-CoV, SARS-CoV-2 da RaTG13 suna da nisa sosai don haka yana da wuya a kimanta alaƙar su.
Wannan yana nufin cewa ba za a iya samun kwari masu ɗaukar SARS-CoV-2 ba idan ba a sami kwari iri ɗaya ba.
Wataƙila, dabbobi masu ɗaukar SARS-CoV-2 da ke ɗaukarwa an kashe su a cikin babban kanti na abincin teku na Hunan, wanda ya haɗa da yawancin shari'o'in asali na COVID-19, wanda ke nuna cewa ba a iya watsa su daga dabbobi zuwa mutane ba.
Binciken kwanan nan kan binciken metagenomic ya nuna cewa dabbobi masu shayarwa da ke cikin haɗarin lalacewa, da ake kira pangolin (Manis javannica), na iya zama masu ɗauke da beta-CoVs na farko da suka haɗu da SARS-CoV-2.
Waɗannan sabbin kwayoyin halittar Pangolin CoV suna da kashi 85-92% na tsarin nucleotide tare da SARS-CoV-2.
Duk da haka, suna da alaƙa da 90% na kama da ARTG13 a cikin jerin abubuwan nucleotide.
A cikin rukunin masu cutar, ana rarraba ƙwayoyin cuta kamar SARS-CoV-2 zuwa ƙananan ƙwayoyin cuta guda biyu, ɗayan yana da kamanceceniya sosai da mai karɓar ƙarshen ƙarshen SARS-CoV-2 (RBD) tare da alamar jerin amino acid 97.4%.
Ko da yake tsarin kwayoyin halitta ya fi girma fiye da yadda aka tsara a baya, SARS-CoV-2 da RaTG13 RBDs sun bambanta, sabanin yadda ya bayyana.
Binciken da aka yi a baya a kan pangolins da suka kamu da cutar ya gano cutar a cikin samfurori na huhu, wanda ya kasance daidai da SARS-CoV-2.
Wannan binciken ya ɗauki hanyoyi daban-daban na taro da kuma shirya hannu don yin kwayar halitta ta gaba, wanda ya ƙunshi kusan kashi 86.3% na tsawon kwayar cutar.
Ba za mu iya musanta cewa pangolin na iya zama dabba mai ɗaukar SARS-CoV-2 ba.
Amma, saboda bambancin tsari tsakanin SARS-CoV-2 da beta-CoVs masu alaƙa da SARS-CoV-2 da ke cikin pangolin, a halin yanzu babu wata alama da ke nuna cewa SARS-CoV-2 ya fito kai tsaye daga pangolin.
Bugu da ƙari, nesa tsakanin SARS-CoV-2 da RaTG13 ya fi ƙasa da nesa tsakanin SARS-CoV-2 da beta-CoVs na Pangolin SARS-CoV-2.
Hanyar juyin halitta ta SARS-CoV-2 a cikin tsuntsayen dare, pangolins da sauran dabbobi masu shayarwa na ci gaba da kasancewa mai ɗorewa.
Amma an sami babban tsari na homology a cikin RBDs kuma sun haɗa da beta-CoVs, SARS-CoV-2 da RaTG13 waɗanda aka haɗa da SARS-CoV-2 da Pangolin SARS-CoV-2 tare da babban tsarin tsara tsarin kwayoyin halitta.
RBDs masu haɗuwa da pangolin SARS-CoV-2 (masu karɓar ƙarancin haɗuwa) suna da babban kamani tsakanin beta-CoVs da SARS-CoV-2 wanda ke da bambanci da zaɓin-haɗe-haɗe mai zurfi wanda ke haifar da juyin halitta.
Shawarwarin counter-da ke shafar sake haɗuwa tsakanin beta-CoV da RaTG13 da ke da alaƙa da pangolin SARS-CoV-2 a cikin masu wasan kwaikwayo na daji na uku.
Ana rarraba haɗin kai tsakanin beta-covid a matsayin ƙarfin matsa lamba na canji.
An yanke hukuncin ne saboda asalin SARS-CoV-2.
An yi nazarin gano HCoV-229E, HCoV-OC43, HCoV-NL63, da HCoV-HKU1, tare da HCoV-1 wanda ke haifar da cutar.
Shaidar phylogenetic ta nuna cewa HCoV-NL63 da HCoV-229E na iya samo asali ne daga cutar ta Leptovirus, kuma an gano ƙwayoyin cuta na HCoV-OC43 da HCoV-HKU1 a cikin beraye.
ARCoV.2 (Appalachian Ridge Cove) wanda aka gano a cikin malam buɗe ido na Arewacin Amurka ya nuna kusancin dangantaka da HCoV-NL63.
A gefe guda, an gano cewa HCoV-229E yana da alaƙa da wani nau'in COVID na malam buɗe ido da aka samo a Ghana, wanda aka kira Hipposideros/GhanaKwam/19/2008, kuma an ɗauka cewa raƙuma sune masu ɗaukarsa.
Don a bayyana, an kwatanta ra'ayinmu game da H. echinoderms a hoton 1 da kuma tebur 2.
Binciken ilimin halittu ya ba da hujja game da abubuwan da suka faru na watsa bayanai na HCoVs a tarihi.
A cikin 1890s, an sami barkewar cutar numfashi lokacin da HCoV-OC43 ya canza daga dabbobi zuwa mutane.
Ba a san yadda HCoV-229E ke yaduwa tsakanin jinsuna ba.
An gano wasu kwayoyin cutar alpha-CoVs da ke da alaƙa da HCoV-229E.
A cikin waɗannan akwai alpha-covin alpaca.
Yawancin hanyoyin bayanai suna tallafawa yaduwar kwayar cutar kai tsaye daga tsuntsayen dare zuwa mutane.
Na farko, mutane suna iya haɗuwa da tsuntsaye a cikin yanayin da suke ciki, ba alpacas ba.
Maimakon haka, mutane ba su da dangantaka ta kusa da alpacas.
Na biyu, alpha-CoVs na malam buɗe ido da aka haɗu da HCoV-229E sun bambanta kuma ba su haifar da cutar a cikin malam buɗe ido ba, yayin da alpha-CoV na alpaca ya haifar da barkewar cutar numfashi a cikin dabbobi masu cutar.
A ƙarshe, ba a gano cutar alpha-CoV a cikin dabbobin daji ba.
Don haka, kada mu daina yin zato cewa alpacas na iya samun Alpha-CoV daga mutane, wanda ke da alaƙa da HCoV-229E.
A gaskiya ma, ƙudaje ne tushen ƙwayoyin cuta masu cutarwa ga mutane, ciki har da cutar rabies, Ebola, Nipah da Hendra.
Saboda haka, ba abin mamaki ba ne cewa jemage na iya watsa HCoV-229E kai tsaye ga mutane.
A madadin haka, har ma da malam buɗe ido na Alpha-CoVs na iya ɗaukar ƙwayoyin cuta zuwa mutane kamar MERS-CoV, alpacas da raƙuma na Larabawa yayin da ake amfani da su azaman tarin kwayoyin HCoV-229E.
MERS-CoV na iya zama misali mai kyau na cutar da ke yaduwa daga nau'in tsuntsu zuwa raƙumi, daga raƙumi zuwa mutum.
An fara gano asalin MERS-CoV a cikin tsuntsayen dare, kuma ana ƙarfafa shi ta hanyar bincike mai yawa.
A bayyane yake cewa bats suna samar da tarin masu kunna kwayar cutar don musayar bayanai da kuma watsa bayanai.
Tsawon lokaci, haɗuwa da yawa, kusanci da ƙarfi da ƙwarewar tsuntsayen malam buɗe ido ke samarwa yana ba da yanayi mai kyau don yada kwayar cutar.
A gefe guda, MERS-CoV ya mallaki raƙuma shekaru da yawa.
Ya dace da waɗannan raƙuman da suka canza daga matsakaiciyar ɗaukar kaya zuwa madaidaiciyar ajiya da ajiya ta halitta.
MERS-CoV yana haifar da rashin lafiya mai sauƙi, amma yana riƙe da ƙananan canje-canje a cikin waɗannan dabbobin.
A matsayin cutar da ba ta taɓa faruwa ba, cutar ta zama mai saurin yaduwa kuma mutane za su ci gaba da kasancewa masu haɗari ga MERS-CoV har sai an dakatar da yaduwar cutar.
Rashin yaduwar SARS-CoV-2 ya bambanta da na dangin raƙuma a cikin yaduwar MERS-CoV.
Musamman, beta-CoVs na pangolin suna da haɗari ga lafiyar pangolins.
Za su iya zama masu watsawa na ƙarshe na beta-CoVs da ke hulɗa da SARS-CoV-2, kamar yadda ƙuda take a cikin shari'ar SARS-CoV.
Yawancin yiwuwar watsawa daga dabbobi zuwa mutane tare da masu cutar SARS-CoV-2 ana buƙatar bincika su a cikin karatun gaba sannan a sarrafa su ta hanyar binciken waje.
Da farko, tsuntsayen bats na iya zama masu ɗaukar kwayar cutar da ke da alaƙa da SARS-CoV-2 da kuma irin su SARS-CoV-2.
'Yan Adam na iya raba yanayin rayuwa kamar' yan tsuntsaye ta hanyar ciyar da dabbobi ko hakar ma'adinai.
Na biyu, daga sabbin kamuwa da cutar da ke da alaƙa da masu ɗaukar kwayar cutar pangolin da kuma SARS-CoV-2.
Mutane suna kamuwa da cutar sa'ad da suke farauta da kuma cin dabbobi.
Dabbobi masu shayarwa da yawa, gami da dabbobin gida, na iya zama masu saukin kamuwa da SARS-CoV-2.
An ba da izinin binciken dabbobi da na daji don dalilai na rigakafi.
Na uku: Kamar yadda aka ambata a sama, tsarin sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
Ana ci gaba da neman asalin dabba na SARS-CoV-2.
Ba kamar nau'ikan dabbobin da ke dauke da cutar ba, manyan abubuwa guda uku a gefen kwayar cutar suna da mahimmanci don daidaita COVID a duk iyakokin kwayar halitta.
Da farko, ana auna babban bambancin a cikin kwafin RNA don sakamakon.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ƙididdigar yawan canjin kwayar cuta, bisa ga matakin daidaitawar kwayar cuta ga masu ɗaukar kwayar cuta, ana iya rarraba su daga matsakaici zuwa matsakaici, tare da matsakaicin canjin canji na ~10-4 sau biyu a kowace shekara.
Kwayoyi suna da ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙaran
Abin sha'awa, ana san cewa resveratrol nucleotide analogue yana hana kwayar cutar ta hanyar riƙe wannan exoribonucleotide da RNA-dogara RNA polymers.
Remdesivir yana ɗaya daga cikin mafi kyawun wakilai masu maganin SARS-CoV-2 da ake gwadawa a cikin gwaji na asibiti.
Amma, ƙwarewar haifuwar kwayar cuta ta ninka ta masu ɗauke da ita sau miliyan.
Bugu da ƙari, idan kwayar cuta ba ta dace da mai ɗaukar ta ba, yawan canjin jini yana da yawa.
Idan aka kwatanta da SARS-CoV, wanda ke da yawan yaduwar kwayar halitta: yawan yaduwar kwayar halitta ta SARS-CoV-2 ya yi ƙasa sosai, wanda ke nuna cewa yana da daidaituwa sosai ga mutane.
Wataƙila, ya riga ya saba da wani mai ɗauke da cutar da ke kusa da mutane.
Baya ga SARS-CoV-2, yana shafar MERS-CoV, wanda ya dace da raƙuma masu ɗauke da ruwa ɗaya.
A matakin ɗan adam, allurar rigakafin kwayar halitta da maganin rigakafi ba za su yi nasara da sauri ba tare da SARS-CoV-2.
Na biyu, babban RNA genome a cikin kwayar halitta yana haifar da ƙarin filastik a cikin haɓakar kwayar halitta ta hanyar canji da sake haɗawa, don haka yana haɓaka damar co-juyin halitta don kwayoyin halitta, yana ba da damar ƙirƙirar sabon coronavirus a lokacin da yanayi ya dace.
Wannan yana tallafawa ta hanyar tsarin karatun da aka tsara da kuma aikin sunadarai da aka sanya a ƙarshen genome 3′.
"Abu na uku, lokacin da Covech RNA ya ninka, zai iya ninka kansa da kuma canza kansa ta hanyar hanyar ""zaɓar kwafi"" ta musamman".
A cikin mai ɗaukar hoto, wanda ke aiki azaman mai haɗawa, sauye-sauyen tsalle-tsalle suna faruwa sau da yawa yayin kwafin COVID RNA.
RNAs masu cikakken tsayi da ƙananan ƙwayoyin cuta na iya haɗuwa tare don ƙirƙirar sabbin ƙwayoyin cuta.
An gano kwayar halitta ta halitta ta HCoV-HKU1 da HCoV-OC43 a cikin SL-CoV da batCoV-HKU9 na tsuntsaye masu rai.
Yadda kamuwa da cutar ta shafi mutum
Bayan waɗannan dalilai uku na kwayar cutar da aka lissafa a sama, alaƙar kwayar cuta ita ce mafi mahimmancin kuma mafi tasiri ga yaduwar cutar daga nau'ikan masu ɗaukar hoto.
An dauki misali na sake haɗuwa da SARS-CoV, wanda ya nuna shaidar zaɓi mai kyau yayin abubuwan da ke faruwa a cikin kwayoyin halitta.
Dangane da nazarin kwatancen, daidaituwa tsakanin mutane da SARS-CoV, SARS-CoV, yana nuna saurin daidaitawa a kan masu ɗaukar hoto daban-daban, musamman a cikin musayar S-protein RBD.
RBD a cikin furotin na COVIDS gabaɗaya yana ɗaure da mai karɓar ƙwayoyin cuta kuma yana da zaɓi mai yawa na mai hana amsawar rigakafi.
A cikin SARS-CoV, RBD yana cikin rukunin S1 na amino acid na 318 zuwa 510, wanda ke haɗa ACE2 na mutum zuwa mai karɓar shigarwar kwayar cuta.
SARS-CoV RBD (mai karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar karɓar
Hakanan, an gano amino acid guda 6 daban-daban daga kwayar cutar mutum da ta kwayar cuta kuma 4 daga cikin waɗanda ke musayar mai karɓar ACE2 suna cikin abubuwan haɗin mai karɓar mai karɓar.
CiVet SARS-CoV yana da K479 da S487T musayar a cikin RBD (mai karɓar ƙarancin ƙwayar cuta) kuma ya haɓaka haɗin haɗin furotin mai haɗawa a cikin mai karɓar ACC2 na ɗan adam.
A wasu kalmomi, waɗannan masu canza amino acid guda biyu na iya zama masu mahimmanci ga kwayar cutar don shiga cikin mutane.
Yana da ban sha'awa cewa SARS-CoV-2 yana yaduwa ta hanyar kwayoyin halitta iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV na iya dakatar da haɗin S-protein da ke nuna S-protein a cikin rukunin S1 zuwa ACE2.
A zahiri, binciken cryo-EM ya nuna cewa wannan haɗin yana da haɗuwa sau 10 zuwa 20 fiye da tsakanin ACE2 na ɗan adam da furotin S na SARS-CoV.
Dole ne a yanke shawara ko ana buƙatar wasu masu karɓar masu karɓar SARS-CoV-2 don kamuwa da cutar.
Abin mamaki, HCoV-NL63 yana da alaƙa da ACE2 amma yana da wani S-body.
Akwai wasu masu karɓar HCoVs da yawa, kamar aminopeptide A don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Bayan an kawo su cikin kwayoyin halitta daga dabbobi, ba su da wani babban matsayi a nasarar canza waɗannan kwayar cutar zuwa mutane.
Baya ga masu karɓar kwayoyin halitta, tasirin watsawa a cikin jinsin HCoVs yana ƙarƙashin rinjayar wasu masu ɗauke da ƙwayoyin cuta da sauran dalilai.
Rarraba waɗannan furotin masu ɗauke da kwayoyin halitta tsakanin mutane da manyan masu ɗauke da su, kamar tsuntsayen dare, raƙuma masu tsayi ɗaya, da berayen da ke da dogon fuska na iya haifar da iyakancewar watsa ƙwayoyin cuta.
Don samun nasarar yaduwar jinsuna, Echovirus dole ne ya cire matsalolin dogaro da mai masauki kuma ya kawar da masu hana mai masauki.
A wannan yanayin, suna da mahimmanci don ƙayyade kwayoyin halitta, rarrabewa da kuma rarraba su a cikin hanyar sadarwa ta hanyar kwayar cutar.
Yin amfani da fasahar CRISPR mai fasaha na iya zama da amfani don tantance abubuwan da ke haifar da ƙuntatawa da ƙuntatawa na mai ɗaukar SARS-CoV-2 wanda ba shi da ƙarancin ƙwayoyin halitta.
Yadda Novel Hchkovich Ya Tashi: Komawa Gida
Bambancin tsuntsayen malam buɗe ido yana haifar da babbar dama ga sabon kwayar cuta.
A wannan yanayin, ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwarƙwarƙwarƙwarƙwarƙwarƙwarƙwar ƙwarƙwarƙwar ƙwar ƙwarƙwar ƙwar ƙwar ƙwarƙwar ƙwar ƙwarƙwarƙwarƙwar ƙwar ƙwar ƙwarƙwarƙwar ƙwar ƙwarƙwarƙwar ƙwar ƙwarƙwarƙwar ƙwar ƙwarƙwarƙwar
Bugu da ƙari, sauyawa da kuma sake fasalin jinsin suna aiki a matsayin matakai biyu a cikin wannan tsari, suna ƙayyade tsarin HCoV.
Alal misali, gano ƙwayoyin ƙwayoyin cuta na ƙwayoyin cuta yana da damar da za ta iya canza yanayin kwayar cutar.
Daga cikin sunadarai masu amfani da SARS-CoV, an gano ORP8 yana da mahimmanci ga daidaitawa ga mutane, wanda aka gano don shigar da sunadarai daban-daban na ORP8 duk da cewa an ware su daga barbashi masu alaƙa da SARS-CoV.
An gano asarar halayen SARS-CoV-29-nucleotide a cikin ƙoƙarin warewa a farkon barkewar cutar a cikin ɗan adam.
Wannan cirewa yana haifar da haɓaka mai dacewa ta hanyar raba ORF8 zuwa ORF8a da ORF8b.
Bugu da ƙari, SARS-CoV na iya kasancewa da alaƙa da tarihin cutar Alpha da Gamma-CoVs.
An kuma gano wuraren sake haɗuwa a cikin nsp9, yawancin nsp10, da kuma sassan nsp14.
Hakazalika, cutar MERS-CoV ta sake haifar da abubuwan da suka faru a cikin kwayoyin halitta a cikin sauro a Saudi Arabia.
Tare da SARS-CoV da MERS-CoV, an lura da abubuwan sake haɗuwa a cikin wasu HCoVs, wanda shine yanayin da HCoVs ke sake haɗuwa da kwayoyin halittar su tare da wasu HCoVs na dabbobi.
Ana buƙatar yin taka tsantsan da cutar ta mutum, musamman ma a cikin yanayin da zaɓaɓɓun zaɓuɓɓuka kamar su tsarin rigakafi mai ƙarfi, wanda zai iya haifar da bambancin da ba zato ba tsammani a cikin kwayar cutar.
Misali na wannan rashin amfani shine rage tsawon tsawon ORF4 a cikin HCoV-229E prototype, wanda ke nufin ɓacewar nucleotides biyu.
An gano ƙwayoyin cuta na ORAF4 na jemage da raƙumi da ke da alaƙa da HCoV-229E, wanda ke nuna shigar da alpha-CoV single nucleotide na alpaca saboda canjin sutura.
A ƙarshe, juyin halitta na sabon HCVs yana motsawa ta hanyar matsin lamba a cikin masu ɗaukar ajiya.
Tsuntsayen dare ba sa nuna alamun ko kuma suna nuna alamun da ke nuna cewa tsuntsayen dare suna da dangantaka mai kyau da tsuntsayen.
An nuna cewa jemage sun dace da COVID a zahiri da kuma zahiri.
Alal misali, tsuntsaye suna yin shiru da dare don kada su nuna alamun cutar kafin su kamu da cutar.
A gefe guda, mafi girman alamar alamun haɓakar histokompatibility a cikin tsuntsaye shine ƙananan matakin don hana haɓakar haɓakar ƙwayar halitta mai haɗari NKG2/CD94, wanda ke hana ayyukan ƙwayoyin halitta na halitta.
Hakanan, haɓakar haɓakar ƙwayar cuta ta ƙwayoyin cuta (ROS) da aka samar na ƙwayoyin cuta na ƙwayoyin cuta na iya haifar da matsin lamba akan kwayar cuta ko kuma hana sake karantawa ta hanyar exoribonucleus, don haka, matsin lamba na zaɓi don samar da kwayar cutar yana haifar da cutar mai saurin kamuwa da cuta lokacin da mai ɗaukar cuta ya shiga cikin ƙwayar cuta.
Ƙarin ƙwayoyin cuta na COVID-19 na iya haɓaka ta hanyar haɗuwa, wanda ke haifar da gano sabbin sunadarai ko alamun sunadarai don daidaitawa da mai ɗaukar su.
Saboda haka, ba daidaituwa ba ne cewa waɗannan abubuwa uku na Novel Hchkovch sun faru a cikin shekaru ashirin da suka gabata.
CoVs ba sa haifar da rashin lafiya ko alamun rashin lafiya ga manyan masu ɗauke da su kamar bats da raƙuma.
Ba su da ƙarfin rigakafi ga mai ɗaukar cuta, kuma suna fama da yunwa.
Wannan ya ci gaba da zama abin ban mamaki game da dalilin da yasa masu dauke da cutar marasa alamun cutar suka bayyana kuma suka haifar da mummunan yanayin kamuwa da cutar ga mutane.
Alamun cututtuka masu tsanani galibi suna faruwa ne yayin da ake samar da cytokines da yawa a wuraren da akwai tsayayyar rigakafi da ƙarfin rigakafi, wanda idan ya yi tsanani, cutar huhu tana ƙaruwa.
Akasin haka, amsar rigakafi a cikin masu ɗaukar alamun ta ragu daga kwayar cutar COVID.
Irin wannan dabarar don sakin ƙwayoyin cuta na iya samun sakamako mai amfani don maganin SARS-CoV-2.
Amsar interferon tana da ƙarfi sosai a cikin malam buɗe ido.
Don haka, gudanar da nau'in I na interferon ya kamata ya kasance da amfani aƙalla a farkon lokacin kamuwa da cutar SARS-CoV-2 a cikin ɗan adam.
Bugu da ƙari, farkon NLRP3 na ƙwayoyin cuta ba su da kyau a cikin tsuntsaye masu dare.
A cikin wannan ra'ayi, za a iya amfani da kullewar NLRP3 na ƙwayoyin cuta don magance COVID-19 tare da MCC950.
An fara cutar SARS-CoV da MERS-CoV gaba ɗaya, kuma an bi asalin SARS-CoV-2.
Beta-CoVs suna dauke da SARS-CoV kuma suna da kashi 95% na kwayar halittar nucleotide, yayin da SARS-CoV-2 ke dauke da SARS-CoV kuma suna da kashi 96% na kwayar halittar nucleotide.
Amma an gano cewa dabbobi da sauran dabbobi a kasuwa suna da kwayar cutar da ta yi kama da SARS-CoV-2 kuma ba a gano masu watsa SARS-CoV-2 ba.
An gano cewa pangolin beta-CoVs yana da ban mamaki ga SARS-CoV-2, yana nuna cewa pangolins na iya zama mafi kusa da masu ɗaukar su ko kuma pangolin beta-CoVs na iya ɗaukar ƙarshen ɓangarorin kwayoyin SARS-CoV-2.
Ko da yake akwai tambayoyi, babu wata hujja game da ra'ayin cewa SARS-CoV-2 an ƙirƙira shi ne ko kuma mutum ne ya ƙirƙira shi.
COVID-19 ya dawo cikin hankali saboda barkewar cutar SARS-CoV-2 kwanan nan.
Nazarin kwayar cuta a cikin tsuntsaye da sauran dabbobi ya canza fahimtarmu game da asalin cutar kwayar cuta da mahimmancin masu ɗaukar dabbobi don watsawa ga mutane.
An ba da tabbacin tabbaci cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga jemage kuma ana watsa su ga mutane ta hanyar masu ɗaukar hoto.
Da a ce an rufe kasuwanni kuma an kashe masu sayar da kayayyaki saboda cutar SARS-CoV ta samo asali ne daga saduwa da mutane da ƙudaje a kasuwa, da cutar SARS-CoV ta tsaya.
A cikin irin wannan ma'anar, la'akari da cewa akwai nau'ikan beta-CoVs na pangolin da ke da alaƙa da SARS-CoV-2, ya kamata a cire pangolins daga kasuwannin da ke da ruwa don hana watsawa daga mutum zuwa mutum.
Koyaya, ko SARS-CoV-2 yana yaduwa ga mutane ta hanyar pangolins da sauran dabbobi ko kuma yadda ake yaduwa zai iya zama abin bincike a nan gaba.
A gefe guda, MERS-CoV ya kasance cikin raƙumi mai ɗauke da ruwa na dogon lokaci.
Ana amfani da raƙuman don sufuri, nama, madara, ulu da kayayyakin fata ga al'ummomin yankin.
An rarraba su daga Gabas ta Tsakiya zuwa Afirka.
Don haka, ba za a iya yin hadaya da dukan raƙuma ba don hana MERS-CoV kamar yadda aka yi a kasuwar dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da barkewar cutar MERS, ana buƙatar ɗaukar hanya mai mahimmanci, wanda ke da amfani tare da sauran matakan kula da kamuwa da cuta don samun alluran rigakafi masu tasiri don rigakafin MERS-CoV, wanda ke kamuwa da raƙuma.
Idan ba mu kawar da waɗannan ƙwayoyin cuta ba, za su iya haifar da sabon ƙwayoyin cuta da ke haifar da annoba.
An samu wasu nau'ikan cutar zoonotic a cikin daji.
Musamman ma, ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwarƙun ƙwarƙun ƙwarƙun ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙ
Waɗannan kwayar cutar ta zoonotic sun canza kuma idan aka sake haɗa su, akwai yiwuwar cewa sabbin kwayar cutar za su zama masu saurin yaduwa da / ko kisa ga yara a nan gaba.
Don rage haɗuwa da mutane da dabbobi, ya kamata a dakatar da amfani da dabbobin daji don abinci a wasu yankuna na kasar Sin.
Ganin haɗarin SARS, MERS da COVID-19, ana buƙatar kasancewa cikin shiri sosai da kuma cikakken shiri don magani da wuri.
A gaskiya ma, yawancin ƙwayoyin cuta sun daɗe sosai a duniya.
Suna ci gaba da kasancewa a cikin yanayin da suke ciki har sai an samar da yanayi mai kyau don rarraba su.
Ko da yake malam buɗe ido suna da zarafi da yawa na yaɗa ƙwayoyin cuta, idan mutane suka guje musu, za su rage haɗuwa da malam buɗe ido da kuma wasu dabbobin daji.
Kulawa da dabbobi masu shayarwa koyaushe yana da mahimmanci don fahimtar yanayin halittu na kwayar cuta da masu ɗaukar su na halitta, wanda ke tabbatar da mahimmancin sa don hana yaduwar cututtuka daga dabbobi zuwa mutane da kuma cutar ta gaba.
A taƙaice: Hanya mafi inganci ga mutane don hana asalin kwayar cutar ita ce nisantar asalin muhalli wanda ke ɗaukar ƙwayoyin cuta.
Akwai ƙananan abubuwa da yawa da ke nuna asalin SARS-CoV-2.
Idan jemage yana watsa SARS-CoV-2 ta hanyar kwayar halitta zuwa pangolin, to ana buƙatar nazarin abin da jemage da pangolin ke da alaƙa.
Na biyu, idan kuwa jemage na da wani aiki kai tsaye wajen yada kwayar cutar ga mutane, dole ne a gano yadda mutane za su iya kamuwa da jemage.
Na uku, idan dabba mai shayarwa ta uku ita ce mai watsawa na gaske, dole ne a bayyana yadda take hulɗa da sauran jinsuna, gami da mutane, bats, da pangolins.
A ƙarshe, saboda yawancin dabbobi masu shayarwa, gami da dabbobin gida, na iya zama masu saurin kamuwa da SARS-CoV-2, dole ne a gudanar da sa ido da bincike kan kamuwa da cuta.
Ana sa ran cewa jemage, pangolins ko wasu dabbobi za su iya zama masu ɗaukar kwayar cutar SARS-CoV-2 ko wasu irin su.
Bincike mai gudana a wannan fannin yana bayyana tsarin juyin halitta na SARS-CoV-2 a cikin dabbobi tare da shawarwari don taimakawa hanawa da sarrafa COVID-19 a cikin mutane.
Ana buƙatar sabunta ƙa'idodin gwaji don shari'ar da ake zargi da cutar COVID-19 da kuma shari'ar da ba a tabbatar da ita ba.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar saurin jagora don ganowa da magance kamuwa da cutar 2019 Novel Coronavirus (2019-nCoV) kuma wannan jagorar tana ba da ƙwarewarmu kuma tana ba da kyakkyawan tunani don yaƙar wannan annobar a duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, kuma iliminmu da faɗakarwarmu suna ƙaruwa a hankali tare da ci gaba da binciken bincike da ƙwarewar gwaji na asibiti, don haka, hanyoyin bincike da magani suna ci gaba da kasancewa a halin yanzu.
A cikin wannan wasikar, mun amsa ga sharhinmu game da jagororinmu kuma mun gabatar da sabon tsarin bincike bisa ga sabon gwajin bincike da jagorar magani don COVID-19 (siffa ta bakwai) bisa ga sabon gwajin gwaji da jagorar magani na Kwamitin Kiwon Lafiyar Jama'ar Jamhuriyar Jama'ar Sin.
A watan Disamba na 2019, sabon coronavirus (2019-nCoV) ya haifar da barkewar cutar, wanda yanzu ake kira cutar coronavirus ta 2019 (COVID-19) kuma an sake sanya wa kwayar cutar suna mai tsanani na cututtukan numfashi mai tsanani (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annobar duniya.
Don yaƙar cutar SARS-CoV-2, ƙungiyarmu ta shirya jagorar shawarwari na gaggawa kuma an buga ta akan layi a cikin binciken likita na soja a ranar 06 ga Fabrairu, 2020.
Tun da aka buga shi, an mai da hankali sosai ga wannan littafin.
Ka tuna, kodayake, cewa COVID-19 sabuwar cuta ce, fahimtarmu da iliminmu suna ƙaruwa a hankali bisa ga binciken da ake samu yanzu da kuma ayyukan asibiti; saboda haka hanyoyin bincike da hanyoyin magani suna ci gaba da ingantawa.
Misali, Jagororin Ganowa da Kula da Lafiya na COVID-19 da Kwamitin Kiwon Lafiya na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya bayar, wanda ya fito a cikin jimlar fitowa bakwai daga ranar 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, tare da wasu canje-canje masu mahimmanci.
Yanzu jagorarmu ta karɓi ra'ayoyi daga gare su, waɗanda suka ba da shawarar sauƙaƙe sakamakon sakamakon bisa ga kwarewar asibiti.
Aikin su ya kawo mana sabon shaida da kuma amfani ga cutar a duk duniya.
Muna goyon bayan wannan aiki mai muhimmanci kuma muna godiya.
Koyaya, aikin su yana buƙatar sabuntawa bisa ga sabon bincike da jagororin magani na COVID-19 (siffa ta bakwai ta gwaji) da kuma binciken da aka yi kwanan nan.
A cewar fitowar ta bakwai (Maris 32020), yanayin da ake zargi dole ne ya cika bayanan bayanan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Tarihin cututtukan cututtuka: (1) Tarihin tafiya ko zama a Wuhan da kewaye da garin da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 kafin bayyanar cututtukan, ko wasu shari'o'in COVID-19 da aka ba da rahoton; (2) Tarihin hulɗa da masu cutar SARS-CoV-2 (tare da gwajin alumic acid); (3) Tarihin hulɗa da marasa lafiya da ke cikin Wuhan da kewaye da garin da ke kusa da garin da suka fara bayyanar cututtukan, ko wasu al'ummomin da ke da alaƙa da COVID-19 tare da zazzabi ko alamun numfashi; (4) Jerin tabbatar da shari'o'in da suka faru a cikin makonni 2 daga ƙananan rukunin shari'o'i (watau gida, ofis, gida, da sauransu) (≥ 2 yankuna).
Bayanan asibiti: (1) zazzabi da / ko alamun numfashi; (2) tare da manyan alamun bayyanar cututtukan COVID-19; (3) jimlar adadin ƙwayoyin farin jini tare da ƙididdigar ƙwayoyin lymphocytes na yau da kullun, raguwa, ko raguwa a farkon matakin.
Binciken tabbataccen yanayin ya kamata ya dogara ne akan yanayin da ake zargi: (1) tabbataccen gwajin PCR na ainihin lokacin SARS-CoV-2; (2) cikakken tsarin kwayoyin halittar kwayar cutar wanda ke nuna rashin jituwa ga sanannen sabon coronavirus; (3) gwajin ƙwayar cuta don takamaiman IgM antigen da IgG antigen don SARS-CoV-2 mai kyau a cikin gwajin kunne, ko canji daga mara kyau zuwa tabbatacce daga takamaiman IgG antigen zuwa SARS-CoV-2, ko sau 4 a matakin murmurewa fiye da lokaci mai tsanani.
Ana iya ganin gwajin PCR na ainihi don kwayar nucleic acid a cikin numfashi ko samfuran jini don ƙarin bugu na biyu (Janairu 182020) da na uku (Janairu 222020).
An ƙara gwajin gwajin jini a fitowar ta huɗu (Janairu 272020) da ta biyar (Fabrairu 82020).
Waɗannan gyare-gyare, waɗanda suka dogara da aikin da masu binciken ke ci gaba da yi, za su taimaka wajan gano ingantattun kayan aikin nucleic acid don saurin bincike da kuma ƙara samfuran numfashi daban-daban, gami da samfurin jini, da kuma samar da sakamako mai kyau na ƙwayoyin cuta na musamman a cikin ma'aunin da aka tabbatar.
Bugu da ƙari, akwai ƙarin bayanai da ke nuna cewa ya kamata mu mai da hankali ga marasa lafiya da ke da alamun cutar da kuma waɗanda ba su da alamun cutar.
Saboda haka, saboda an rarrabe mutane ba tare da alamun asibiti a matsayin masu haɗari ba, ana buƙatar sake fasalin jadawalin aikin Zhou et al.
Hakanan dole ne a tabbatar da tsarin sakamako a cikin gwaji da nazarin asibiti.
A ƙarshe, za mu ba da hujja kai tsaye kuma mu gayyaci masu karatu su ba da ra'ayinsu.
Muna ba da shawarar yin bincike game da shari'ar da ba a zata ba da kuma zargin da ba a tabbatar ba, bin sabbin umarnin ƙasashen da suka fito.
Ƙungiyarmu tana ci gaba da ɗaukaka ƙa'idodinmu don taimaka wa mutane.
Bangladesh ta ba da rahoton sabbin mutuwar biyar mafi girma a rana saboda COVID-19
A jiya, Bangladesh ta tabbatar da sabbin mutuwar biyar a ranar sakamakon COVID-19.
Wannan shi ne adadin mutane da suka mutu a rana guda sakamakon cutar.
Har zuwa jiya, Cibiyar Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton asarar da cutar ta yi, wanda ya haɗa da mutane 114 da ke jinya da kuma 33 da suka warke.
An samu mutuwar mutane 17 a cikin jimlar.
A cikin wani rahoto na labarai a yanar gizo, Daraktan IEDCR, Dokta Mirjaddi Sabrina Flora, ya ce cikin wadanda suka mutu akwai maza hudu da mace daya.
A cewar Dr. Merjaday, marasa lafiya biyu sun haura shekaru 60, biyu suna tsakanin shekaru 51 zuwa 60, daya kuma yana tsakanin shekaru 41 zuwa 50.
Ya kuma ce biyu daga cikin 'yan bindigar sun fito ne daga Dhaka.
A ranar 11 ga Maris, Hukumar Lafiya ta Duniya ta ayyana CIDID-19 a matsayin annoba.
Jami'in asibitin ya shaida wa kamfanin dillancin labarai na Anadolu cewa, Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengali, wanda ake kula da shi a asibitin Kuwait Maitree, yana cikin wadanda suka mutu.
A ranar Asabar, a cikin sanarwar bidiyo ta kan layi, Ministan Sufuri da gadaje na Bangladesh Obaidul Quader ya ce za a rufe zirga-zirgar jama'a har zuwa Asabar mai zuwa fiye da yadda aka tsara.
Wannan rufewar zirga-zirgar jama'a da farko ya fara ne a ranar 26 ga Maris kuma an shirya zai ƙare a ranar Asabar, 4 ga Afrilu.
Har ila, an ƙyale sufuri na kayayyaki masu muhimmanci - magani, mai, da abinci.
An fara samun cutar COVID-19 a Bangladesh a ranar 8 ga Maris, ta hanyar mutane biyu da suka dawo daga Italiya da matar ɗaya daga cikinsu.
Tun daga ranar 19 ga Maris, ukun sun warke.
Yawan masu cutar SARS-CoV-2 a duniya ya wuce miliyan daya
A ranar Alhamis, jimlar adadin masu kamuwa da cutar coronavirus na SARS-CoV-2 ya zarce miliyan daya a duk duniya, a cewar Jami'ar Johns Hopkins.
Akalla mutane 52 sun mutu sakamakon cutar coronavirus.
A lokacin da Malawi ta tabbatar da cutar coronavirus ta farko, Zambia ta sami mutuwar farko da ke da alaƙa da cutar coronavirus.
Koriya ta Arewa ta bayyana cewa tana daya daga cikin 'yan kasashen da suka rage marasa cutar coronavirus tun ranar Alhamis.
Hukumar Lafiya ta Duniya ta sanar a jiya cewa an tabbatar da jimillar mutane 1,051,635 da suka kamu da cutar, gami da mutane 79,332 a cikin awanni ashirin da hudu bayan da aka yi ruwan sama a ranar 4 ga Afrilu (0800 UTC) a tsakiyar Turai.
An samu sama da mutane dubu 244 da suka kamu da cutar coronavirus a Amurka, tare da mutuwar akalla mutane 5,900.
CBS News ta ruwaito, tana ambaton bayanan Jami'ar Johns Hopkins, cewa mutane sama da 1,000 sun mutu a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duk duniya, ƙasashe sun ba da sanarwar cewa sun ɗauki matakan tsaurara don hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow Sergei Sobyanin ya tsawaita dokar hana fita zuwa ranar 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa Rasha za ta ci gaba da karbar albashi ba tare da zuwa aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta yanke shawarar tsawaita dokar ta baci ta kasa da kwanaki 15 da kuri'u 215, 10 a kan, da kuma kuri'a daya a kan.
Saudiyya ta tsawaita dokar hana fita a cikin biranen alfarma na Makka da Madina zuwa yini duka, wanda a baya, ana yin ta ne kawai tsakanin karfe 3 na yamma da karfe 6 na safe.
Thailand na shirin aiwatar da dokar hana fita daga karfe 10 na dare zuwa 4 na dare.
Gwamnan Ohio Mike DeWine ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa ranar 1 ga Mayu.
Shaguna a Ostareliya sun rage yawan takarda bayan gida a kasuwa guda
A ranar Lahadi da Asabar da dare, sarƙoƙin kantin sayar da kayayyaki na Australiya, Wellworth da Coles, sun rage ƙuntatawa na sayarwa zuwa biyu da fakiti ɗaya a kan takardar bayan gida guda ɗaya a duk shagunan da ke ƙasar.
ALDI kuma ya gabatar da iyakancewar WAN-PAK a ranar Litinin.
An sanya waɗannan ƙuntatawa a kan hanyoyin haɗin yanar gizo da shafukan Facebook.
An bayar da rahoton cewa masu amfani da kaya sun adana kaya saboda tsoron COVID-19 da yiwuwar keɓewa.
A ranar Laraba, Woolworths ta sauke takarda bayan gida / kayan kwalliyar kayan wanka a cikin tsari.
Waɗannan canje-canjen sun biyo bayan iyakancewar musayar da aka gabatar a cikin kunshin huɗu na baya wanda Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris, bi da bi.
A wani taron manema labarai a ranar 8 ga Maris, Coles ya ce: "Soyuka da yawa har yanzu suna sayarwa a cikin awa ɗaya na jigilar kayayyaki" kuma bukatar "ba ta taɓa faruwa ba", ALDI ya kira wannan a matsayin "ba zato ba tsammani" a cikin rubutun Facebook a ranar Talata.
A makon da ya gabata, tallace-tallace sun karu sosai, a cewar mai magana da yawun Woolworths.
Shagon Costco a Canberra ya rage adadin da aka yarda da shi zuwa fakiti biyu a makon da ya gabata.
Don rage ƙarancin, Coles ya ba da umarnin manyan fakiti daga masu samar da kayayyaki kuma ya ƙara yawan isarwar; Woolworths ya ba da umarnin ƙarin kayan da aka shirya don siyarwa, kuma ALDI ya shirya tallace-tallace na musamman da aka riga aka shirya don Laraba.
Russell Zimmerman, darektan zartarwa na kungiyar masu sayar da kaya, ya ce masu sayarwa suna son kara tallace-tallace, amma takunkumin da majalisar ta sanya kan lokacin isar da manyan motoci ya sanya hakan ya zama da wahala.
Yana tsammanin farashin samfur zai ragu yayin da masu samar da kayayyaki da sauran su ke jiran samar da wasu nau'ikan filastik.
ALDI ta sanar a ranar Litinin cewa wasu shagunan ba za su gudanar da ranar musamman ta Laraba ba bayan an saki hannun jari a gaba.
A wani rahoto da News.com.au ta bayar, Dr Gary Mortimer, masanin sayar da kayayyaki daga Jami'ar Fasaha ta Queensland, ya ce shagunan suna cika da kayayyaki da ake sayarwa a kowane dare.
Takardar bayan gida / takarda ta kayan aiki ce mai girma, wanda ke haifar da ƙaramin adadi a cikin shagunan kuma lokacin da aka sayar, ana samar da sararin buɗewa, wanda ke haifar da ƙarancin ƙarancin.
"A cewar ABC, ra'ayin Coles da Woolworths shi ne cewa idan akwai abubuwa da yawa a kan ɗakunan ajiya, za ku iya rage yawan ruwan sama da ake samu ta hanyar sayen kayan tsabtace jiki da tawul", in ji Russell Singham.
Wani mai kera takarda na bayan gida mai sake zagayowar ya ce a ranar Laraba da ta gabata cewa kayayyakin da suke da su sun kusan karewa.
Kimberly-Clark, na kamfanin Connex Toilet Soft, da Solaris Paper, wanda ke aiki a kan tarin shara, sun ce suna aiki 24/7 don tallafawa samarwa, kamar yadda News.com.au ta ruwaito.
Shafin yanar gizo na Domain.com ya ba da rahoton wasu masu siyar da kadarori da ke ba da takardar bayan gida kyauta ga kowane mai neman a Melbourne saboda ba za a yi wasu gwanjo ba saboda masu siye suna hutu a ranar aiki mai tsawo.
Litattafan NT News na ranar Alhamis, wanda Darwin ke bugawa kowace rana, ya haɗa da shafi takwas don kwafa da kuma amfani da takarda na bayan gida.
Masu adana kaya da farko ba su yarda da sanya takunkumi ba, amma a cewar wani rahoto daga ABC Australia a ranar 3 ga Maris, sun ce ba su da shirin gabatar da takunkumi kan sayayya.
Russell Zimmerman ya kara da cewa akwai bukatar wasu kayayyaki da suka hada da abin rufe fuska, masu tsabtace jiki, kayan bushewa, wanke hannu da foda.
Hakazalika, babban kanti na Ocado na Burtaniya a waje da Ostiraliya ya sanar a ranar Lahadi cewa za a sayar da takardun 12 na Andres Pujols kawai.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba ta duniya
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana yaduwar COVID-19 a matsayin annobar duniya da cutar coronavirus SARS-CoV-2 ke haifarwa.
Kalmar "Pan-Am" ba ta nuna irin yanayin da cutar ke da shi ba, amma kawai yadda ta yadu, kuma hakan ya nuna cewa gwamnatocin WHO sun dauki mataki cikin gaggawa:
"Duk ƙasashe har yanzu suna iya canza yanayin annobar".
"Darakta Janar na Hukumar Lafiya ta Duniya, Tedros Adhanom Ghebreyesus ya ce, "" idan ƙasashe suka bincika, su kula, su ware, su bincika, kuma su ba da amsa ga jama'a, """
"A cikin wannan yanayin, muna bukatar mu yi aiki tuƙuru don mu magance matsalar.
"A cewar tsohon darektan kula da rigakafin cututtuka na Amurka, Dokta Tom Frieden, cutar ta zama ""ba a taɓa gani ba""".
"A cikin wata sanarwa da aka buga a CNN a watan Fabrairu, ya ce, ""Babu wani kwayar cuta ta numfashi da ta faru banda mura tun daga lokacin da ta faru har zuwa lokacin da ta sake yaduwa a duniya"."
"Gera Jesus ya bayyana ra'ayi iri ɗaya cewa ba mu ga annoba kamar coronavirus ba. """
Ya ci gaba da cewa, "kuma ba mu taɓa ganin annobar da za a iya sarrafawa a lokaci guda ba".
Wannan sabon yanayin ya biyo bayan shawarar da Hukumar Lafiya ta Duniya ta yanke na ayyana yaduwar cutar a matsayin gaggawa ga lafiyar jama'a.
Darakta na Cibiyar Kula da Cututtuka da Cututtuka ta Kasa ta Amurka, Dr. Anthony Fusey, ya ce cutar ta kara tsanantawa saboda yaduwar cutar ta shiga cikin al'umma.
Tun daga ranar Alhamis, Associated Press ta ba da rahoton cewa akwai mutane 126,000 da ke da cutar COVID-19 a duk duniya, kuma fiye da 4,600 sun mutu sakamakon hakan.
Cutar kwayar cutar coronavirus ta 2019 20 annobar cutar kwayar cutar coronavirus ce ta 2019 (COVID-19) wacce ke ci gaba da yaduwa, kuma tana haifar da cutar coronavirus mai saurin kamuwa da cuta ta 2 (SARS-CoV-2).
An ayyana cutar a matsayin gaggawa ta duniya ga lafiyar jama'a a Wuhan, China, Disamba 2019, Janairu 30th, 2020; an ayyana cutar a ranar 11th, 2020 Maris.
A ranar 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe 210, wanda ya yi sanadiyar mutuwar mutane 97,000.
An warkar da mutane kusan 364,000.
An kiyasta cewa adadin mutuwar cutar ya kai kashi 4 cikin dari a China, kuma a sauran sassan duniya, ya kai kashi 13.04 cikin dari a Algeria zuwa .08 cikin dari a New Zealand.
Alamun alamun sune zazzabi, tari, da wahalar numfashi.
Matsaloli sun haɗa da ciwon huhu da ciwon damuwa na gaggawa.
Lokaci daga lokacin kamuwa da cutar zuwa bayyanar alamun cutar yawanci kwanaki biyar ne, amma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Babu wani allurar rigakafi ko magani da aka tsara don cutar.
Babban magani shine alamomi da tallafi. Matakan kariya da aka ba da shawarar sun haɗa da wanke hannu, rufe baki lokacin yin fitsari, nisantawa da wasu mutane, da lura da kai da keɓewa ga waɗanda suke tunanin sun kamu da cutar.
Hukumomi a duk duniya sun amsa ta hanyar aiwatar da takunkumin hana tafiye-tafiye, keɓewa, ƙuntatawa na lokaci, sarrafa haɗarin aiki, da rufe wuraren aiki.
Cutar ta haifar da mummunan damuwa na zamantakewar tattalin arziki a duniya, jinkiri da soke wasannin wasanni, abubuwan addini, siyasa da al'adu, da kuma ƙarancin kayayyaki a cikin tashin hankali.
Makarantun sakandare da jami'o'i a cikin ƙasashe 193 a cikin gida ko na duniya sun rufe, wanda ya shafi kusan kashi 99.4 na yawan ɗalibai.
Bayanai marasa inganci game da cutar da ke yawo a yanar gizo suna haifar da ƙiyayya da keɓewa ga 'yan ƙasa daga China, Kudancin da Gabashin Asiya da sauran ƙasashen da cutar ta bayyana.
Saboda rage tafiye-tafiye da rufe masana'antu masu nauyi, gurɓatar iska da fitar da carbon sun ragu.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Yuebei), sun sanar da zargin wani sabon kamuwa da cutar nimoniya a ranar 31 ga Disamba, 2019, wanda ba a san asalinsa ba, kuma an fara bincike a watan Janairun 2020.
Yawancin abubuwan da suka faru suna da alaƙa da kasuwar sayar da abincin teku ta Hunan, kuma ana tsammanin cutar ta zoonotic ce.
Kwayar cutar da ta haifar da yaduwar ta sananne ne da SARS-CoV-2, sabon kwayar cuta da aka gano wanda ke da alaƙa da kwayar cutar coronavirus ta tsuntsaye, kwayar cutar coronavirus ta pangolin, da SARS-CoV. Mutumin da ya fara nuna alamun cutar ya kamu da cutar a ranar 1 ga Disamba 2019 kuma ba shi da alaƙa da rukunin kasuwa mai ruwa.
Kashi biyu bisa uku na shari'o'in da aka bayyana a farkon watan Disamba na shekarar 2019 suna da alaƙa da kasuwa.
A ranar 13 ga watan Maris, 2020, South China Morning Post ta ruwaito cewa, a ranar 17 ga watan Nuwamba, 2019, an gano mutum na farko da ya kamu da cutar a cikin wani mutum mai shekaru 55 mai suna Sau, wanda ke zaune a lardin Hubei. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, adadin sabbin masu cutar a China ya ragu, kuma a gefe guda, ya fara ƙaruwa a Italiya, Iran da Koriya ta Kudu.
Akwai yiwuwar samun ƙananan lokuta da aka ruwaito, musamman a tsakanin waɗanda ke da alamun rashin lafiya.
A ranar 26 ga Afrilu, an sami ƙananan lokuta a cikin matasa 'yan ƙasa da shekaru 19, wanda ya kai kashi 2.4% na yawan masu cutar a duniya. Patrick Valance, babban mai ba da shawara kan cutar a Burtaniya, ya kiyasta cewa ana buƙatar yin allurar rigakafin kashi 60% na yawan mutanen Burtaniya kafin a sami nasarar magance cutar.
"Laifi" yana nufin mutanen da aka gwada don COVID-19 da waɗanda aka tabbatar da sakamakon gwajin su daidai da ƙa'idodin hukuma.
A ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawan jama'arta, kuma ƙasashe da yawa, kamar Italiya, Netherlands, Spain, da Switzerland, suna da ƙa'idodin hukuma don ba a gwada waɗanda ke da alamun rashin lafiya kawai.
A cewar wani bincike da aka buga a ranar 16 ga watan Maris, kusan kashi 86% na yaduwar COVID-19 a China ba a san su ba har zuwa ranar 23 ga Janairu. Waɗannan yaduwar da ba a yi rajista ba sune tushen kashi 79% na yaduwar cutar.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya yi hasashen cewa adadin masu kamuwa da cutar a Italiya zai fi na masu cutar.
Hasashen farko na ƙimar sake haifar da asali (R0) don COVID-19 ya kasance daga 1.4 zuwa 2.4.
Binciken da Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta buga ya kammala cewa zai iya zama 5.7.
Yawancin mutanen da ke da COVID-19 suna murmurewa.
Ga waɗanda ba su sani ba, tsawon lokacin da mutum zai mutu daga bayyanar cututtuka daga 6 zuwa 41 days, mafi yawan lokuta 14 days.
Ya zuwa ranar 10 ga Afrilu, 2020, an yi rahoton mutuwar kusan 97,000 da ke da alaƙa da COVID-19.
Ya zuwa ranar 5 ga watan Fabrairu, kashi 80% na mutuwar da aka yi a China sun kasance sama da shekaru 60, kuma kashi 75% suna da cututtukan jini da ciwon sukari.
Idan ba a haɗa da mutuwar da ba a bincika ba, kamar mutuwar gida, mutuwar likitan iyali, da sauransu, yawan mutuwar COVID-19 na iya zama mafi girma.
Bayanai na wani ɓangare a Italiya sun gano cewa adadin mutuwar da aka hana a lokacin annobar ya ninka na COVID sau 4-5 fiye da na mutuwar da aka yi a hukumance.
"Mai magana da yawun Cibiyar Kula da Cututtuka da Rigakafin (CDC) ta Amurka ""Mun san cewa an rage kimantawa na [yawan mutuwar da aka bayyana]" ya ce irin wannan rahoton da aka yi da shi a Amurka ba zai faru ba a lokacin annobar, kamar yadda ya faru a lokacin yaduwar cutar H1N1 Swine Flu a shekarar 2009.
An fara samun mutuwar farko daga kasar Sin a Philippines a ranar 1 ga watan Fabrairu, kuma ta farko a Faransa a ranar 14 ga watan Fabrairu a wajen Asiya.
A ranar 28 ga watan Janairu, Iran, Koriya ta Kudu da Italiya sun yi fice a cikin adadin mutanen da suka mutu a wajen kasar Sin.
A ranar 13 ga Maris, fiye da ƙasashe arba'in da yankuna a kowace nahiya banda Antarctica sun ba da rahoton mutuwar.
Waɗannan lambobin sun bambanta a yankuna daban-daban, amma ana matsa su ta hanyar yawan gwaje-gwajen da aka tsara, ingancin kiwon lafiya, likitoci da masu ba da shawara, lokacin da cutar ta fara, da kuma abubuwan da ke tattare da al'umma kamar shekaru, jinsi, da lafiyar jama'a.
A cewar kididdigar Jami'ar Johns Hopkins, yawan mutuwar mutane a duniya ya kai kashi 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Adadin yana dabam dabam a kowace ƙasa.
A China, yawan mace-macen da ke dauke da cutar ya ragu daga kashi 17.3% (don waɗanda ke da alamun cutar daga Janairu 1-10, 2020) zuwa kashi 0.7% (don waɗanda ke da alamun cutar bayan Fabrairu 1, 2020). Sauran matakan sun haɗa da yawan mutuwar cutar (CFR), wanda shine kashi na yawan mutanen da suka mutu daga cutar da aka bincika, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda shine kashi na yawan mutanen da suka kamu da cutar (wanda aka bincika da waɗanda ba a bincika ba) waɗanda suka mutu daga cutar.
Waɗannan ƙididdigar ba su da iyakance a cikin lokaci, kuma ana bin su idan an sami ƙayyadaddun mutane da cutar ta hanyar takamaiman tsarin shari'ar.
Masana da yawa sun yi ƙoƙari su lissafa waɗannan adadi don wasu mutane.
Cibiyar Kiwon Lafiya ta Oxford ta kimanta cewa mutuwar cutar ta iya zama tsakanin kashi 0.1 zuwa 0.39 bisa dari, bisa ga shaidar Jami'ar Oxford.
Ana yin la'akari da wannan zangon tare da binciken farko na gwajin COVID-19 da aka yi a Jamus da kuma ƙididdigar ƙididdigar da aka yi a CFR.
WHO ta ce ana iya sarrafa cutar.
Yana da wahala a faɗi da tabbaci lokacin da annobar ta kai kololuwa da tsawon lokacin da za ta ci gaba kuma zai iya bambanta daga wuri zuwa wuri.
Cibiyar nazarin cutar ta Penn State ta gudanar da bincike kan cutar Marsage Penn, inda cutar ta ci gaba da yaduwa.
Amma ba za mu iya tunanin lokacin da hakan zai faru ba.
"Zhong Nanshang, babban mai ba da shawara kan lafiya ga gwamnatin kasar Sin, ya yi ikirarin cewa idan dukkan kasashen duniya suka bi shawarar Hukumar Lafiya ta Duniya kan matakan dakile yaduwar cutar, za a iya "dakatar da ita a watan Yuni".
"A ranar 17 ga Maris, Adam Kucharski na Lafiya da Magungunan Yankin London ya ce SARS-CoV-2 ""zai iya kasancewa a cikin shekara ɗaya ko biyu"."
"A cewar wani binciken kwalejin Imperial wanda Neil Ferguson ya jagoranta, nisantar jiki da sauran matakan da ake buƙata (wataƙila watanni 18 ko fiye) "" har sai an sami allurar rigakafi".
"William Schaffner na Jami'ar Vanderbilt ya ce, "Wannan kwayar cutar coronavirus tana da saukin yaduwa, saboda haka yana da wuya a ce ta ɓace gaba ɗaya, kuma ina tsammanin za ta iya dawowa kowace shekara kuma ta zama cuta ta yanayi".
Ana tantance cutar dawowa ta hanyar rigakafin rigakafi da kuma maye gurbin DNA.
Alamun cutar COVID-19 ba su da bambanci kuma mutanen da ke fama da cutar ba za su iya nuna alamun cutar ba.
Alamomi biyu na yau da kullun sune zazzabi (88%) da tari mai bushe (68%).
Alamomin da ba a saba gani ba sun haɗa da gajiya, numfashi mai saurin gudu (ACTA), rashin jin ƙamshi, numfashi, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, rawar jiki, amai, tari mai saurin gudu, zawo, ko kuma kumburi.
Cibiyoyin Kula da Cututtuka da Rigakafin (CDC) na Amurka sun lissafa alamun gaggawa kamar wahalar numfashi, ciwon kirji ko damuwa, tashin hankali, wahalar tafiya, da kumburi a fuska ko lebe. Idan waɗannan alamun suka bayyana, ana ba da shawarar neman kulawa ta gaggawa.
Masu binciken sun ba da shawarar cewa duk waɗanda ke da alaƙa da mutanen da ke da cutar, waɗanda ba su da alamun cutar, amma sakamakon gwajin ya nuna tabbataccen kamuwa da cuta, ya kamata a ba da shawarar cewa a kula da su sosai kuma a gwada su don kawar da kamuwa da cuta.
China ta kiyasta rashin alamun cutar daga kadan zuwa kashi 44 cikin dari.
Lokacin haifuwa na yau da kullun (lokaci tsakanin kamuwa da cuta da bayyanar cututtuka) yana cikin kwanaki ɗaya zuwa 14, galibi kwanaki biyar. Misali na rashin tabbas, ƙididdigar yawan mutanen da ke da COVID-19 waɗanda suka rasa ƙamshi ya fara da kashi 30% kuma daga baya ya ragu zuwa 15%.
Za a bayyana wasu cikakkun bayanai game da yadda cutar ke yaduwa a nan gaba.
Ana yaduwar cutar ne ta hanyar kusanci da ƙananan ɗigon ruwa yayin yin fitsari, hancinsa, ko magana, a tsakanin mita 1-2 (ƙafa 3 zuwa 6).
Bincike ya nuna cewa tari mara rufewa na iya haifar da danshi mai nisan mita 4.5 (ƙafa 15) zuwa mita 8.2 (ƙafa 27).
Wasu sun kammala cewa ana iya watsa kwayar cutar ta hanyar ɗigon magana, wanda zai iya zama a cikin iska na dogon lokaci. Ana iya haifar da ɗigon numfashi yayin numfashi, gami da magana, amma kwayar cutar ba ta cikin iska gaba ɗaya.
Wasu mutane suna iya sauka a kan bakinsu ko hancinsu ko kuma su jawo su cikin huhu.
CPR (karfafawa na jiki) na iya sa mutum ya kamu da cututtuka da ake samu ta hanyar iska.
Mutum zai iya yada cutar ta hanyar taɓa idanu, hanci, ko baki bayan ya taɓa wani abu mai cutarwa, har da fata.
Ko da yake akwai barazanar yaduwa ta hanyar fitsari, wannan barazanar ba ta da yawa.
Gwamnatin China ta musanta cewa SARS-CoV-2 ba ta da alaƙa da magana. Ta ce cutar tana da saurin yaduwa a cikin kwanaki uku na farko da aka fara gano ta, duk da cewa ba ta nuna alamomi kuma ana iya yada ta ta hanyar hanci.
An tabbatar da cutar a cikin mutane kwanaki uku kafin su fara nuna alamun cutar, wanda ke nuna cewa cutar na iya yaduwa kafin a fara nuna alamun cutar.
Rahotanni kaɗan ne kawai na cutar da aka tabbatar a cikin dakin gwaje-gwaje, amma an sami irin wannan yaduwar a wasu ƙasashe da ba su da cutar ta NICKY.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ba a san yadda cutar ke yaduwa ba, ko mutum ɗaya zai iya yada cutar daga mutane biyu zuwa uku. Kwayar cutar na iya rayuwa a saman abubuwa na tsawon awanni zuwa kwanaki.
Musamman a kan filastik (polypropylene) da bakin karfe 304, kwayar cutar na iya rayuwa har zuwa kwanaki uku, har zuwa awanni huɗu a kan jan ƙarfe.
Amma wannan ya bambanta dangane da zafi da zafin jiki. An kuma gano dabbobi da sauran dabbobi masu cutar COVID-19 da kyau.
Babu wata hujja da ta nuna cewa dabbobi za su iya yada cutar ga mutane, amma hukumomin Burtaniya sun ba da shawarar wanke hannu bayan taɓa dabbobi kamar yadda ake yi da zarar mutum mai cutar ya taɓa farfajiya.
Coronavirus 2 (SARS-CoV-2) wani sabon kwayar cuta ne na cututtukan numfashi mai tsanani, wanda aka fara ganowa a cikin mutane uku da ke da cutar huhu a Wuhan wanda ke da alaƙa da rukunin cututtukan cututtukan numfashi masu tsanani.
Dukkanin halaye na sabon kwayar cutar SARS-CoV-2 suna faruwa a yanayi kamar yadda yake a cikin coronavirus. A waje da jikin mutane, ana kashe kwayar cutar da sabulu a gida, saboda sabulu yana kawar da garkuwar jiki. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
An yi imanin cewa zoonotic ya samo asali ne daga asalin.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar coronavirus ta tsara ta kwayoyin halitta tare da nau'ikan biyu na betacoronavirus, subgenus serbicovirus (lineage B) da sauran nau'ikan da aka samo daga cutar ta Lyme.
Samfurin kwayar cutar coronavirus na bat (BatCov RaTG13) ya yi daidai da kashi 96% a duk matakan kwayoyin halitta.
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa bambancin amino acid daya ne kawai a wasu sassan tsarin kwayoyin halittar kwayoyin halittar kwayoyin halittar mutum da na kwayar cutar pangolin.
Kwatanta dukkanin kwayoyin halittar mutum ya gano cewa kusan kashi 92% na kwayoyin halitta sun kasance tsakanin kwayar cutar ta Pangolin da SARS-CoV-2, wanda ya isa ya tabbatar da cewa pangolins sune matsakaiciyar masu ɗaukar hoto.
Ana iya magance kamuwa da kwayar cutar ta hanyar alamun bayyanar cututtuka, amma ana tabbatar da shi ta hanyar juyawa da juyawa ta hanyar polymerase chain reaction (rRT-PCR) ko CT.
Binciken da aka yi a Wuhan wanda ya kwatanta PCR da CT ya nuna cewa CT ya fi PCR rauni, amma yana da ƙananan haske da yawa daga cikin halayen gani da ke da alaƙa da sauran cututtukan huhu da hanyoyin cututtuka.
Ya zuwa watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa kada a yi amfani da CT don tantance COVID-19 ko a matsayin gwajin layin farko.
A ranar 17 ga watan Janairu, Hukumar Lafiya ta Duniya ta fitar da jagororin farko don tsarin gwajin RNA na musamman don binciken SARS-CoV-2.
Gwajin yana amfani da ainihin lokacin juyawa na juyawa na polymerase chain reaction (rRT-PCR).
Ana iya yin gwajin a kan numfashi ko samfurin jini.
Sakamakon yana samuwa a cikin 'yan sa'o'i zuwa rana ɗaya.
Ana yin gwajin ne ta hanyar shafawa cikin hanci, kuma ana iya ɗaukar samfurin makogwaro. Yawancin dakunan gwaje-gwaje da ƙungiyoyi suna samar da gwaje-gwaje na serological, wanda ke gano ƙwayoyin cuta.
Tun daga ranar 6 ga Afrilu, 2020, babu ɗayan waɗannan da aka amince da amfani da su sosai.
A Amurka, gwajin cutar da Selkex ya haɓaka an yarda da shi ne kawai a cikin dakunan gwaje-gwaje da aka amince da su don sabis na gaggawa.
Radiographs da CT da kuma halayyar mutane da alamomi sun haɗa da gilashin da aka narkar da shi wanda ba shi da siffar da kuma ruwa tsakanin ƙwayoyin cuta da kuma samfurori.
Radiological Society na Italiya yana aiki da bayanan hoto na duniya akan layi wanda ke nuna abubuwan da aka tabbatar.
Saboda haɗuwa da wasu cututtuka kamar adenoviruses, ƙarancin hoto wanda ba a tabbatar da shi ta hanyar PCR don gano COVID-19 yana da iyaka.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya yi la'akari da shi azaman kayan aikin bincike a cikin annobar, wanda ya fi sauri kuma ya fi hankali, kodayake hoton ya nuna ɗan bambanci ga cutar.
An tsara hanyoyin sadarwa na kwakwalwa na Artificial Intelligence - wanda ke da alaƙa da gano abubuwan da ke cikin kwayar cutar ta hanyar radiography da CT.
Hanyoyin da za su taimaka wajen watsa cutar, gami da tsabtace jiki gaba ɗaya, wanke hannu, guje wa taɓa idanu, hanci ko baki ba tare da wanke hannu ba, da yin haushi da hancin kan kayan shafawa da kuma zubar da kayan shafawa kai tsaye cikin shara.
Ana ba da shawarar cewa mutanen da suka riga sun kamu da cutar su sanya abin rufe fuska kafin su je wuraren taron jama'a.
Ana kuma ba da shawarar nisantar da kai don hana yaduwar cutar. Gwamnatoci da yawa sun dakatar ko kuma sun ba da shawarar duk balaguron da ba dole ba daga ko zuwa ƙasashen da cutar ta fi yaduwa.
Koyaya, cutar ta kai ga yaduwar al'umma a sassa da yawa na duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'umma, wasu membobin al'umma ba su san inda ko yadda suka kamu da cutar ba. Ana ba da shawarar masu kula da lafiya da ke kula da al'ummomin da ke fuskantar cutar su yi amfani da matakan kariya na yau da kullun, kula da taɓawa da kuma kiyaye idanunsu.
Amfani da bayanan wuri ta hanyar wayoyin salula na gwamnati don wannan dalili ya haifar da damuwa ga mutane, Amnesty International da kungiyoyi sama da 100 sun yi kira da a takaita irin wannan sa ido.
An gabatar da aikace-aikacen wayoyin hannu da yawa don amfani da su akan filagogo, kuma a ranar 7 ga Afrilu, 2020, masana da yawa suna jiran samun wani sabon abu kamar Bluetooth.
Masu amfani za su sami saƙo idan sun kasance kusa da wanda aka gwada tabbatacce ga COVID-19. Ana yada ra'ayoyin da ba daidai ba game da yadda za a hana kamuwa da cuta, misali, wanke hanci da wanke baki da wanke baki ba su da tasiri.
Duk da ƙungiyoyi da yawa da ke aiki don ƙirƙirar, babu allurar rigakafi da aka samu don COVID-19.
Ana ba da shawarar wanke hannu don rage yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na akalla dakika ashirin, musamman bayan sun je bayan gida ko kuma idan hannayensu sun kasance da datti sosai, kafin su ci abinci, da kuma bayan sun taɓa hanci, tari, ko hancin.
Wannan shi ne saboda wankewa da sabulu yana kashe kwayar cutar a waje da jikin mutum.
CDC ta ba da shawarar yin amfani da tsabtace hannu da ke da kashi 60% na barasa a wuraren da sabulu da ruwa ba su samuwa.
WHO ta ba da shawarar cewa kada mutane su taɓa idanunsu, hancinsu, ko bakinsu da hannayensu da ba a wanke ba.
Za'a iya tsabtace abubuwa da mafita da yawa (tsaftacewa don bakin karfe a cikin minti ɗaya), 6271% ethanol, 50100% propopellol, 0.1% sodium hypochloride, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Sauran magungunan, kamar su benzalkonium chloride da chryohexidine gluconate, sun ragu da inganci.
CDC ta ba da shawarar cewa a wuraren da ake zargin ko tabbatar da cutar COVID a cikin wuraren sabis, ofis ko wuraren wanka, wanka, wuraren amfani da jama'a da wuraren amfani da wutar lantarki, tebur, kwamfutar gama gari, ATM, da sauransu, ana buƙatar tsabtace su da maganin kashe ƙwayoyin cuta.
Kungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hancinsu da hannu ko kuma takunkumi yayin yin fitsari ko hancinsa kuma su zubar da duk wani takunkumi nan da nan.
Ana ba da shawarar yin aikin tiyata ne kawai ga mutanen da ke fama da cutar saboda yana hana yaduwar kwayar cutar da kuma hana yaduwar cutar yayin magana, hancin mutum da tari.
Hukumar Lafiya ta Duniya ta ba da jagororin lokacin da kuma yadda za a yi amfani da abin rufe fuska.
"A cewar Stephen Griffin, masanin ƙwayoyin cuta a Jami'ar Liège, "suna iya rage yawan mutane da ke taɓa fuskokinsu, suna kawar da tushen kamuwa da cuta da zai iya faruwa idan ba a wanke hannayensu ba da kyau".
A.T.D. ta ba da shawarar cewa mutane masu lafiya kada su sa abin rufe fuska da hanci idan suna da alaƙa da waɗanda ke tallafawa waɗanda ke da COVID-19 kuma suna da rashin lafiya, duk da cewa sun fahimci cewa yana da kyau a rufe fuska da hanci.
Kasashe da yawa sun fara ƙarfafa amfani da abin rufe fuska ga 'yan ƙasa.
A Amurka, CDC ta ba da shawarar yin abin rufe fuska na masana'anta da ba na likita ba. China ta ba da shawarar yin amfani da abin rufe fuska na likita wanda ba a amfani da shi ba, musamman ga masu lafiya, musamman lokacin da suke kusanci da wasu mutane (mita 1 (ƙafa 3) ko ƙasa da haka).
Yana ba da shawarar sanya abin rufe fuska lokacin amfani da jigilar jama'a ko kasancewa a wuraren da mutane ke yawa.
Jami'an lafiya na Thailand suna ƙarfafa mutane su sa abin rufe fuska da aka yi da tufafi kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita waje ba tare da rufe fuska ko hanci da baki ba.
A ranar 16 ga Maris, Vietnam ta umarci kowane ɗan ƙasa ya kare kansa da wasu ta hanyar sanya abin rufe fuska lokacin da ya fita daga gida zuwa wuraren jama'a.
Gwamnatin Austria ta bukaci duk wanda ya shiga kantin sayar da kayan masarufi ya sanya abin rufe fuska.
Isra'ila ta bukaci dukkan 'yan kasarta da su sanya abin rufe baki da baki a waje.
Taiwan, wanda ke samar da abin rufe fuska miliyan goma a rana tun rabin watan Maris, ta ba da umarnin sanya abin rufe fuska ga fasinjojin jirgin kasa da waɗanda ke amfani da bas na birni daga ranar 1 ga Afrilu.
Panama ta bukaci duk wanda ya fita ya sanya abin rufe fuska, kuma ta ƙarfafa waɗanda ba za su iya sayen abin rufe fuska ba su yi aiki a gida.
An kuma yi amfani da abin rufe fuska sosai a Japan, Koriya ta Arewa, Malaysia, da Singapore.
Nisa da jama'a ko (wanda aka fi sani da nesa ta jiki) ya ƙunshi kiyaye yanayin yaduwar cutar da rage hulɗa tsakanin mutane don rage yaduwar cutar.
Matakan sun hada da keɓewa, hana tafiya, rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo da cibiyoyin kasuwanci.
Mutane na iya aiwatar da matakan nisantar da jama'a ta hanyar zama a gida, ta hanyar iyakance tafiye-tafiye, ta hanyar guje wa wuraren taron jama'a, ta hanyar yin ban kwana ba tare da taɓa su ba, ta hanyar nisantar da kansu daga wasu.
Yawancin gwamnatoci a halin yanzu suna ba da shawara da kuma tilasta nisantar jama'a a cikin jihohin da cutar ta shafa.
Hukumar kula da lafiya ta Amurka ta ba da shawarar cewa yawan taron jama'a ya ragu daga 250 (idan babu alamun COVID-19) zuwa 50, sannan zuwa 10.
"A ranar 22 ga Maris, 2020, Jamus ta hana kowa yin hulɗa da mutane fiye da biyu. Tsofaffi da masu lura da yanayin kiwon lafiya, waɗanda ke da ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, rashin ƙarfi na jiki, da rashin lafiya mai tsanani da sauran abubuwan da ke tattare da cutar, sun ba da shawarar CDC su bar gidajensu a duk lokacin da zai yiwu a yankin da cutar ta ɓarke. A ƙarshen Maris, WHO da sauran kungiyoyin kiwon lafiya sun fara amfani da kalmar ""nesa da jama'a"" a matsayin "nesa da jiki", saboda haka, manufar ita ce rage haɗuwa ta hanyar kiyaye alaƙar jama'a ta hanyar Intanet ko Facebook. "
Amfani da kalmar nisantar zamantakewa yana nufin mutanen da ya kamata su shiga cikin cikakkiyar zaman kansu, maimakon ba da shawarar ci gaba da hulɗa da wasu ta wasu hanyoyi. Wasu hukumomi sun ba da jagororin kiwon lafiyar jima'i don amfani a lokacin annobar duniya.
Wannan ya haɗa da ba da shawara cewa a yi jima'i da wanda ba shi da cutar ko alamun cutar.
Ana ba da shawarar keɓewa a gida ga waɗanda ake zargi da kamuwa da cutar da kuma waɗanda ke da COVID-19.
Hukumomin kiwon lafiya sun ba da cikakkun jagororin keɓewa. Gwamnatoci da yawa suna ba da shawarar cewa mutane a wuraren da cutar ta bulla su keɓe kansu.
An ba da ƙa'idodin keɓe kai masu ƙarfi ga waɗanda ke cikin manyan ƙungiyoyin haɗari.
Ana ba da shawarar cewa mutanen da ke iya kasancewa cikin haɗari ga wani wanda ke da cutar COVID-19 da waɗanda suka yi tafiya kwanan nan zuwa ƙasa ko yanki inda cutar ta yadu su keɓe kansu na kwanaki 14 daga ranar ƙarshe ta haɗari.
Dabarun sarrafa yaduwar shine toshewa ko hanawa da ragewa.
Ana yin takunkumin a farkon lokacin annobar, da nufin ganowa da keɓe waɗanda ke da cutar da kuma gabatar da wasu sabbin hanyoyin sarrafa kamuwa da cuta don rage yaduwar cutar ga sauran al'umma.
Idan ba za a iya dakatar da yaduwar cutar ba, za a tura gwaji zuwa matakin juriya, kuma za a ɗauki matakan rage yaduwar da magance tasirinsa ga tsarin kiwon lafiya da al'umma.
Ana iya ɗaukar matakan riƙewa da jurewa tare.
Yana buƙatar ƙarin matakan da za a ɗauka don juyar da annobar ta duniya ta hanyar rage ƙimar haifuwa zuwa ƙasa da 1. Wani ɓangare na kula da annobar cuta mai yaduwa shine ƙoƙarin rage yaduwar cutar ta amfani da hanyar da aka sani da hanyar yaduwa.
Wannan zai ba da ƙarin lokaci don samar da alluran rigakafi da magani, don hana ayyukan kiwon lafiya su cika.
Hanyoyin kariya na waje da magunguna da za su iya sarrafa cutar sun haɗa da tsabtace hannu da rufe baki da hanci da keɓewa, rufe makarantu don nisantar da jama'a, soke taron jama'a, sa al'umma su shiga cikin al'umma don tabbatar da yarda da irin waɗannan ƙuntatawa, da kuma tsaftace wuri.
Wasu ƙasashe ma sun ɗauki matakai daban-daban don hana yaduwar cutar.
Koriya ta Kudu ta gabatar da gwaji da keɓewa, kuma ta ba da sanarwa yayin da masu kamuwa da cutar ke motsawa.
A wani bangare, Singapore ta sake hukunta wadanda suka yi hakan, a yayin da ta nuna goyon bayanta ga wadanda suka ware kansu na wani dan lokaci.
Taiwan ta kara samar da abin rufe fuska da kuma rarraba kayayyakin kiwon lafiya.Binciken Burtaniya da Amurka ya nuna cewa ragewa (rage yaduwar cutar amma ba dakatar da ita ba) da sarrafawa (juyawa ci gaban cutar) suna da manyan kalubale.
Amfani da manufofi masu kyau yana rage mutuwar da rabi yayin da rage cututtukan cututtukan cututtuka na farko da kashi biyu bisa uku. Amma dubban mutuwar da rashin tsarin kiwon lafiya ya nuna cewa akwai matsaloli da yawa.
Ana iya fifita amfani da hanawa yayin da cutar ke yaduwa a cikin mutane, amma ya kamata a jira (ko har sai an sami allurar rigakafi, idan hakan ta fara faruwa), lokacin da yanayin ya dace, yaduwar ta dawo da sauri.
Matsaloli na dogon lokaci don hana yaduwar cutar na haifar da rikicewar zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar da aka amince da ita don COVID-19, amma an ci gaba da ƙoƙarin haɓaka, gami da gwajin magunguna na yanzu.
shan magunguna da ruwa da hutawa za su iya rage alamun cutar.
Dangane da nauyin, ana iya buƙatar maganin oxygen, masu ba da jini da taimakon numfashi.
Yin amfani da magungunan hana ɗaukar ciki zai iya jawo sakamako mai tsanani.
Ana nazarin wurare da yawa da aka ba da izinin kula da cututtukan da ke haifar da kwayar cutar don kula da COVID-19.
"Kungiyar Lafiya ta Duniya ta ce wasu ""magungunan gargajiya da na gida"" na iya taimakawa a rage alamun cutar SARS-CoV-19".
WHO ta ce, haɓaka ƙarfin buƙatun marasa lafiya na COVID-19 da inganta kiwon lafiya sune matakan da aka ɗauka don hana yaduwar cutar.
ECDC da Hukumar Lafiya ta Duniya sun ba da umarni ga asibitoci da sabis na kiwon lafiya na farko, gami da mai da hankali kan ayyukan dakin gwaje-gwaje game da gwajin COVID-19, kawar da hanyoyin a duk lokacin da zai yiwu, ganowa da keɓe marasa lafiya masu cutar COVID-19 da haɓaka ƙarfin kula da marasa lafiya masu tsanani ta hanyar horar da ma'aikata da haɓaka adadin injunan numfashi da gadaje.
Akwai ra'ayoyi da yawa game da asalin abin da ya faru na farko (Mutalaki Zero).
An fara samun rahoton cutar coronavirus a Wuhan, Hubei, China a ranar 1 ga Disamba, 2019.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya ragu a hankali.
Yawancin waɗannan suna da alaƙa da kasuwar siyar da abincin teku ta Hawanyan, ban da waɗanda ke sayar da dabbobi masu rai, kuma wata ka'idar ita ce cutar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi, ko kuma a wasu kalmomin, asalin zoonotic. An gano asibitin cutar huhu da ba a sani ba a ranar 26 ga Disamba kuma an kula da Zhang Jixian, likita wanda ya sanar da CDC na Wuhan Jiangang a asibitin lardin Hebei a ranar 27 ga Disamba.
"A ranar 30 ga Disamba, wata kungiyar likitoci a babban asibitin Wuhan ta gargadi abokan aikinta game da barkewar cutar coronavirus mai kama da SARS".
Likitoci takwas daga cikin su, ciki har da Li Wenliang, 'yan sanda sun yi gargadin cewa suna yada jita-jita, yayin da wani likita mai suna Ai Fen ya yi horo daga shugabanta saboda yada jita-jita.
Hukumar Lafiya ta Birnin Wuhan ta fitar da sanarwa a ranar 31 ga Disamba kuma ta sanar da WHO.
An ba da rahoton isasshen magungunan cutar huhu da ba a sani ba ga hukumomin kiwon lafiya a Wuhan don a gwada su a farkon watan Janairu. A lokacin farkon fasalin yaduwar cutar, adadin masu cutar ya ninka sau biyu a kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, zama cibiyar sufuri da manyan musayar jiragen kasa a cikin ƙaura da kuma bayan Sabuwar Shekarar China, ya taimaka wa cutar ta yadu zuwa wasu lardunan China.
A ranar 20 ga watan Janairu, China ta ba da rahoton kusan sabbin mutane 140 a rana ɗaya, gami da mutane biyu a Beijing da mutum ɗaya a Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa mutane 6,174 sun kamu da cutar a cikin lokacin daga Janairu 20, 2020. A ranar 26 ga Maris, Amurka ta wuce China da Italiya a yawan adadin wadanda aka tabbatar da cutar. A ranar 9 ga Afrilu, 2020, an samu sama da mutane miliyan 1.61 a duniya, tare da mutuwar mutane sama da 97,000 da kuma warkarwa sama da 364,000.
Kimanin ƙasashe da yankuna 200 suna da aƙalla mutum ɗaya da ke da cutar.
Yawancin ƙasashe a yankin Schengen sun dakatar da motsi na kyauta kuma sun fara sarrafa kan iyakoki saboda barkewar cutar a Turai.
Matakan ƙasa sun haɗa da dokar hana fita (ba fita daga gida, zama a wuri ko rufewa) da kuma dokar hana fita.Ya zuwa ranar 2 ga Afrilu, kusan miliyan 300 ko kashi 90% na mazauna Amurka suna cikin dokar hana fita, kusan miliyan 50 a Philippines, miliyan 59 a Afirka ta Kudu, da kuma mutane biliyan 1.3 a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 na duniya suna cikin wani yanayi na rashin tsaro, daga biliyan biyu zuwa biliyan 2.6. Wannan ya ƙunshi kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An gano shari'ar farko ta COVID-19 a Wuhan a ranar 1 ga Disamba, 2019, yayin da wani rahoto da ba a tabbatar da shi ba ya nuna cewa an gano shari'ar ta farko a ranar 17 ga Nuwamba.
Dr. Zhang Jixian ta gano wani nau'in cutar sankarar bargo da ba a sani ba a ranar 26 ga Disamba, sannan ta sanar da CDC (Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka) a Wuhan a asibitin ta a ranar 27 ga Disamba, 2020.
A ranar 27 ga Disamba, 2019, gwajin kwayoyin halitta akan samfuran marasa lafiya ya nuna cewa akwai kwayar cutar coronavirus irin ta SARS.
An fitar da sanarwar ƙidaya a ranar 31 ga Disamba ta Hukumar Lafiya ta Birnin Wuhan.
An sanar da Hukumar Lafiya ta Duniya a ranar.
A lokacin da aka yi wannan sanarwar, likitocin ruwa sun sami gargadi daga 'yan sanda kan yada jita-jita.
Hukumar Lafiya ta Kasa ta kasar Sin ta ce babu wata hujja mai karfi game da yaduwar cutar daga mutum zuwa mutum.
A karshen watan Janairu, babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya bayyana gwamnatin kasar Sin a matsayin "yakin mutane" don dakile yaduwar cutar.
A cikin abin da aka bayyana a matsayin mafi girman keɓewa a tarihin ɗan adam, an dakatar da keɓewar tsabtace jiki, ko tafiya cikin Wuhan a ranar 23 ga Janairu, kuma an aiwatar da umarnin a cikin birane 15 a Hubei, wanda ya shafi kusan mutane miliyan 57.
An hana amfani da motocin mutane a cikin birni.
An soke bikin sabuwar shekara ta kasar Sin (Janairu 25) a wurare da dama.
Jami'ai sun kuma sanar da cewa za a gina asibiti na wucin gadi mai suna Hushenshan Hospital a cikin kwanaki 10.
An gina wani asibiti kuma mai suna Lechenchan Hospital don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, kasar Sin ta sauya wurare 14 na musamman kamar wuraren nishaɗi da filayen wasa a Wuhan zuwa asibitocin gida. Gwamnati ta ɗauki ƙarin matakan hana yaduwar COVID-19 a ranar 26 ga Janairu, gami da sabon sanarwa da sanarwar da ta shafi matafiya da tsawaita ranar bukukuwa na musamman.
Jami'o'i da makarantu a duk fadin jihar sun rufe.
An dauki matakai da yawa a yankunan Hong Kong da Macau, musamman game da makarantu da jami'o'i.
An dauki matakan aiki daga nesa a yankuna da dama na kasar Sin.
An hana tafiya a cikin da kuma wajen Hubei.
Gidajen tarihi sun rufe na ɗan lokaci yayin da na canza jigilar jama'a a duk faɗin ƙasar Sin.
"An sanya dokar hana fita ta gari a birane da dama, kuma kusan mutane miliyan 760 (kimanin rabin yawan jama'ar kasar Sin) suna fuskantar dokar hana fita daga gida. Tun bayan barkewar cutar a duniya a watan Maris, hukumomin kasar Sin sun dauki tsauraran matakai don hana kwayar cutar shiga China daga wasu kasashe".
Alal misali, Beijing ta sanya wa masu zuwa daga waje takunkumin shiga cikin kwanaki 14. A ranar 23 ga Maris, cutar ta kamu da cutar a China kwanaki biyar da suka gabata.
A ranar 24 ga watan Maris, Firayim Ministan kasar Sin Li Keqiang ya ba da rahoton cewa an dakatar da masu kamuwa da cutar a cikin gida kuma an sarrafa yaduwar cutar a kasar Sin.
A ranar, an sassauta takunkumin motsi a Hubei, watanni biyu bayan dokar hana fita daga Wuhan. Ma'aikatar Harkokin Wajen China ta sanar a ranar 26 ga Maris, 2020, cewa ba za a iya barin masu biza ko izinin zama a kasar ba daga ranar 28 ga Maris, amma ba a bayyana lokacin da za a soke wannan manufar ba.
Mutanen da ke son shiga China dole ne su nemi biza a ofisoshin jakadancin kasar Sin ko ofisoshin jakadancin.
Gwamnatin kasar Sin ta yi kokarin dawo da kamfanoni da masana'antu daban-daban da aka rufe saboda COVID-19 zuwa aiki tun daga ranar 21 ga Maris, 2012, kuma ta ba da tallafin kuɗi don ƙarfafa da kuma ƙarfafa waɗannan ƙungiyoyin. Duk da cewa yana da alaƙa da bikin Qingming na shekara-shekara, hukumomin kasar sun ayyana ranar 26 ga Maris, 2012 a karfe 4:00 na yamma a matsayin ranar makoki ta ƙasa, tare da yin addu'ar hankali na minti 3.
An bayar da rahoton yaduwar COVID-19 daga China zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020.
Hukumar lafiya ta kasar ta ba da rahoton karuwar lamuran da aka tabbatar a ranar 20 ga Fabrairu, musamman saboda taron da ake yi a wani sabon addini a Daegu da ake kira Shincheonji Church of Jesus.
Shincheonji ya ziyarci Wuhan don ya nuna shakku game da yiwuwar asalin yaduwar cutar.
A ranar 22 ga watan Fabrairun 2020, kusan kashi 13 cikin dari na mutane 9,336 da ke cikin cocin sun nuna alamun cutar, wanda ya kai 1,261. Koriya ta Kudu ta ba da sanarwar dokar ta baci a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, akwai sama da mutane 2,000 da suka kamu da cutar, wanda ya karu zuwa 3,150 a ranar 29 ga Janairu.
An sanya dukkan sansanonin sojin Koriya ta Kudu cikin keɓewa bayan da sojoji uku suka kamu da cutar.
Hakanan an yi tasiri ga jadawalin jirgin sama kuma saboda haka an canza shi.Koriya ta Kudu ta gabatar da shirin mafi girma da tsari a duniya don tantance jama'a daga cutar da gano duk wani mai cutar da kuma ganowa da keɓe waɗanda suka tuntube su.
Hanyoyin tantancewa sun haɗa da tilastawa kai tsaye don alamun bayyanar cututtuka a sabbin masu shigowa ta duniya ta hanyar aikace-aikacen hannu, gwajin kwayar cutar a cikin mota inda za a sanar da sakamakon a rana mai zuwa, da haɓaka ƙarfin gwaji zuwa 20,000 kowace rana.
Ko da yake shirin Koriya ta Kudu bai rufe birane gaba ɗaya ba, an nuna yana da tasiri wajen shawo kan annobar. A farkon lokacin, an hana al'ummomin Koriya ta Kudu yin aiki sosai saboda matakin da Shugaba Moon Jae-in ya ɗauka don magance rikicin.
Yawancin 'yan Koriya suna aiki a kan tattara sa hannu don neman a tuhumi Shugaba Moon ko kuma su yaba masa saboda yadda gwamnatin ta bi da annobar.
A ranar 23 ga Maris, Koriya ta Arewa ta ba da rahoton ƙaramin adadin masu cutar a rana ɗaya cikin makonni huɗu.
Daga ranar 29 ga Maris, zuwa farkon 1 ga Afrilu, duk sabbin masu shigowa da kaya daga ƙasashen waje za su kasance cikin keɓewa na makonni biyu.
Rahotanni sun nuna cewa a ranar 1 ga Afrilu, Koriya ta Kudu ta nemi taimako daga kasashe 121 daban-daban don gwajin cutar.
Iran ta ba da rahoton cutar SARS-CoV-2 ta farko a cikin Kwau a ranar 19 ga Fabrairu, kuma mutane biyu sun mutu a wannan ranar, a cewar ma'aikatar lafiya da ilimi.
Matakan da gwamnati ta dauka sun hada da rufe kide kide da sauran taron al'adu, wasannin motsa jiki, sallar Juma'a, jami'o'i, makarantun firamare da sakandare.
Iran ta ware tiriliyan biyar na riyal don yaki da cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairu, 2020 cewa babu wani shiri na rufe wuraren da cutar ta bulla, amma kawai a kebe mutane.
Ko da yake ana ci gaba da samun cunkoson ababen hawa tsakanin biranen da ke gaban Sabuwar Shekarar Farisa, an sanar da shirin rufe hanyoyin da ke tsakiyar biranen a watan Maris.
Wuraren ibada na Shi'a a Qom sun kasance a bude ga mahajjata har zuwa 16 ga Maris, 2020. Bayan China, Iran ta zama cibiyar yaduwar cutar a watan Fabrairu.
A ranar 28 ga watan Fabrairu, kasashe sama da goma za su yi tafiya zuwa Iran, suna mai da hankali kan zargin da ake yi na rufe cutar a Iran, wanda hakan zai iya haifar da yaduwar cutar fiye da 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An rufe majalisar dokokin Iran a ranar 3 ga Maris bayan da aka gwada 23 daga cikin mambobi 290 da suka kamu da cutar.
A ranar 12 ga watan Maris, masu sa ido kan kare hakkin dan adam sun bukaci hukumomin kurkuku na Iran da su saki wadanda aka tsare a kurkuku ba tare da wani sharadi ba saboda nuna adawa da 'yancin dan adam, da kuma sakin duk wadanda suka cancanci zaman lafiya.
An ce ana iya samun yaduwar cutar a wuraren da aka rufe kamar gidajen yari, inda ba a samun isasshen magani.
A ranar 15 ga Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana ɗaya, mafi yawan adadin da aka rubuta a ƙasar tun lokacin da annobar ta fara.
Akalla 'yan siyasa 12 na yanzu ko na baya da jami'an gwamnati na Iran sun mutu a ranar 17 ga Maris da cutar.
A ranar 23 ga Maris, Iran ta kamu da sabon kamuwa da cutar coronavirus sau 50 a cikin awa daya, kuma mutum daya ya mutu a kowane minti goma.
A cewar Hukumar Lafiya ta Duniya, adadin masu cutar a Iran ya ninka na wadanda aka samu a kasar sau biyar.
Amurka ta ce takunkumin da ta kakaba wa Iran na iya lalata karfin tattalin arzikin kasar na magance annobar.
Babban Kwamishinan Majalisar Dinkin Duniya na 'Yancin Dan Adam ya bukaci a soke takunkumin tattalin arziki da aka sanya wa kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da yaduwar cutar a Italiya a ranar 31 ga Janairu, lokacin da wasu 'yan yawon bude ido biyu' yan China suka gwada ingancin SARS-CoV-2 a Rome.
Gwamnatin Italiya ta sanar da dokar ta baci ta dakatar da zirga-zirgar jiragen sama daga China zuwa Italiya da Italiya zuwa China saboda karuwar cutar a cikin ɗan gajeren lokaci.
An sake samun wasu nau'ikan marasa alaƙa na COVID-19 tun daga tabbatar da shari'o'i 16 a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabon umarnin doka don sarrafa yaduwar cutar, gami da keɓe mutane sama da 50,000 a cikin birane daban-daban 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce babu shiga da fita daga yankunan da cutar ta shafa.
An riga an ba da umarnin dakatar da ayyukan kasuwanci da kuma abubuwan wasanni a waɗannan yankuna. A ranar 4 ga Maris, lokacin da mutuwar 100 ta kai Italiya, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i gaba ɗaya a duk ƙasar.
Duk manyan abubuwan wasanni, gami da wasannin kwallon kafa na Serie A, an tsara su a rufe har zuwa Afrilu, amma a ranar 9 ga Maris, an dakatar da dukkan wasanni gaba ɗaya na aƙalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da duk ayyukan kasuwanci a kusa da wurin ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Italiya na Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) ta buga shawarwari kan ɗabi'ar likita game da hanyoyin kula da gaggawa da za a iya amfani da su.
A ranar 19 ga Maris, Italiya ta zarce China da mutuwar mutane 3,405 sakamakon annobar da ke da nasaba da cutar coronavirus.
A ranar 22 ga Maris, an ba da rahoton cewa Rasha ta aika da jiragen sama na soja tara da ke dauke da kayan aikin likita zuwa Italiya.
Ya zuwa ranar 5 ga Afrilu, akwai mutane 128,948 da aka tabbatar da cutar a Italiya, mutuwar 15,887 da kuma warkewar 21,815, mafi yawan waɗannan sun faru ne a yankin Lombardy.
Babban ɓangaren tsofaffin mutanen Italiya da rashin iya gwada duk waɗanda ke da cutar sun haifar da yawan mutuwar, in ji rahoton CNN.
Amsar Burtaniya ga cutar ta kasance ɗaya daga cikin mafi sassaucin ra'ayi a cikin ƙasashe da suka fi fama da cutar, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta ɗauki kowane matakin nisantar jama'a ko keɓewa ga 'yan ƙasa ba.
A sakamakon haka, gwamnati ta fuskanci suka kan rashin kulawa da kulawa da kuma yin la'akari da barazanar da jama'a suka gabatar. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke ba da shawarar cewa kowa ya guji tafiye-tafiye da hulɗar zamantakewa da ba dole ba, mutane su yi aiki daga gida idan za su iya, kuma su guji wuraren da za su iya zuwa kamar mashaya, gidajen abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, ya ba da umarnin rufe duk wuraren nishaɗi kamar mashaya da wuraren motsa jiki da wuri-wuri, kuma ya ba da sanarwar cewa zai biya har zuwa kashi 80% na albashi ga albashi har zuwa £ 2,500 a wata. A ranar 23 ga Maris, Firayim Minista ya ba da sanarwar tsauraran matakan nisantar jama'a, ya hana mutane fiye da biyu su kasance tare da ƙuntata tafiye-tafiye da ƙuntata ayyukan waje, yana ba da izini kawai ga ayyukan da suka dace.
Ba kamar yadda aka saba ba, 'yan sanda za su tilasta wa' yan sanda su tarwatsa taron tare da tara kuɗi.
"An umarci rufe yawancin kasuwancin, gami da manyan kantuna, kantunan magani, bankuna, shagunan kayan aiki, shagunan sayar da kaya da gareji, sai dai waɗanda aka amince da su a matsayin ""masu amfani""".
An gano shari'ar farko ta COVID-19 a arewa maso yammacin Washington a cikin Pacific a kan mutumin da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rukunin aikin kwantar da hankali na White House Coronavirus a ranar 29 ga Janairu.
A ranar 31 ga Janairu, ya ayyana dokar ta baci ta kiwon lafiya, ya sanya takunkumi kan matafiya daga China.
A ranar 28 ga Janairun 2020, Cibiyar Kula da Cututtuka ta Gwamnatin Amurka ta sanar da cewa ta samar da nata kayan gwajin.
Duk da haka, Amurka ta yi jinkirin farawa a cikin bincike, wanda ya hana fahimtar ainihin adadin yaduwar a kan kari.
A watan Janairu, an dakatar da aikin gwaji saboda gwamnatin tarayya ba ta samar da kayan gwaji masu inganci ba. Gwamnatin tarayya ta iyakance ta amince da kayan gwaji a hannun kungiyoyi masu zaman kansu (makarantu, kamfanoni da asibitoci) har zuwa ƙarshen Janairu, da kuma yanayin da zai hana mutane yin gwaji har zuwa farkon Maris (bayan haka ana buƙatar takardar likita).
A cewar The Washington Post a ranar 27 ga Fabrairu, an yi gwajin ƙasa da 4,000 a Amurka.
Atlantic ta ba da rahoton cewa an gudanar da gwaje-gwaje ƙasa da 14,000 har zuwa 13 ga Maris.
"A ranar 22 ga Maris, Associated Press ta ba da rahoton cewa, ""Mutane da yawa da ke da alamun cutar da umarnin likita sun jira na sa'o'i ko kwanaki don yin gwaji"." Bayan mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, wasu jihohi kuma ba da daɗewa ba suka bi sahu".
An dakatar da makarantu a yankin Seattle a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar suna rufe. A ranar 6 ga Maris, 2020, Jami'ar Imperial College London ta Amurka ta ba da shawara ga rukunin masana ilimin cututtukan cututtuka game da tsinkayen rikicin da sabon coronavirus zai haifar a ƙasar.
A wannan ranar, Shugaba Trump ya sanya hannu kan Dokar Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen Shirye-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-shiryen-
Kamfanoni sun sanya dokar hana zirga-zirga, soke tarurruka, da kuma karfafa ma'aikata su yi aiki daga gida.
An soke abubuwan wasanni da shirye-shirye. A ranar 11 ga Maris, Trump ya sanar da dakatar da yawancin jiragen sama daga Turai sai dai Burtaniya, wanda zai fara aiki na kwanaki 30 daga ranar 13 ga Maris.
A rana mai zuwa, an ƙara Isra'ila da Burtaniya zuwa wannan haramcin.
A ranar 13 ga Maris, an ayyana dokar ta baci ta kasa, wanda ya haifar da sakin kudaden tarayya don magance rikicin.
A farkon ranar 15 ga Maris, an rufe ko rage sa'o'in aiki a yawancin kasuwancin da ke Amurka don rage yaduwar cutar.
An samu bullar cutar a duk jihohi 50 da Columbia a ranar 17 ga Maris. A ranar 23 ga Maris, an tabbatar da cutar coronavirus 10,700 a Newark City, fiye da adadin masu cutar da aka samu a Koriya ta Kudu.
A ranar 25 ga Maris, gwamna ya bayyana cewa yana aiki da nisantar jama'a, yana mai cewa an rage kimantawar ci gaban daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga Maris, mutane 672 sun mutu sakamakon cutar, yayin da aka tabbatar da mutane 32,308 a Birnin New York kadai. A ranar 26 ga Maris, Amurka da China da Italiya ne kawai suka fi kowace ƙasa a duniya.
A cewar rahotannin kafofin watsa labarai a ranar 30 ga Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita umarnin nisantar jama'a har zuwa 30 ga Afrilu.
A ranar, jirgin ruwan asibiti mai ɗaukar gadaje 1,000 USNS Comfort ya isa New York.
A ranar 3 ga Afrilu, Amurka ta yi rahoton mutuwar mutum 884 a cikin awanni 24 sakamakon cutar coronavirus.
A ranar 3 ga Afrilu, cutar ta kashe mutane sama da 100,000 a jihar New York. An soki Fadar White House saboda rage girman barazanar da kuma jagorantar jami'an kiwon lafiya da masana kimiyya don daidaita maganganun jama'a da kuma sarrafa sakonnin da ke da alaƙa da cutar a ƙarƙashin ofishin Mataimakin Shugaban Mike Pence.
Amincewar gwamnatin Trump da ta shawo kan rikicin ya haifar da rarrabuwa tsakanin magoya bayan jam'iyyar.
Wasu jami'an Amurka da masu sharhi sun soki Amurka saboda dogaro da shigo da kayan aiki masu mahimmanci daga China, gami da kayayyakin kiwon lafiya masu mahimmanci.
An yi amfani da nazarin hanyoyin zirga-zirgar jiragen sama don tsara taswira da hasashen hanyoyin rarrabawa kuma an buga shi a cikin mujallar Travel & Medicine a tsakiyar Janairu 2020.
Bangkok, Hong Kong, Tokyo, da Taipei sun dauki nauyin mafi yawan fasinjoji daga Wuhan bisa ga bayanan kungiyar sufurin jiragen sama ta duniya na 2018.
Dubai, Sydney da Melbourne manyan wurare ne da mutane ke zuwa daga Wuhan.
Bali ita ce mafi ƙarancin biranen da aka ba da rahoto a cikin biranen 20 da aka fi so a cikin shirye-shirye, kuma an yi niyyar zama biranen Ostiraliya.
Ana sa ran samun ƙarin bayanai game da COVID-19 a nan gaba, kuma Ostiraliya za ta mai da hankali kan iyakoki da kula da hulɗa don amsa cutar.
An ba da sanarwar tsaro na gaggawa na mutum a cikin Ostiraliya a ranar 21 ga Maris.
Don inganta keɓewar sufuri na jama'a a Wuhan da Hubei, ƙasashe da yawa suna shirin fitar da 'yan ƙasa da ma'aikatan diflomasiyyarsu daga yankin tare da izinin hukumomin China, musamman ta hanyar jiragen da aka keɓe don wannan dalili.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Ostiraliya, Faransa, Argentina, Jamus, da Thailand sune manyan ƙasashe da ke shirin ba da izinin tafiya ga 'yan ƙasa kawai.
"Ba za a kori 'yan kasar Pakistan daga kasar Sin ba idan ba haka ba".
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu tare da' yan Poland huɗu, Ba'amurke ɗaya da Indiya.
'Yan ƙasar Poland, China da Indiya sun sauka a Poland kafin jirgin Brazil ya tashi zuwa Brazil.
An ware 'yan Brazil da suka je birnin Juan daga sansanin soja da ke kusa da birnin Jubrão-Lea.
A wannan ranar, an cire mutane 215 na Kanada (176 daga jirgin, da 39 daga jirgin sama na biyu da gwamnatin Amurka ta yi hayar) daga ruwa zuwa CFB Trenton kuma an kebe su na makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama dauke da 'yan Kanada 185 ya sauka a CFB Trenton.
A ranar 3 da 4 ga watan Fabrairu, hukumomin Australia sun kai 'yan kasar 277 cibiyar tsare mutane a tsibirin Kirsimeti, inda suka zauna har tsawon kwanaki 14.
Jirgin saukar da New Zealand ya isa Auckland a ranar 5 ga Fabrairu, kuma an kebe fasinjojinsa (gami da wasu 'yan Australia da Pacific) a sansanin sojan ruwa na Wuhan Gaparoa, a arewacin Auckland.
A ranar 15 ga Janairu, Amurka ta sanar da cewa za ta kwashe 'yan kasarta daga jirgin ruwan Diamond Princess.
Jirgin saman Canada mai fasinjoji 129 da suka sauka daga Diamond Princess a ranar 21 ga Fabrairu ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar daga Iran. A ranar 14 ga Maris, jirgin saman jirgin saman Afirka ta Kudu ya dawo da' yan Afirka ta Kudu 112.
An yi gwajin likita kafin a fitar da su, kuma an dakatar da 'yan Afirka ta Kudu da ke nuna alamun cutar coronavirus.
Sai kawai 'yan Afirka ta Kudu da sakamakon gwajin su bai yi kyau ba ne aka dawo da su.
Sakamakon gwajin ya nuna cewa duk 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, ma'aikatan otal,' yan sanda da sojoji waɗanda ke cikin aikin agaji da ke cikin kulawa da ke cikin kwanaki 14 na kulawa da keɓewa a Ranch Resort don kiyayewa, suna da lafiya.
A ranar 20 ga Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar ta duniya.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta sanar da cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban kasar Sin da ke karatu a jami'o'in Amurka sun hada kai tare da wasu kayan aiki don taimakawa yankunan da cutar ta shafa a kasar Sin, kuma an bayar da rahoton cewa sun aika da abin rufe fuska da hanci 50,000 na N95 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu. An aika da kayan rufe fuska da hanci 200,000 tare da FedEx, tare da wasu kayan aikin rigakafin cutar kamar safofin hannu da gashin gashi zuwa asibitin Wuhan Union a cikin jirgin sama na gaggawa. `
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da cewa za su ba da tallafin dala miliyan 100 ga WHO don tallafawa ci gaban bincike da magani na allurar rigakafi a Afirka da Kudancin Asiya.
A cewar Interaction, Richard Gordon ya aika da abin rufe baki da hanci na 3.16 daga Wuhan zuwa Walla a ranar 6 ga Fabrairu, China ta aika da abin rufe baki da hanci 200,000 zuwa Philippines.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura tallafin dala miliyan 2.26 zuwa China.
Japan ta ba da gudummawar abin rufe fuska da abin rufe fuska miliyan biyu ga Wuhan; Turkiyya ta ba da gudummawar kayan aikin likita; Rasha ta ba da gudummawar tan 13 na kayayyakin kiwon lafiya na musamman ga Wuhan; Malaysia ta ba da gudummawar safar hannu miliyan 18 ga Wuhan da China; Jamus ta ba da gudummawar kayan aikin likita na musamman da takalma 10,000; Amurka ta ba da gudummawar tan 17.8 na kayan aikin likita ga China, ta yi alkawarin ba da dala miliyan 100 ga kasar da cutar ta shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayayyakin kiwon lafiya da kwararru don taimakawa Italiya da cutar coronavirus ta shafa.
Wani dan kasuwa mai suna Jack Ma ya tura kayan gwaji miliyan 1.1, abin rufe fuska miliyan 6, da kayan kariya 60,000 zuwa Addis Ababa, Habasha don Tarayyar Afirka ta rarraba.
Daga baya, ya aika da kayan gwaji 5,000, abin rufe fuska 100,000 da iska 5 zuwa Panama.
Ma ya kuma ba da gudummawar kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun nuna damuwarsu game da abin rufe fuska da kayan gwaji da aka yi a China.
Alal misali, Spain ta fitar da kayan gwaji na coronavirus 58,000 da aka yi a China saboda sun kasance 30% daidai. Hakazalika, Netherlands ta dakatar da amfani da abin rufe baki 600,000 na kasar Sin.
Belgium ta mayar da abin rufe fuska 100,000 da ba za a iya amfani da su ba, wanda a farko an yi imanin cewa an sayo su ne daga China, amma a zahiri sun fito ne daga Colombia.
A wani bangare kuma, an samu karbuwa sosai daga kasashen Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya fara bayar da tallafin gaggawa ga kasashe masu tasowa.
WHO ta yaba wa hukumomin kasar Sin kan matakan da suka dauka na dakile cutar.
"WHO ta lura da kwatancen da aka yi tsakanin barkewar cutar SARS a 2004-04, da jami'an kasar Sin suka yi ta boyewa, wanda ya kawo cikas ga kokarin hanawa da sarrafawa, kuma rikicin na yanzu na gwamnatin tsakiya ne ""Ya ba da bayanan lokaci na yau da kullun don kawar da firgici kafin bikin sabuwar shekara ta wata"".
A ranar 23 ga Janairu, wakilin Majalisar Dinkin Duniya, Godin Gale, ya amsa shawarar da hukumomin tsakiya suka yanke na hana zirga-zirga a Wuhan, ya ce "ko da yake ba shawarar WHO ba ce", amma kuma "ƙudurin da aka ɗauka na kama cutar a inda ta fi yaduwa kuma ba a taɓa gani ba a tarihin lafiyar jama'a". A ranar 30 ga Janairu, Hukumar Lafiya ta Duniya ta sanar da cewa an sami gaggawa ta gaggawa ta duniya (PHEIC) bayan tabbatar da yaduwar mutum zuwa mutum a wajen China da kuma karuwar yawan jama'a a wasu ƙasashe, matakin na shida na PHEIC tun bayan barkewar cutar ta mura ta Swain a shekarar 2009.
"Darakta Janar na Hukumar Lafiya ta Duniya, Tedros Adhanom PHEIC ya ce "yana da matukar damuwa game da yaduwar duniya, musamman a cikin ƙasashe masu karamin kuɗi da matsakaitan kuɗi waɗanda ba su da ingantaccen tsarin kiwon lafiya".
"Game da martani ga aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa ""babu wani dalili da zai sa a tsoma baki ba tare da son rai ba a tafiye-tafiye da kasuwanci na duniya"" da kuma ""Kungiyar Lafiya ta Duniya ba ta ba da shawarar hana kasuwanci da motsi ba""".
A ranar 5 ga watan Fabrairu, WHO ta nemi tallafin dala miliyan 675 daga kasashen duniya don sake nazarin shirye-shiryen ƙasashe masu karamin kuɗi.
Mr. Tedros ya kuma ce "Mu kamar yadda muke da rauni, haka muke da ƙarfi", kuma ya yi kira ga al'ummomin duniya su saka hannun jari a yau ko kuma su biya ƙarin daga baya.A cikin sanarwar manema labarai a ranar 11 ga Fabrairu, Hukumar Lafiya ta Duniya ta kira cutar COVID-19.
A ranar, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince da cewa dukkan rundunar Majalisar Dinkin Duniya za ta mayar da martani.
Ƙungiyar Kula da Bala'i ta Majalisar Dinkin Duniya ta kafa don ba da damar Majalisar Dinkin Duniya ta daidaita aikin ta kuma mayar da hankali kan amsar kiwon lafiya, yayin da sauran hukumomin za su iya amfani da iliminsu don yin amfani da tasirin cutar da ci gabanta a kan yanayin zamantakewa, tattalin arziki.
A ranar 14 ga Fabrairu, an gudanar da wani aiki tare da kungiyar lafiya ta duniya tare da kasar Sin don taimakawa masana na cikin gida da na duniya a kasar Sin don taimakawa wajen gudanar da gudanar da gudanar da bita da bita ta hanyar gudanar da bita da taro. A ranar 25 ga Fabrairu, WHO ta ce duniya ta kamata ta yi karin aiki don shirya yadda za ta iya don gudanar da ziyarar filin don tantance tasirin ayyukan mayar da martani a bangarorin larduna da kananan hukumomi, gami da manyan cibiyoyin kasa da birane da yankunan karkara.
"Domin amsawa ga barkewar cutar a Iran, WHO ta tura wani rukunin hadin gwiwa don tantance matsalar. A ranar 28 ga Fabrairu, jami'an WHO sun ce kimantawar barazanar cutar coronavirus a duniya za ta tashi daga ""mai girma"" zuwa ""mai matukar girma"" matakin babban faɗakarwa da haɗari".
Mike Ryan, babban daraktan shirin gaggawa na Hukumar Lafiya ta Duniya, ya ce: "Wannan gwaji ne na gaske ga kowace gwamnati a duniya".
Wannan kwayar cutar na iya zuwa kuma kuna buƙatar kasancewa a shirye,  ɗaukar matakan kariya masu dacewa zai ba duniya damar jure mafi munin .
"Ryan ya kara da cewa, bayanan yanzu ba su tabbatar da cewa hukumomin kiwon lafiyar al'umma sun amince da cewa irin wannan sanarwar ""dukkanin mutane a duniya suna da hadarin kamuwa da cutar"" ba, don haka ba za su iya bayyana cutar a duniya ba".
A ranar 11 ga Maris, WHO ta ayyana cutar coronavirus a matsayin annoba ta duniya.
Darakta Janar ya ce Hukumar Lafiya ta Duniya "ta damu matuka da yadda ake yada cutar da kuma yadda ake rashin daukar mataki". Hukumar ta WHO ta fuskanci suka saboda rashin kula da cutar sosai, gami da jinkirin ayyana cutar a matsayin annoba ta duniya da kuma jinkirin ayyana dokar ta baci ta jama'a.
An samu sa hannu kan murabus din shugaban Hukumar Lafiya ta Duniya, Theodoros Adhanom, wanda ya kai mutane 733,000 a ranar 6 ga watan Afrilu.
26 ga Maris, 2020 Yawancin masana kare hakkin bil'adama na Majalisar Dinkin Duniya sun mai da hankali kan hana keta haƙƙin kowa a cikin wannan annobar COVID-19.
Masana sun ce kowa yana da hakkin ya hada kai don ceton rayuka kuma gwamnati tana da alhakin jagorantar hakan.
Kungiyar ta ce bai kamata a yi amfani da rashin kudi ko kiwon lafiya don kai hari kan wasu kungiyoyi ba.
Masana sun jaddada cewa kowa yana da hakkin samun lafiya, gami da nakasassu, 'yan tsiraru, tsofaffi, mutanen da aka kora daga gidajensu, marasa gida, waɗanda ke cikin matsanancin talauci, waɗanda ke kurkuku, da kuma 'yan gudun hijira da sauran ƙungiyoyin da ba a bayyana su ba waɗanda ke buƙatar tallafin gwamnati.
Cibiyoyin sadarwa na kasa da kasa suna aiki tare don magance matsalolin tattalin arziki da zamantakewar da COVID-19 ya haifar.
Kungiyar hadin gwiwa da ci gaban tattalin arziki ta samar da wani dandamali wanda ke ba da cikakkun bayanai da cikakkun bayanai kan manufofin da ke cikin lokaci da kuma bayar da shawarwari da shawarwari ga kasashe a duk duniya.
Karfafa tsarin kiwon lafiya da tattalin arzikin duniya ta hanyar manufofi don magance tasirin kullewa da ƙuntatawa na balaguro, haɓaka cibiyar dijital, gami da bin diddigin manufofin ƙasa, da kuma ba da damar ƙasashe su koya daga juna don amsa ayyukan coronavirus da kuma sauƙaƙe daidaitaccen martani na duniya.
Michelle Gove, daga Amurka, daga Burtaniya, daga Benin, da Eduardo Borsono, dan Shugaba Jar Borsono na Brazil, sun soki gwamnatin China saboda sun yi zargin cewa cutar ta samo asali ne daga lardin Hubei na kasar Sin kuma China ce ta kamu da cutar.
An kori wasu shugabannin jam'iyyar CPC a tsakiyar China saboda sun yi watsi da kokarin killacewa a tsakiyar kasar, a matsayin wata alama ta cewa yadda jam'iyyar siyasa ta amsa barkewar cutar a yankunan ya haifar da korafi.
Wasu masu sharhi sun yi imanin cewa an dauki wannan matakin ne don hana fushin jama'a kan babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping game da yaduwar cutar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun musanta cewa cutar ta farko ta coronavirus ta fara ne daga ruwa, suna mai da hankali kan cewa COVID-19 na iya samo asali ne daga Amurka ko Italiya.
"Gwamnatin Donald Trump ta Amurka ta kira coronavirus da ""Covid-19 na China"" ko ""Covid-19 na Wuhan"" saboda China ta "daukaka shi zuwa cutar da ba ta iya ganowa ba a duniya", a sakamakon haka wasu masu sukar sun zarge shi da wariyar launin fata da kuma ""rashin ikon gudanar da shi na sarrafa cutar"".
The Daily Beast ya ce, a Amurka, tushen sadarwa na zamani da ke tattare da abubuwa marasa rai shine kawai game da kasar Sin a matsayin hanyar sadarwa a Majalisar Tsaro ta Kasa.
An umurce mu da mu watsa wannan sakon ta kowace hanya da za mu iya, ciki har da taron manema labarai da shirye-shiryen talabijin. Kasashen waje kamar Politica, Foreign Policy da Bloomberg sun ce kokarin da China ke yi na tura tallafi ga kasashen da ke fama da cutar wani bangare ne na tasirin farfagandar duniya.
Shugaban hukumar kula da harkokin wajen Tarayyar Turai, Joseph Borelli, ya yi gargadin cewa akwai yiwuwar tasirin siyasa ta duniya ta hanyar siyasa ta alheri da ta alheri.
"Borrell ya ce, "China tana ba da sakon cewa ita abokiyar aminci ce kuma mai dogaro da Amurka".
China ta yi ta ba da taimako ga Venezuela da Iran sau da yawa, tana kira ga Amurka da ta sassauta takunkumin da ta kakaba wa Syria, Venezuela, da Iran.
An dakatar da takunkumin Amurka a ranar 3 ga Afrilu kan masks 100,000 da Jack Ma ya ba Cuba.
An zargi jami'an Amurka da amfani da kudaden agaji da aka shirya ba wasu kasashe don kansu.
An samu sabani tsakanin Jamus, Austria, Switzerland, Czech Republic da Italiya game da rufe fuska da baki.
Turkiyya ta kuma kama daruruwan kayan aikin numfashi da ake kaiwa Spain.
A farkon watan Maris, Tarayyar Turai ta soki gwamnatin Italiya saboda rashin hadin kai da Italiya, wadda cutar coronavirus ta shafa.
"Shugaban Italiya a Tarayyar Turai, Maurizio Massari, ya ce, "China ita kadai ce ta amsa da baki biyu".
Wannan ba misali ba ne mai kyau ga haɗin kan Turai.
A ranar 22 ga Maris, shugaban Rasha Vladimir Putin ya yi magana da Firayim Ministan Italiya Giuseppe Conte ta waya, bayan ya shirya don likitocin tsaro, kayan aikin likita, da motocin da ke yin feshi su isa Italiya.
A cewar wani babban ɗan siyasa da ya ƙi a bayyana sunansa, jaridar La Stampa ta Italiya ta ba da rahoton cewa kashi 80 cikin ɗari na taimakon da Italiya ta bayar ba shi da amfani ko kuma ba shi da amfani.
"Wani majiya ya soki Rasha a matsayin mai kawo rigima a kan ""geopolitics da diplomasiyya""".
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun nuna godiya ga tace rahotannin kafofin yada labarai.
Rasha ta aika da jirgin sama mai jigilar kayayyaki zuwa Amurka.
"Mai magana da yawun Kremlin Dmitry Peskov ya ce, "A cikin goyon bayan abokan aikin Amurka, [Putin] ya yi tsammanin cewa masana'antun kayan aikin likitancin Amurka da kayan aiki za su iya dawowa idan ya cancanta".
A cikin shekarar 2020, an shirya atisayen soji na NATO Defender 2020 a Jamus, Poland da Baltic, babban aikin NATO tun ƙarshen Yakin Cacar Baki.
"Sakatare Janar na Kungiyar Kare Makaman Nukiliya Kate Hudson ya soki ayyukan Defender 2020". "A cikin rikicin lafiyar jama'a na yanzu, ba wai kawai rayuwar sojojin Amurka da yawancin kasashen Turai da ke cikin lamarin ke cikin hatsari ba, har ma da rayuwar mazauna kasashen da suke aiki". "Gwamnatin Iran ta kamu da cutar sosai, tare da kusan 'yan majalisa goma sha biyu da suka kamu da cutar da kuma' yan siyasa goma sha biyar na yanzu ko na baya".
A ranar 14 ga Maris, 2020, Shugaban Iran Hassan Rouhani ya rubuta wasiƙar da aka aika wa gwamnatocin duniya, yana mai cewa takunkumin tattalin arziki da Amurka ta sanya a kan kasarsa babban cikas ne ga ƙoƙarin hana cutar. Cutar ta haifar da saurin aiwatar da manufofin zamantakewar Amurka tare da sauran ƙasashe masu tasowa (kiwon lafiya na duniya, kula da yara na duniya, babban kasafin kuɗi don kayan aikin kiwon lafiya, da sauransu).
Masu binciken siyasa sun yi hasashen cewa hakan na iya shafar damar da Donald Trump ke da ita na sake zaɓar shugaban kasa a zaben 2020.
"Koriya ta Kudu ta zargi Japan da rashin fahimta da kuma rashin ƙarfi bayan da ta sanar da cewa, "Duk wanda ya zo daga Koriya ta Kudu zai kasance a cikin wani wurin da gwamnati ta tsara na tsawon makonni biyu".
A farkon lokacin da Shugaba Moon Jae-in ya dauki matakin magance rikicin, an takaita ayyukan al'ummomin Koriya ta Kudu sosai.
Yawancin 'yan Koriya suna sanya hannu kan takarda kai don hukunta wata a sama saboda cutar ta ci gaba da yaduwa, ko kuma suna yaba da martani.
Wasu manazarta sun nuna damuwa cewa zai iya taimaka wa gwamnatoci su karfafa ikonsu.
A Hungary, majalisar dokokin ta ba Firayim Minista Viktor Orbán damar yin aiki har abada bisa ga dokar, dakatar da majalisa lokaci-lokaci, da kuma dakatar da zaɓe, da kuma ɗaukar mataki kan waɗanda ke yada labaran karya game da kwayar cutar da abin da gwamnati ke yi don magance rikicin.
An zargi annobar coronavirus da karancin kayayyaki da yawa, karuwar amfani da duniya don magance cutar, sayayyar firgita, da dakatar da aiki a masana'antu da kayan aiki.
Hukumar Abinci da Magunguna ta Amurka ta yi gargadin cewa ana iya samun karancin magunguna da na'urorin kiwon lafiya saboda karuwar bukatar masu amfani da kuma katsewar masu samar da kayayyaki.
Yawancin mazauna yankin sun lura da karancin kayayyaki, tare da ɗakunan ajiya da ke ɗauke da abinci, takarda na bayan gida / kayan kwalliya, da ruwan kwalba da aka yi amfani da su.
Masana'antar fasaha ta yi gargadin cewa za a iya jinkirta jigilar kayayyaki, musamman na lantarki.
A cewar Darakta Janar na WHO, Tedros Adhanom, bukatar kayan kariya na mutum ya karu sau 100.
Wannan buƙatar ta haifar da hauhawar farashin sau ashirin fiye da yadda aka saba kuma ta haifar da jinkirin samar da kayayyakin kiwon lafiya na watanni huɗu zuwa shida.
Hukumar Lafiya ta Duniya ta yi gargadin cewa, rashin kayan kariya na mutum a duniya ya haifar da rashin lafiya, wanda zai iya jefa ma'aikatan lafiya cikin hadari.
A Ostiraliya, annobar ta duniya ta ba da sabuwar dama ga masu sayen kayayyakin Australiya don siyar da kayayyakin China.
Wannan aikin ya haifar da karancin abinci na yara a cikin manyan kantuna, kuma daga baya gwamnatin Ostiraliya ta soke shi. Duk da cewa yaduwar COVID-19 ya fi yawa a arewacin Italiya da Wuhan, duk yankuna biyu sun tsira daga karancin abinci saboda cutar filagotu.
Matakan da China da Italiya suka dauka don hana adana kayayyaki masu mahimmanci da kuma haramtacciyar kasuwanci sun yi tasiri, wanda ya taimaka wajen magance matsalar karancin abinci a Turai da Arewacin Amurka.
Arewacin Italiya ba ta da babbar ragi saboda yawan amfanin gona, amma wakilan masana'antu sun ce farashin na iya ƙaruwa.
Ana iya samun abinci a kan kantuna na ɗan lokaci, wanda ke haifar da a cikin birnin Wuhan kanta, jami'an gwamnatin China sun saki kayan naman alade don tabbatar da cewa akwai isasshen abinci ga jama'a.
A Italiya, akwai irin wannan dokar da ke buƙatar masana'antun abinci su ajiye ajiyar kuɗi don irin wannan haɗarin.
An kuma ga tasirin tattalin arzikin duniya a China: A cewar rahotannin kafofin watsa labarai na 16 ga Maris, tattalin arzikin China ya yi rauni sosai kuma tallace-tallace na siyarwa ya ragu da kashi 20.5% a farkon watanni biyu na 2020, sakamakon matakan da gwamnati ta dauka don rage yaduwar cutar.
Kasar Sin ta zama cibiyar tattalin arziki da masana'antu, kuma cutar ta tashi daga can.
Agathe Demarais na Sashin Kula da Tattalin Arziki ya ce, kasuwanni za su ci gaba da yin canji har sai an samu karin bayani.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa koma bayan tattalin arziki da cutar ta haifar a duniya zai iya zama mafi muni fiye da barkewar cutar SARS ta 2002-2004.
Masana a Jami'ar St. Louis Washington sun kiyasta cewa sarkar samar da kayayyaki ta duniya za ta iya zama da nauyin dala biliyan 300 a cikin shekaru biyu.
An bayar da rahoton cewa kungiyar kasashen da ke fitar da man fetur (OPEC) tana neman kasuwa saboda bukatar man fetur da farashin man fetur na kasar Sin ya fadi kasa.
Kasuwancin hannayen jari na duniya ya fadi a ranar 24 ga Fabrairu saboda karuwar karuwar masu cutar COVID-19 a wajen kasar Sin.
A ranar 27 ga watan Fabrairu, saboda fargabar yaduwar cutar coronavirus, yawancin alamun kayayyaki na Amurka, gami da NASDAQ-100, S&amp;P 500 Index, da Dow Jones Industrial Average sun yi faduwarsu mafi girma tun daga 2008, tare da raguwa da maki, wanda shine mafi girman raguwar rana ɗaya tun rikicin kuɗi na 2007-08.
Duk alamun uku sun ƙare mako tare da raguwa sama da 10%.
A ranar 28 ga watan Fabrairu, Scope Ratings GmbH ta tabbatar da cewa China kasa ce mai 'yanci da ke da ikon yanke shawara kan lamuni.
Farashin hannun jari ya sake faduwa saboda barazanar cutar coronavirus, tare da babban koma baya a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai yi sanyi.
Masanin tattalin arziki Mohamed El-Erian ya yaba wa manyan bankuna da jihohi kan matakan gaggawa na wucin gadi.
Babban bankuna na Amurka suna amsawa da sauri fiye da yadda suka yi don fitowa daga rikicin kuɗi na 2008.
Yawon shakatawa yana ɗaya daga cikin ɓangarorin da suka fi fama da ƙuntatawa na balaguro, rufe wuraren jama'a da abubuwan jan hankali, da shawarwarin gwamnatoci na dakatar da duk wata tafiya a duniya.
Sakamakon haka, kamfanonin jiragen sama da yawa ciki har da British Airways, China Eastern Airlines da Canton sun soke zirga-zirgar jiragen sama saboda karancin buƙatu, kuma kamfanin jirgin sama na yankin na Burtaniya ya faɗi.
A lokacin da aka yi wannan binciken, an gano cewa jirgin ruwan ya yi amfani da ruwa sosai don ya yi tafiya a cikin teku.
An kuma rufe tashoshin jirgin kasa da yawa da tashoshin jiragen ruwa.
Cutar ta bazu a Chunyun, babban dalilin tafiya a lokacin bikin Sabuwar Shekarar China.
Gwamnatocin ƙasa da na yanki sun soke yawancin abubuwan da ke tattare da taron jama'a, gami da bikin Sabuwar Shekara, kuma kamfanoni masu zaman kansu suna rufe shagunan su da abubuwan jan hankali na yawon buɗe ido kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe yawancin wuraren shakatawa da wuraren shakatawa na Sabuwar Shekarar Lunar a cikin Forbidden City na Beijing, tare da ƙara haikalin Carnival Beta na gargajiya na Anna don hana taron jama'a.
Hukumomi a larduna 31, birane da yankuna 24 a kasar Sin sun ba da umarnin a kara ranar bikin Sabuwar Shekara zuwa ranar 10 ga watan Fabrairu, tare da hana wasu wuraren aiki budewa har zuwa ranar.
Waɗannan yankuna suna wakiltar kashi 80% na GDP na ƙasar da kashi 90% na fitarwa.
Hong Kong ta tsawaita matakan da take bi don magance cutar, kuma ta ayyana dokar ta baci, rufe makarantu har zuwa Maris da soke bikin Sabuwar Shekara a Alochen.
Ziyarci masu siyarwa a Turai da Latin Amurka ya ragu da kashi 40%.
'Yan kasuwa a Arewacin Afirka da Gabas ta Tsakiya sun fuskanci ragin kashi 50 zuwa 60 cikin dari.
Wannan ya haifar da raguwar zirga-zirgar ƙafa zuwa cibiyoyin cin kasuwa a watan Maris, wanda ya kai kashi 33 da kashi 43 cikin ɗari idan aka kwatanta da na Fabrairu.
Masu gudanar da manyan kantunan kasuwanci a duk duniya sun ɗauki ƙarin matakan kamar ƙarin tsaftacewa, gwajin zafin jiki don bincika zafin jiki na masu amfani, da soke abubuwan da suka faru.Kwamitin Tattalin Arziki na Majalisar Dinkin Duniya na Latin Amurka ya kiyasta cewa rufewar annobar na iya jefa tsakanin mutane miliyan 14 zuwa 22 a Latin Amurka cikin talauci fiye da waɗanda ba su taɓa fuskantar cutar ba.
A watan Janairu da Fabrairun 2020, kimanin Sinawa miliyan 5 sun rasa ayyukansu lokacin da annobar ta mamaye Wuhan.
Kimanin ma'aikata 300 da yawa na baƙi na karkara na China an tura su gida ko kuma a tsare su a tsakiyar ƙasar a lardin Hubei. A watan Maris na 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Yaduwar cutar coronavirus ta rasa ayyuka miliyan 47 a Amurka kuma Babban Bankin Tarayya na St. Louis ya kiyasta cewa yawan rashin aikin yi zai iya kaiwa kashi 32%. Kullewar Indiya ta bar miliyoyin ma'aikatan baƙi na Indiya (waɗanda ake biyan su albashi na yau da kullun) ba tare da aiki ba. Binciken Cibiyar Angus Reid ya gano cewa kashi 44% na iyalai na Kanada ba su da aiki.
A rabin rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi fa'idodin rashin aikin yi na wucin gadi kuma ma'aikata miliyan 1 na Burtaniya sun nemi tsarin bashi na duniya, kusan kamfanoni miliyan rabin na Jamus sun tura ma'aikatansu zuwa tsarin gwamnati na gajeren lokaci na rage aiki da ake kira Kurzarbeit.
An fara aiwatar da shirin biyan diyya na gajeren lokaci a Faransa da Ingila kamar yadda aka aiwatar a Jamus.
Sashen zane-zane da tarihin al'adu sun sami mummunan rauni saboda annobar, yana shafar ayyukan ƙungiyoyi da ma'aikata da masu zaman kansu a duniya.
Kungiyoyin fasaha da al'adu sun yi ƙoƙari su cika manufofin su na samar da al'adun gargajiya ga al'umma (galibi tare da taimakon gwamnati), kare lafiyar ma'aikatansu da jama'a, da tallafawa 'yan wasan a duk hanyar da za su iya.
A lokacin Maris 2020, dakunan karatu, gidajen tarihi, wuraren shakatawa da sauran cibiyoyin al'adu na duniya sun soke ko kuma an sake shirya abubuwan da aka nuna saboda yawan su ya bambanta.
A sakamakon haka, an yi ƙoƙari sosai don samar da madadin sabis ta hanyar dandamali na dijital. Wani sabon abu da ke ci gaba da saurin cutar shine soke ayyukan addini, manyan abubuwan da suka shafi wasanni, da sauran abubuwan zamantakewa, kamar bukukuwa da kide kide da wake-wake, taron fasaha da nunin kayan kwalliya.
An kuma samu cikas a masana'antar fim. Vatican ta sanar da soke bukukuwan azumi na karshe na Kirista a mako mai tsarki a Rome.
A wasu majami'u, ana iya samun masu halartar ibada ta rediyo, ta hanyar rediyo ko talabijin, yayin da wasu kuma suke yin hakan ta mota.
Tun lokacin da cocin Roma ya sa mutane su taru don bauta kuma St. Peter's Square ya zama 'yanci daga matafiya na Kirista, wasu addinai sun hana mutane su taru don bauta a majami'u kuma sun hana su yin ayyuka na addini.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a wuraren da cutar ta bulla kuma an rufe wuraren ibada a baya, yayin da Saudiyya ta hana masu bautar addini daga kasashen waje shiga da kuma wuraren ibada na Makka da Madina.
Wannan annoba ta zama babbar matsala ga wasanni da kuma shirye-shirye a duniya tun bayan Yaƙin Duniya na Biyu.
An soke wasu abubuwan wasanni da suka hada da gasar zakarun Turai ta 2019/20 UEFA, gasar Premier ta 2019/20 UEFA, gasar cin kofin Turai ta UEFA Euro 2020, kakar NBA ta 2019/20 da kakar NHL ta 2019-20.
"Cutar ta kawo cikas ga shirye-shiryen wasannin Olympics na bazara na 2020, wanda aka shirya a farkon watan Yuli, Kwamitin Wasannin Olympics na Duniya ya sanar a ranar 24 ga Maris cewa za a sake gudanar da taron ""bayan 2020 amma ba bayan bazara na 2021 ba"".
Wannan ya sa mutane da yawa suka shiga caca ta yanar gizo, kuma shafukan caca da yawa na yanar gizo sun ba da rahoton cewa an sami karuwar sabbin masu biyan kuɗi.
Yawancin manyan gidajen wasan kwaikwayo kamar Broadway sun dakatar da duk wasan kwaikwayon.
"Wasu masu fasaha sun bincika yanayi don tsarawa da raba damar watsa shirye-shiryen gargajiya ta hanyar intanet a matsayin madadin, kamar raye-raye na raye-raye ko ""bikin"" na yanar gizo don masu fasaha su yi, watsa shirye-shirye da buga ayyukansu".
Yawancin nishaɗin Intanet da ke da alaƙa da coronavirus sun bazu a kan layi, yawancin su ba zato ba tsammani sun zama barkwanci da nishaɗi.
Tun farkon barkewar cutar COVID-19, an lura da yawan warewa, nuna bambanci da wariyar launin fata tsakanin Sinawa da Asiya, mutanen da ke da asalin Gabashin Asiya, da kuma waɗanda suka fito daga Turai, Amurka da sauran ƙasashe tare da manyan lamura.
An ga abubuwan tsoro, shakku, da ƙiyayya a ƙasashe da yawa, kuma an ga su a Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya ta Pacific.
Rahotanni na watan Fabrairu (lokacin da yawancin masu cutar da aka yi rikodin su ke China) sun nuna cewa mutane a China sun kamu da cutar ko kuma sun nuna cewa zuwan da ya dace shine ramuwar gayya, kamar yadda ƙungiyoyi daban-daban a duniya suka yi.
An ga yadda ake nuna rashin amincewa da kasar Sin a wasu biranen Afirka.
Ya ci gaba da cewa ana nuna bambanci ga Wuhan da Hubei saboda kawai sun kasance asalin cutar.
Ana samun tallafi a kan layi da wajen layi da kuma na Sinawa a yankunan da cutar ta shafa.
A cikin sabon sabon wuri mai zafi, kamar Italiya, inda aka fara samun karuwar cutar COVID-19 a Turai, za a iya samun rashin tabbas da ƙiyayya ga baƙi bayan wannan lamarin. 'Yan ƙasar Malaysia, New Zealand, Singapore da Koriya ta Kudu suna gudanar da takaddun sa hannu don hana mutane shiga ƙasarsu daga China don rage yaduwar cutar.
A Japan, hashtag #ChineseDontComeToJapan ya kasance sananne a shafin Twitter.
An bayar da rahoton karuwar tashin hankali tsakanin jama'ar kasar Sin da sauran mutanen Asiya a Burtaniya da Amurka.
Shugaban Amurka Donald Trump ya fuskanci suka saboda ya kira coronavirus cutar Sin, yana mai nuna wariyar launin fata da adawa da kasar Sin.
Masu zanga-zanga a Ukraine sun kai hari kan bas da ke jigilar 'yan Ukraine da sauran kasashen waje daga Wuhan zuwa Novi Sanjari.
Dalibai daga arewa maso gabashin Indiya, wanda ke iyaka da China, da kuma manyan biranen Indiya sun fuskanci cin zarafi saboda barkewar cutar coronavirus.
"A West Bengal, Dilip Ghosh, shugaban jam'iyyar Bharatiya Janata, ya ce China ta lalata yanayi kuma ""Allah yana rama musu saboda haka"".
"Kosososar kasar Sin da ke Kolkata ta yi tir da maganganun daga baya, tana mai cewa ""ba daidai bane"". A China, wariyar launin fata da wariyar launin fata sun bazu a kan mazauna da ba Sinawa ba saboda annobar, inda aka bayyana 'yan kasashen waje a matsayin ""sharar gida"" da ""ƙetarewa""".
Jaridu da yawa da ba su da sassan da za a biya kawai sun cire waɗannan sassan saboda wasu ko duk labaran da suka bayar game da cutar coronavirus.
Yawancin masu wallafa kimiyya sun buɗe takardun kimiyya da suka shafi cutar.
Wasu masana kimiyya sun raba sakamakon binciken su akan sabobin kamar bioRxiv don saurin shirye-shiryen.
Cutar da ke zuwa  Cutar da ke zuwa da wuri sau da yawa tana da sabon salo kuma tana cikin annobar ko kuma tana yaɗuwa
Duniya da cuta: Takaitaccen Bayani game da Duniya da Cutar Cutar.
Jerin cututtuka da annoba a dukan duniya  Yawan mutanen da cutar ta kashe
Hadarin kiwon lafiya da ke tattare da safarar dabbobi da kuma cututtuka da ke yaduwa daga dabbobi zuwa mutane ko kuma sayar da dabbobi masu ban mamaki
Gwaje-gwajen dakin gwaje-gwaje suna amfani da hanyoyin gano cutar coronavirus ta numfashi ta 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ke da alaƙa da kuma ƙwayoyin cuta da ke amsa wannan kamuwa da cuta.
Ana iya gano kwayar cutar a cikin samfuran ta hanyar RT-PCR kuma tana iya gano RNA na coronavirus.
Wannan gwajin yana da iyaka kuma yana da amfani wajen gano SARS-CoV-2.
Yana taimaka wajen gano ƙwayoyin cuta da suka kamu da su kwanan nan ko kuma waɗanda suke aiki.
Gano ƙwayoyin cuta (serology) yana taimakawa duka ganewar asali da lura da jama'a.
Gwaje-gwajen rigakafi suna nuna yawan mutanen da ke da cutar, gami da yawan mutanen da ke da alamun amma kaɗan ne ko babu alamun.
Sakamakon gwajin zai iya tabbatar da ainihin mutuwar cutar da kuma rigakafin cutar a cikin jama'a.
Saboda iyakancewar aikin bincike, babu wata ƙasa da ke da tabbataccen bayani game da yawan yaduwar cutar a cikin jama'a a watan Maris na 2020.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawan jama'arta, kuma akwai bambance-bambance masu yawa a cikin gwajin tsakanin ƙasashe.
Wannan bambancin yana da yuwuwar tasiri sosai a cikin yawan mutuwar, saboda an fi kimanta shi fiye da yadda ake tsammani a wasu ƙasashe.
Ta amfani da juyawa na juyawa na polymerase chain reaction (rRT-PCR) a lokaci guda, gwajin yana ba da damar bincika samfurin da aka samo ta hanyar amfani da ruwa na hanci ko kuma ta hanyar fitarwa.
Sakamakon yana samuwa a cikin sa'o'i kaɗan zuwa kwanaki 2.
Gwajin RT-PCR wanda aka yi da samfurin ruwa daga makogwaro yana da aminci ne kawai a farkon makon cutar.
Bayan haka, kwayar cutar za ta iya fita daga makogwaro kuma ta ninka cikin huhu.
Ga mutanen da suka kamu da cutar a mako na biyu, ana iya amfani da wani zaɓi na samfurin daga zurfin iska tare da catheter na sha ko samfurin sal (screening).
An yi amfani da ɗayan na farko na gwajin PCR a cikin Janairu 2020 a Berlin, wanda Charité ya yi. Ta hanyar mayar da martani na sarkar polymer (rRT-PCR) a cikin sa'a ɗaya, an samar da gwaje-gwaje 250,000 a cikin ƙungiyar lafiya ta duniya (WHO).
Kasar Ingila ta kuma samar da gwajin a ranar 23 ga Janairu, 2020. Kogenebiotech, wani kamfani na Koriya ta Kudu, ya samar da kayan aikin gwaji na asibiti na PCR-based SARS-CoV-2 (PowerChek Coronavirus) a ranar 28 ga Janairu, 2020.
"Kungiyar BGI a China tana cikin kungiyoyi na farko da suka fara samun gaggawa daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta Kasa ta kasar Sin, kayan aikin ganowa na PCR-based SARS-CoV-2. Cibiyar Kula da Cututtuka da Rigakafin Cututtuka (CDC) a Amurka ta rarraba kwamiti na gano RT-PCR don gwajin lafiyar al'umma ta hanyar kafofin wakilai na duniya a lokaci guda don 2019 Novel Coronavirus (2019-nCoV)".
An sami sakamako mara kyau a cikin gwaje-gwaje uku na kwayoyin halitta saboda gano abubuwan da ba daidai ba a cikin tsofaffin kayan aikin gwaji da kuma katsewa a cikin gwaji a CDC a Atlanta, wanda aka yi nasara a cikin watan Fabrairu na 2020, tare da matsakaita na samfura 100 a rana.
Har zuwa 28 ga Fabrairu, 2020, ba a tabbatar da amincin gwaje-gwaje masu amfani da raka'a biyu ba, kuma har zuwa wannan lokacin, dakunan gwaje-gwaje na ƙasa da na gida ba su sami izinin yin gwaje-gwaje ba.
Hukumar Abinci da Magunguna ta amince da gwajin a ƙarƙashin izinin amfani da gaggawa. Dakunan gwaje-gwaje na kasuwanci a Amurka sun fara gwajin a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da cewa akwai gwajin COVID-19 na RT-PCR na ƙasa.
Quest Diagnostics ya shirya gwajin COVID-19 na ƙasa a ranar 9 ga Maris, 2020.
Babu iyakancewar yawa, kuma ana buƙatar tattara samfuran da kuma rarrabawa bisa ga ƙa'idodin CDC.
An tsara gwajin COVID-19 a Rasha kuma an samar da shi ta hanyar VECTOR, Cibiyar Nazarin Virology da Biotechnology ta Gwamnati.
A ranar 11 ga Fabrairu, 2020, an yi rajistar gwajin tare da Hukumar Kula da Lafiya ta Tarayya. A ranar 12 ga Maris, 2020, an ba da rahoton cewa Mayo Clinic ta samar da gwajin da zai iya gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami izini daga FDA don yin gwajin da ke ba da sakamako a cikin awanni 3.5, wanda ke ba da damar yin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin Amfani da Gaggawa (EUA) ga Abbott Laboratories, wanda shine tsarin Abbott m2000 da ake gwadawa; FDA ta ba da irin wannan izinin ga Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta sami EUA iri ɗaya daga FDA, wanda ke ɗaukar mintuna 45.
FDA ta ba da shawarar izinin fasahar haɓaka isothermal nucleic acid don maye gurbin PCR.
Wannan ba ya buƙatar sake zagayowar zafin jiki mai canzawa, saboda yana haifar da sakamako mai kyau a cikin ƙasa da minti biyar da sakamako mara kyau a cikin minti 13.
Akwai na'urori kusan 18,000 a Amurka a halin yanzu, kuma Abbott yana hanzarta samarwa don samar da gwaje-gwaje 50,000 a kowace rana. Gwaje-gwaje ta amfani da ƙwayoyin cuta na monoclonal suna da alaƙa kai tsaye da furotin nucleocapsid (N protein) na sabon coronavirus kuma ana fatan zai nuna sakamako a cikin mintuna 15 zuwa 20 kamar yadda gwajin saurin mura yake.
Binciken wallafe-wallafen a watan Maris na 2020 ya kammala cewa farashin radiography na kirji a farkon matakan ba shi da yawa, amma sakamakon CT \[computed tomography] na iya kasancewa tun kafin a nuna alamun a wurin.
Abubuwan da suka fi dacewa a kan CT sun haɗa da binary multilobar ƙasa-gilashin opacifiers tare da haɗin kai, rashin damuwa da kuma baya.
Matsin lamba na bambancin bambancin, rashin daidaito da kuma haɗuwa da cutar yana ƙaruwa yayin da cutar ta canza.
Wani bincike da ya kwatanta PCR da CT a cikin ruwa a matsayin tushen ya nuna cewa CT tana da halayen karɓa fiye da PCR, amma tare da iyakance kaɗan, yawancin halayen hoto suna kama da na huhu da kuma tsarin cututtuka.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa kada a yi amfani da CT a matsayin gwaji na farko na COVID-19. A watan Maris na 2020, CDC ta ba da shawarar cewa a yi amfani da PCR a matsayin gwaji na farko.
Amsar rigakafi shine samar da ƙwayoyin cuta don rigakafi, wanda ya haɗa da IgM da IgG.
Ana iya yin gwaje-gwaje a cikin Cibiyar Nazarin Cibiyar (CLT) ko a wurin kulawa (PoCT).
Tsarin atomatik da ake kira HighSprout zai iya yin waɗannan gwaje -gwajen a yawancin dakunan gwaje -gwaje na asibiti, kuma yawan abubuwan da aka gano zai dogara da yawan samarwa a cikin kowane tsarin.
Ana amfani da samfurin jini don CLT, amma ana iya amfani da samfurori na ƙwayar cuta don ganin amsar rigakafi.
Ana samun samfurin jini don PoCT ta hanyar allura.
Ba kamar hanyoyin PCR ba, ba a buƙatar matakin ƙaddamarwa kafin fitarwa. a ranar 26 ga Maris, 2020, cibiyoyin 29 da suka ba da sanarwar hukumar kamar yadda ake buƙata, yanzu suna iya rarraba gwaje-gwajen antibody.
A ƙarshen watan Maris na 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin Turai don gano ƙwayoyin cuta a cikin samfuran jini don IgG da IgA.
Gwajin na iya bincika ɗaruruwan samfura a cikin awa ɗaya kuma ya fi sauri fiye da gano RNA na kwayar cutar ta PCR.
Ana rarrabe ƙwayoyin cuta a cikin kwanaki 14 na kamuwa da cutar. Babu ɗayan kayan aikin gano ƙwayoyin cuta da aka saya a farkon Afrilu a Burtaniya da ke da amfani.
Hong Kong ta ɗauki matakan da za su ba marasa lafiya da ake zargi damar zama a gida, ta hanyar ba da bututun samfurin ga marasa lafiya, wanda za su yi allurar rigakafi, su dawo da shi, kuma su sami sakamakon gwajin daga baya. NHS na Ingila yana shirya don gano masu cutar da ake zargi a gida, yana hana masu cutar da ake zargi daga cutar wasu idan sun bar asibiti, kuma ana amfani da motar asibiti don tsabtace cututtuka.
Cibiyoyin da ba a barin mota ba sun ba da damar yin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin saurin
Ana biyan kuɗin ta inshorar lafiya idan an ba da izinin likita don gwaji.
A cewar shugaban Cibiyar Robert Koch, Jamus na da damar yin gwaje-gwaje 160,000 a mako.
A ranar 19 ga Maris, an yi gwajin tuki a manyan birane da yawa.
Ba a san yawan gwaje-gwajen da aka yi a Jamus ba a ranar 26 ga Maris, 2020 saboda sakamakon tabbatacce ne kawai ake bayar da rahoto.
"Binciken farko na dakin gwaje-gwaje ya nuna cewa aƙalla samfura 483,295 an gwada su daga makon kalanda 12/2020 zuwa 12/2020 kuma an tabbatar da samfura 33,491 (6.9%) na SARS-CoV-2. A Isra'ila, masu bincike a Asibitin Technion da Rambam sun gwada wata hanya don gwada samfura daga marasa lafiya 64 a lokaci guda, kawai idan samfurin da aka haɗa ya tabbata.
Tare da aikin da ke karkashin kulawar Wang Jian, wanda ya kafa BGI, da kuma kwanaki 5, aikin samfurin zai iya tashi da kashi 47% a Hubei, kuma farashin keɓewa zai ninka idan ba a fara yanayin gwaji ba.
An bude wasu a birane 12 a fadin kasar Sin, ciki har da Shenzhen, Tianjin, Beijing da Shanghai, bayan dakin gwaje-gwaje na Wuhan.
A ranar 4 ga Maris, 2020, ana yin gwaje-gwaje na yau da kullun 50,000 a rana. An saki zane mai buɗewa na Origami Assays wanda ke ba da damar bincika samfuran marasa lafiya 1122 na COVID-19 ta amfani da gwaje-gwaje 93 kawai. Waɗannan ƙirar daidaitaccen tsari za a iya yin su a cikin ƙananan dakunan gwaje-gwaje kuma ba sa buƙatar masu riƙe ruwa na robotic.
A watan Maris, ƙarancin kayan gwaji da ƙarancin kayan aiki sun zama babban abin damuwa ga yawan gwaji a cikin EU, UK da Amurka.
Wannan ya sa wasu marubuta su bincika wasu hanyoyin gwaji, kamar dumama samfuran zuwa 98 °C (208 °F) na mintuna 5 don sakin kwayar RNA da kuma ƙarin gwaji.A ranar 31 ga Maris, an sanar da cewa Hadaddiyar Daular Larabawa tana yin gwaji a kan mutum fiye da kowace ƙasa, kuma tana kan layi don isar da shi ga yawancin jama'a.
"Wannan ya ƙunshi masu amfani da motoci da kuma masu amfani da lab na 42 da BGI (wanda ke da tushe a dakin gwaje-gwaje na gaggawa a ""Huo-Yan"" China)".
Lab din da aka gina a cikin kwanaki 14 zai iya yin dubban gwaje-gwaje na RT-PCR a kowace rana, wanda shine na farko a duniya a waje da China da zai iya yin wannan a wannan sikelin.
An samar da wasu hanyoyin bincike daban-daban da ke nuna kwayoyin halittar kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta dauki tsarin samar da kayan aikin Jamus don kasashe masu karamin karfi da kuma wadanda ba za su iya yin nasu ba.
Dokokin Jamus da aka tsara a ranar 17 ga Janairu, 2020, da kuma yarjejeniyar da Cibiyoyin Kula da Cututtuka na Amurka suka tsara ba su kasance a shirye ba har zuwa ranar 28 ga Janairu, wanda ya haifar da jinkiri a cikin gwaji a cikin Amurka da China, yayin da Amurka ta fuskanci matsaloli game da rashin amincin kayan gwaji a farkon annobar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isasshen kayan gwaji don biyan buƙatu da ba da shawarwari daga masana kiwon lafiya ba.
Akasin haka, masana sun ce, samun damar gwaji a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar coronavirus.
Gwamnatin Koriya ta Kudu ta shafe shekaru da dama tana gina cibiyoyin bincike, galibi a dakunan gwaje-gwaje masu zaman kansu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta ba da shawarar gaggauta gwaji don rage yaduwar cutar COVID-19.
A watan Maris na shekarar 2020, kasar Sin ta sanar da cewa akwai matsaloli game da ingancin kayan aikin bincikenta.
A Amurka, gwaje-gwaje da CDC ke yi suna da matsala kuma gwamnati ta kawar da wasu takunkumi da ke hana yin gwaje-gwaje na sirri. Spain ta sayi gwaje-gwaje daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin, amma sakamakon bai yi daidai ba.
Hukumar ta bayyana cewa sakamakon da ba daidai ba zai iya faruwa ne saboda rashin tattara samfurori ko kuma rashin amfani da kayan aikin yadda ya kamata.
A cewar ma'aikatar, za a mayar da kayan aikin da suka ba da sakamakon da ba daidai ba kuma a maye gurbinsu da kayan aikin gwaji na musamman da Shenzhen Bioeasy ke bayarwa. Jamhuriyar Czech da China sun sayi kashi 80% na kayan aikin gwajin da ba daidai ba. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga China, wanda kuma ya ba da bayanan da ba daidai ba.
Firayim Minista Matović ya ba da shawarar a jefa su a cikin Danube. A cewar Ateş Kara, ma'aikacin ma'aikatar lafiya ta Turkiyya, Turkiyya ba ta sanya kayan gwajin da ta saya daga China a cikin jirgin ba saboda yawan kuskuren da ke ciki.
Gwaje-gwaje, keɓewa da bin diddigin mutanen da ke da cutar SARS-CoV-2, sun haifar da sakamako mai kyau.
Masu bincike a birnin VÃ2 na Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu a cikin kwanaki goma a kan mutane 3,400.
Rabin mutanen da suka kamu da cutar ba su da alamun cutar kuma duk abubuwan da aka sani suna cikin keɓewa.
An dakatar da sabbin cututtuka saboda ƙuntatawa kan tafiya zuwa al'umma.
Cutar kwayar cutar coronavirus ta 2020 ta bazu cikin Singapore a hankali fiye da sauran ƙasashe masu tasowa, tare da neman manyan layukan tuntuɓar, ƙuntatawa da keɓewa, amma ba a ɗauki matakan tilastawa rufe gidajen abinci da shagunan sayar da kayayyaki ba.
An soke wasu abubuwan da ake yi, kuma Singapore ta fara ba da shawarar mazauna su zauna a gida har zuwa 28 ga Maris, amma an sake buɗe makarantu a ranar 23 ga Maris bayan hutu.
Yawancin ƙasashe sun sami nasarar sarrafa cutar ta hanyar sa ido kan taɓawa, ƙuntata tafiye-tafiye, gwaji, keɓewa, amma kaɗan ta hanyar iyakance motsi na ƙasa kamar yadda aka yi a Iceland da Koriya ta Kudu.
Kasashen da suka yi gwaji da yawa fiye da yawan mutuwar, a cewar binciken ƙididdiga, suna iya samun ƙarancin kamuwa da cutar, watakila saboda waɗannan ƙasashe suna da sauƙin gano waɗanda ba su da alamun cutar.
WHO ta ba da shawarar cewa ƙasashe da ba su da ƙarfin gwaji da dakunan gwaje-gwaje na ƙasa waɗanda ke da ƙarancin ƙwarewar gwaji don COVID-19 su aika da samfuran farko na COVID-19 guda biyar masu kyau da samfuran COVID-19 guda goma marasa kyau zuwa ɗayan cibiyoyin gwaji na WHO 16 don gwaji mai ƙarfi.
Daga cikin dakunan gwaje-gwaje 16, 7 suna cikin Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka da 1 a Kudancin Amurka, da 1 a Ostiraliya.
A cikin jadawalin da ke gaba, kashi na mutanen da aka gwada, shafi mai kyau yana ƙarƙashin tasirin manufofin gwaji na ƙasar.
Kasashen da ke gwada mutane a asibiti kawai suna da kashi mafi girma na masu cutar fiye da waɗanda ke gwada yawan jama'arsu, ba tare da la'akari da ko suna da alamun cutar ko a'a ba.
Wanke hannu, wanda ake kira tsabtace hannu, yana nufin wanke hannuwan don kawar da datti, mai, ƙwayoyin cuta, da kuma wasu abubuwa da ba su dace ba.
Wanke hannu da sabulu a wasu lokuta masu mahimmanci na rana yana hana yaduwar cututtuka da yawa, kamar zawo da kwalara, waɗanda za a iya ɗauka ta hanyar baki ba tare da wanke hannaye ba.
Misali: Idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci ko bakinsu (watau kyallen takarda), mutane na iya kamuwa da cututtukan numfashi kamar mura ko mura.
Sau biyar mafi muhimmanci da za a wanke hannuwanka da sabulu a rana sun haɗa da: kafin da bayan wanke bayan gida, bayan ka share ƙasan jaririn ko canza diapers, kafin ka ciyar da jariri da kuma kafin ka ci abinci, kafin ka shirya abinci ko kuma bayan ka taɓa nama, kifi, ko kaza.
Idan babu sabulu da ruwa, za a iya wanke hannaye da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu.
Kafin ka dafa abinci, sa'ad da kake dafa shi, da kuma bayan ka gama.
Kafin ka kula da marar lafiya da kuma bayan ka gama.
Bayan ka canja diapers ko kuma bayan ka wanke yaro bayan ya fita bayan gida.
Bayan ka yi tari, tari ko fitsari.
Bayan ka ɗauki naman dabba, ka ciyar da shi ko kuma ka taɓa shara.
Tsabtace hannu na likita yana nufin tsabtace hannu da ke tattare da aikin likita.
Wanke hannu kafin shan magani ko kula da likita na iya hana ko rage yaduwar cututtuka.
Ma'anar wanke hannu a asibiti ita ce a kawar da ƙwayoyin cuta (ƙwayoyin cuta, ƙwayoyin cuta, da kuma wasu abubuwa da za su iya sa mutum ya ji rauni ko kuma ya kamu da cuta).
Ko da yake wannan yana da muhimmanci ga masu dafa abinci ko kuma likitoci, amma yana da amfani ga jama'a.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, gami da rage yaduwar mura, coronavirus da sauran cututtukan cututtuka; hana cututtukan cututtukan gudawa; rage kamuwa da cututtukan numfashi;
kuma tana shirin rage mutuwar jarirai a haihuwar gida.
Wani bincike na 2013 ya nuna cewa ingantaccen al'adar wanke hannu na iya haifar da ƙananan ci gaba a tsayin yara 'yan ƙasa da shekaru biyar.
Ana iya rage yawan mutuwar yara daga cututtukan numfashi da gudawa a ƙasashe masu tasowa ta wajen soma wasu canje-canje masu sauƙi a halayensu, kamar wanke hannu da sabulu da kuma ruwa.
Wannan mataki mai sauƙi zai iya rage mutuwar da ke faruwa daga waɗannan cututtuka da kusan kashi 50.
Hanyoyin da ke inganta wanke hannu na iya rage yawan zawo da kashi ɗaya bisa uku, idan aka kwatanta da samar da ruwa mai tsafta ga yankunan da ke da karancin kuɗi.
Rage yawan zazzabin jini da kashi 48% ana iya danganta shi da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da sauƙi don hana zazzabin jini da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututut
Ciwon huhu shine babban cutar ARI kuma shine sanadin farko na mutuwar yara kusan miliyan 1.8 da ke ƙasa da shekaru biyar a kowace shekara.
A kowace shekara, yara kusan miliyan 3.5 suna mutuwa daga gudawa da kuma cutar sankarar bargo.
A cewar UNICEF, wanke hannu da sabulu da kuma wanke bayan cin abinci da kuma bayan amfani da bayan gida na iya ceton rayuka fiye da duk wani allurar rigakafi ko maganin likita, rage mutuwar gudawa da rabi da kuma mutuwar kamuwa da cututtukan numfashi mai tsanani da kashi ɗaya cikin huɗu.
Wanke hannu yawanci ana haɗa shi da sauran matakan tsabtace jiki a matsayin ɓangare na shirye-shiryen ruwa, tsabtace muhalli da tsabtace mutum (WASH).
Wanke hannu yana kuma hana kamuwa da cututtukan fata da ake samu ta wurin saduwa.
Ƙananan lahani a wanke hannu Wanke hannu akai-akai na iya haifar da lalacewar fata ta hanyar bushewar fata.
Wani bincike da aka yi a Denmark a shekara ta 2012 ya nuna cewa yawan wanke hannu yana iya sa mutum ya yi ciwon fata, musamman ma a tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sau da yawa yana ɗaya daga cikin alamun cutar OCD.
Akwai lokuta biyar masu mahimmanci da wankewa da sabulu ya zama dole a rana don rage yaduwar kamuwa da cuta: bayan amfani da gidan wanka (wurin fitsari, famfo), bayan wanke ƙananan jaririn (canza tsabta), kafin ciyar da jariri, kafin cin abinci, da kuma kafin / bayan shirya abinci ko riƙe nama, kifi ko kaza.
Ana buƙatar yin wanke hannu da kyau don hana yaduwar cututtuka, gami da kafin da bayan kula da rauni ko rauni; bayan yin fitsari; bayan yin fitsari ko kuma shan iska; bayan taɓa ƙazamin dabba ko dabba; da kuma bayan taɓa ƙazamin abu.
A ƙasashe da yawa, ana wanke hannaye da sabulu da kuma ruwa.
A cikin binciken da aka yi a kan wanke hannu a cikin ƙasashe 54 a cikin 2015, an gano cewa a matsakaita kashi 38.7% na gidaje suna wanke hannu a gida. Binciken na 2014 ya nuna Saudi Arabiya tana da kashi 97 cikin ɗari mafi girma. Amurka tana da kashi 77 cikin ɗari, kuma China tana da kashi 23 cikin ɗari mafi ƙanƙanci.
A cikin Philippines, sashen ilimi ya aiwatar da shirin kula da lafiya mai mahimmanci wanda aka ambata a matsayin misali na aiki don inganta lafiyar yara da ilimi.
Manufar wannan shirin na kasa shine sanar da mutane sau biyu a shekara game da wanke hannuwanku da sabulu, goge haƙoranku da fluoride, da kuma kashe ƙwayoyin cuta.
An yi amfani da shi sosai a ƙasar Indonesia.
Ana iya kawar da ƙwayoyin cuta daga fata ta ƙara ruwa a sabulu ko sabulu mai ruwa.
Babban aikin sabulu da wanke ruwa shine rage shingen bayani da haɓaka narkewa.
Ruwan da kansa ba shi da isasshen tsabtace fata, saboda mai da furotin da ke cikin ƙasa ba za su iya cirewa cikin ruwa ba.
Duk da haka, tsaftacewa yana taimakawa ta hanyar ruwa mai kyau ..
Ana iya sake amfani da sabulu mai bushe don ya riƙe ƙwayoyin cuta da aka samu daga amfani da shi.
Wasu bincike da aka yi game da yadda ake yaduwar ƙwayoyin cuta a cikin sabulu mai ƙarfi da aka gurɓata sun nuna cewa ba sa kawo matsala sosai domin suna kawar da ƙwayoyin cuta daga kumfa.
CDC har yanzu ta ce sabulu mai ruwa ya fi dacewa don rarraba masu kula da hannu.
An ba da sabulu na antibacterial a cikin al'umma da ke da masaniya game da halaye masu lafiya.
Har zuwa yau, babu wata hujja da ke nuna cewa amfani da maganin rigakafi ko maganin rigakafi yana fifita ƙwayoyin cuta masu jurewa a cikin yanayi.
Duk da haka, sabulu na antibacterial suna dauke da kayan aiki na antibacterial kamar Tricon, wanda ke dauke da jerin kwayoyin halitta.
Don haka, ko da yake nau'ikan maganin rigakafi ba su da tasiri kamar yadda ake tsammani idan ba a zaɓi su da sabulu na antibacterial ba.
Baya ga wakilan kare fata, siffofin da suka ci gaba kamar su mai kula da pH, benzyc acid mai aiki da ƙwayoyin cuta da ƙarin kayan sanyaya fata (aloe vera, bitamin, aloe vera, tsire-tsire na tsire-tsire) na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid).
Ruwa mai zafi wanda ya dace don wanke hannu bai isa ya kashe ƙwayoyin cuta ba.
Kwayoyin cuta suna girma da sauri a zafin jiki (37 °C).
Duk da haka, ruwan zafi da sabulu sun fi ruwan sanyi da sabulu tasiri wajen kawar da ƙura da ƙwayoyin cuta.
Amma, akasin abin da mutane da yawa suke tunani, binciken kimiyya ya nuna cewa ruwan zafi ba ya rage yawan ƙwayoyin cuta a hannayenmu.
Wani zaɓi kuma shi ne tsabtace hannu da ba a amfani da ruwa ba.
A ƙarshen shekarun 1990 da farkon karni na 21, zaɓuɓɓukan tsabtace hannu ba tare da barasa da ruwa ba (wanda aka fi sani da wanke hannu da giya, wanke hannu da maganin kashe ƙwayoyin cuta, ko wanke hannu) ya fara zama sananne.
Yawancin su an tsara su ne don amfani da su a cikin gel tare da wakili mai ƙanshi kamar carbomer (polymer na oxalic acid), ko a matsayin ruwa na glycerin, ko don amfani da ƙura da rage tasirin bushewa don rage amfani da barasa.
Ƙara hydrogen peroxide mai haɗuwa yana ƙaruwa da aikin maganin ƙwayoyin cuta. Masu tsabtace hannu waɗanda ke da aƙalla kashi 60 zuwa 95% na barasa suna kashe ƙwayoyin cuta.
Magungunan tsabtace jiki na giya suna kashe ƙwayoyin cuta, ƙwayoyin cuta masu ƙarancin magani (MRSA da VRE), tarin fuka da wasu ƙwayoyin cuta (HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura da hepatitis) da fungi.
Bayan da aka sanya 70% na giya a hannu, bayan da aka shafe 30 seconds, maganin shafawa na hannu yana cire 99.97% na kwayoyin cuta daga hannuwanku (ragewa 3.5, daidai da decibel 35) da kuma 99.99% zuwa 99.999% (ragewa 4 zuwa 5) 7 kwayoyin cuta daga hannuwanku a cikin minti 1.
Masu wanke hannu da ke dauke da barasa ba su da cikakken tasiri wajen kawar da ƙwayoyin cuta na ƙwayar cuta (ko norvovirus), wanda shine mafi yawan cututtukan cututtukan hanji. Ya kamata a yi amfani da maganin kashe ƙwayoyin cuta ko wanke hannu da barasa don bushewa ko rufe hannu biyu.
Ana shafawa gaba da baya da ƙarshen yatsunsu duka na kusan sakan 30 har sai ruwa, kumfa ko gel ya bushe.
Dole ne a wanke yatsun hannu da hannu biyu da kyau. Cibiyoyin Kula da Cututtuka da Rigakafin Amurka sun ba da shawarar amfani da tsabtace hannu, musamman lokacin da ƙazantar hannu ta bayyana.
Yawan amfani da waɗannan wakilan ya dogara ne da sauƙin amfani da su da kuma kashe ƙwayoyin cuta da sauri, amma ba za su maye gurbin wanke hannu ba idan sabulu da ruwa ba su da su.
Amfani da tsabtace hannu na giya a kai a kai na iya haifar da bushewar fata idan ba a haɗa man shafawa da / ko kayan shafawa a cikin tsari ba.
Ana iya rage ko kawar da sakamakon bushewar giya ta ƙara glycerin da/ko wasu kayan shafawa zuwa dabara.
A cikin gwajin asibiti, masu tsabtace hannu da ke da barasa sun haifar da ƙarancin haushi da bushewar fata fiye da sabulu ko sabulu na maganin ƙwayoyin cuta.
Ba safai ake samun rashin lafiyar fata da cututtukan kashi ko kuma rashin lafiyar hannu da giya ko kuma abin da ke cikin kayan wanke hannu da giya.
Ana iya samun cututtukan fata masu saurin tashi idan aka kwatanta da wanke hannu da sabulu da ruwa.
Duk da ingancinsu, wakilai marasa ruwa ba sa wanke hannuwan kayan ƙwayoyin halitta, amma suna lalata su cikin sauƙi.
Saboda haka, sabulu da ruwa ba su dace da tsabtace hannu ba don hana yaduwar ƙwayoyin cuta da yawa, saboda ƙwayoyin cuta na iya kasancewa a hannu.
Ingancin tsabtace hannu ba tare da barasa ba ya dogara ne akan kayan aiki da kayan yaji, tare da ingancin-ƙananan giya da kuma giya.
A kwanan nan, an lura cewa maganin da ake amfani da shi a cikin sinadarin ya yi muni sosai bayan an yi amfani da shi sau da yawa, amma ba kamar shan giya ba.
A cikin al'ummomin da ba su da kuɗi, mutane da yawa ba za su iya sayen sabulu ba kuma su yi amfani da laka ko ƙasa a maimakon haka.
Ƙura ko ƙasa za su iya yin aiki fiye da ruwa, amma ba za su yi aiki sosai kamar sabulu ba.
Abin damuwa shi ne, ƙasa ko kuma ƙasa da ke cike da ƙwayoyin cuta suna iya sa mutane su kamu da cuta maimakon su rage yawan cutar.
Kamar sabulu, toka tana kashe ƙwayoyin cuta domin tana sa ruwa ya zama ruwan gishiri.
A lokacin da sabulu ba shi da samuwa, Hukumar Lafiya ta Duniya ta ba da shawarar yin amfani da toka ko yashi a madadin sabulu.
Tsarin wanke hannu da aka ba da shawarar Cibiyoyin Kula da Cututtuka na Amurka don hana yaduwar cututtuka ya haɗa da:
Ka wanke hannayenka da ruwa mai zafi ko mai sanyi.
Ana ba da shawarar ruwan da ke gudana saboda tafkuna na iya gurɓata kuma Yah ba zai haifar da bambancin zafin jiki ba.
Yi amfani da sabulu mai yawa a hannayenka, ciki har da bayan hannayenka, tsakanin yatsunsu da ƙarƙashin ƙugu.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai idan akwai sabulu maimakon ruwa kawai.
Ka yi bincike na aƙalla dakika 20.
Yin tausa yana sa a cire ƙwayoyin cuta daga fata kuma yin tausa na dogon lokaci yana kawar da ƙwayoyin cuta da yawa.
Ku wanke su sosai da ruwa mai gudu.
Wanke hannu a cikin wanka zai iya sake gurɓata hannu.
Ka yi amfani da tawul mai tsabta ko kuma ka bar iska ta bushe.
Hannun da ke da rigar da kuma rigar suna da saukin kamuwa da cutar. Yankunan da aka fi mantawa da su sune babban yatsa, wuyan hannu, tsakanin yatsunsu, da ƙarƙashin yatsunsu.
Ƙunƙarar ƙusa da ƙusa mai ƙusa na iya haifar da ƙwayoyin cuta.
Ana ba da shawarar amfani da ruwan wanki don hana hannaye bushewa, saboda bushewar fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin kamuwa da cuta.
"Za a iya yin zaɓuɓɓuka masu rahusa don sauƙaƙe wanke hannu a wuraren da babu ruwan famfo da / ko sabulu, misali: cire ruwa daga Jericho mai rataye ko ramuka masu dacewa da rijiyoyi da / ko amfani da sandar idan ya cancanta a ƙasashe masu tasowa. Idan akwai ƙarancin samar da ruwa (kamar a makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai zaɓuɓɓuka kamar tanadin ruwa, ""TPP-taps"" da sauran zaɓuɓɓuka masu rahusa".
TP-Tap fasaha ce mai sauƙi da aka yi amfani da ita ta amfani da ƙugiya mai ɗaure da igiya da ƙaramin ruwa da ganga na sabulu.
Duk da cewa bushe hannu da kyau wani muhimmin bangare ne na tsabtace hannu, akwai wasu muhawara game da yadda za a bushe hannu da kyau a wuraren wanka na jama'a.
Bincike da yawa ya nuna cewa tawul ɗin takarda sun fi na lantarki tsabtace hannu da ake samu a ɗakunan wanka da yawa.
A cikin 2008, an gudanar da bincike a Jami'ar Westminster a Landan, wanda ya kwatanta matakan tsabtace jiki na tawul ɗin takarda, bushewar hannu mai zafi, da bushewar hannu ta iska ta Turai ta Tasis Symposium, wanda masana'antar takarda ta tallafawa don kwatanta matakan tsabtace jiki na takarda.
Jimlar adadin kwayoyin cuta da aka gano bayan wanke hannu da bushewa da busar iska mai zafi ya karu da kashi 194% a yatsunsu da 254% a hannaye.
Drying tare da busar iska ta iska ya nuna karuwar yawan kwayoyin cuta da kashi 42% a kan matsakaicin ƙwayoyin cuta da kashi 15% a cikin linzamin kwamfuta.
Bayan wanke hannu da bushewa da tawul ɗin takarda, yawan ƙwayoyin cuta ya ragu da kashi 76% a matsakaita a yatsun hannu da kashi 77% a tafin hannu. Masana kimiyya sun gudanar da gwaje-gwaje don gano yiwuwar gurɓatar da sauran masu amfani da gidan wanka da yanayin gidan wanka saboda kowane nau'in bushewa.
Mai bushewa da iska, wanda ke fitar da iska a saurin mita 180 a awa daya (650 km / h) yana da ikon warware ƙwayoyin cuta daga hannaye da na'urar da kuma gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka har zuwa mita 2.
Yin amfani da busar iska mai zafi yana yada ƙwayoyin cuta zuwa mita 0.25 daga busar.
A shekara ta 2005, wani bincike da kamfanin TÃœV Produkt und Umwelt ya yi ya bincika hanyoyin bushe hannu dabam dabam.
An lura da waɗannan canje-canje a ƙididdigar ƙwayoyin cuta bayan bushe hannaye.
Akwai masana'antun bushewa da yawa, kuma bushewa da hannu ya bambanta da bushewa da tawul ɗin takarda.
Wanke hannu da wanke hannu a lokacin tafiya lokacin da sabulu da ruwa ba su samuwa.
Ya kamata a yi amfani da sabulun hannu da ke ɗauke da giya da kashi 60 cikin ɗari.
Tun da daɗewa bayan likitan Hungary Ignaz Semmelweis ya gano cewa yana da amfani wajen hana cututtuka a asibiti (a shekara ta 1846), wanke hannu ya zama wajibi a aikin likita.
Ma'aikatan asibiti suna da na'urorin da ke tunatar da su cewa idan sun manta su wanke hannayensu, su yi hakan.
A cikin wani binciken da aka yi, an gano cewa yawan kamuwa da cutar ya ragu.
Wanke hannu na likita yana ɗaukar aƙalla dakika 15 kuma ana yin sa da sabulu da ruwa ko gel don yadawa da tausa kowane ɓangaren hannu.
Dole ne a wanke hannaye tare da yatsunsu.
Idan akwai datti a kan yatsunsu, za su iya cirewa da goga.
Yana da muhimmanci a goge hannaye da kyau kuma a bushe su da tawul mai tsabta domin ƙwayoyin cuta suna iya kasancewa a hannaye a cikin ruwa.
Bayan bushewa, rufe ruwan ta amfani da tawul na takarda (kuma buɗe duk wata hanyar fita idan ya cancanta).
Wannan zai hana hannayenku sake kamuwa da wannan cutar.
"Manufar wanke hannu a cikin yanayin kiwon lafiya shine kawar da cututtukan da ke tattare da su da kuma hana su yaduwa".
Jaridar New England Journal of Medicine ta ruwaito cewa wanke hannu ya zama abin da ba a yarda da shi ba a yawancin wuraren kiwon lafiya, wanda ke haifar da ƙarin likitoci da ma'aikatan jinya da ke mantawa da wanke hannayensu kafin su taɓa marasa lafiya, suna yada ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da sauran hanyoyin sauki na iya rage yawan jini da ke tattare da kateter da kashi 66 cikin ɗari. Hukumar Lafiya ta Duniya ta buga wata takarda game da wanke hannu da tsabtace hannu a cikin fannonin kiwon lafiya.
Ana kuma iya samun tsarin tsabtace hannu na ƙungiyar don amsar jama'a a shafin yanar gizon.
An yi wani muhimmin bita da Whitby et al.
Idan ana buƙatar sanarwar bin ƙa'idodin kulawa, kayan aikin kasuwanci na iya auna da tabbatar da tsabtace hannu.
"Kungiyar Lafiya ta Duniya ta kira wanke hannu ""lokatai biyar""".
Bayan sun kamu da jini ko kuma ruwa
kafin aikin da ba shi da gurɓataccen abu, da kuma
Bayan kula da mai haƙuri. Ƙara sunadarai masu kashe ƙwayoyin cuta zuwa sabulu (sabulu na maganin cututtuka ko na ƙwayoyin cuta) yana nuna mai wanke hannu.
Ana buƙatar irin wannan aikin cirewa kafin aikin tiyata ko kuma a cikin gida inda ƙwayoyin cuta masu jurewa da ƙwayoyin cuta ke yaduwa. Don yin aikin tiyata, ana buƙatar 'mashi' hannuwanku, bututun wanka wanda za'a iya buɗewa da rufewa ba tare da taɓa hannu ba, tawul ɗin bushe don bushewa bayan wanke hannuwanku, wanke wasu chlorhexidine ko iodine, da kuma goga mai bushe don shafawa, da sauran kayan aikin kashe ƙwayoyin cuta don tsabtace ƙusa.
Dole ne kowa ya sa kayan ado.
Wannan aikin yakan ɗauki minti biyu zuwa shida kafin a wanke hannuwanku da kuma ƙafãfunku.
Ba a bukatar lokaci mai tsawo na gwaji (minti 10) ba.
A lokacin da ake yin wanka, ya kamata a hana ruwa daga igiya ya koma hannayenka.
Bayan an gama wanke hannaye, sai a bushe hannayen da zane mai tsabta kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu kafin a kula da marar lafiya da kuma bayan an gama kula da shi.
Don sarrafa cututtukan staph a asibitoci, an gano cewa mafi girman fa'idar wanke hannu yana da kashi 20% na wankewar farko, kuma ƙaramin ƙarin fa'ida yana da ƙaruwa da yawa idan yawan wanke hannu ya wuce 35%.
Wanke hannu da sabulu na yau da kullun yana haifar da fiye da sau uku na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Amma sabulu da ruwa sun fi inganci fiye da kayan wanke hannu na barasa don rage kwayar cutar H1N1 da Clostridium difficile daga hannaye. Matsaloli don inganta tsabtace hannu a cibiyoyin kiwon lafiya na iya haɗawa da koyar da ma'aikata game da wanke hannu, ƙara wanke hannu da barasa, da rubutaccen bayanin kula da magana ga ma'aikata.
Ana bukatar ƙarin bincike don sanin ko waɗanne daga cikin waɗannan hanyoyin ne suka fi tasiri a wurare daban -daban na kiwon lafiya.
A ƙasashe masu tasowa, ana ganin wanke hannu da sabulu da kuma sabulu a matsayin kayan aiki mai mahimmanci don kiyaye kuɗi, lafiya da abinci mai kyau.
Duk da haka, rashin ingantaccen samar da ruwa, sabulu ko kayan wanke hannu a gidajen mutane, makarantu da wuraren aiki yana sanya ƙalubalen cimma ƙa'idodin wanke hannu na duniya.
Misali, duk da cewa akwai wasu hanyoyin da ba su da tsada don gina wuraren wanke hannu, a yawancin yankunan karkara na Afirka, akwai karancin wuraren wanke hannu kusa da kowane gidan wanka na sirri ko na jama'a.
Amma, ƙananan wanke hannu na iya zama sakamakon al'ada da aka kafa maimakon rashin sabulu ko ruwa.
Sanarwa da ilimantarwa game da wanke hannu da sabulu na iya tasiri yanke shawara na manufofi, haɓaka wayar da kan jama'a game da fa'idodin wanke hannu da haifar da canji mai ɗorewa a cikin ɗabi'ar jama'a.
Don wannan ya yi aiki yadda ya kamata, kulawa da kimantawa suna da mahimmanci.
Binciken da aka yi na bincike 70 ya gano cewa hanyoyin da al'umma ke amfani da su suna da tasiri wajen ƙara wanke hannu a cikin LMICs, yayin da kamfen ɗin talla na zamantakewar ba shi da tasiri. Misali ɗaya na inganta wanke hannu a makarantu shine tsarin tauraro uku na UNICEF wanda ke ƙarfafa makarantu su ɗauki matakai masu sauƙi, marasa tsada don tabbatar da ɗalibai suna wanke hannayensu da sabulu, a tsakanin sauran buƙatun tsabta.
Idan aka cika ƙananan ƙa'idodi, makarantu na iya haɓaka daga tauraro ɗaya zuwa uku.
Gina wuraren wanke hannu na iya zama wani ɓangare na kamfen ɗin wayar da kan jama'a game da wanke hannu don rage cututtuka da mutuwar yara.
Wani misali kuma shine yakin wayar da kan jama'a game da wanke hannu a duniya wanda ke ƙoƙarin kawo canji a cikin halayyar. Saboda annobar coronavirus ta 2019-2020, UNICEF ta ƙarfafa inganta emojis na wanke hannu.
Wasu ƙananan karatu suna kallon jimlar farashin wanke hannu a cikin ƙasashe masu tasowa dangane da DALYs.
Amma, wani bincike ya nuna cewa ƙarfafa wanke hannu da sabulu ya fi sauran hanyoyin tsabtace ruwa da tsabtace jiki tasiri.
Mahimmancin wanke hannu ga lafiyar ɗan adam, musamman ga mutanen da ke cikin mawuyacin yanayi, kamar mata masu haihuwa ko sojoji da ke cikin asibiti, an fara gane su ne a tsakiyar karni na 19 ta hanyar majagaba biyu na tsabtace hannu: likitan Hungary Ignaz Semmelweis wanda ke aiki a Vienna, Hungary da kuma Florence Nightingale, Ingilishi wanda ya kafa aikin jinya na zamani.
A lokacin, mutane da yawa sun gaskata cewa ƙamshi mai ƙanshi da ake kira miasma ne ke jawo cututtuka.
Cutar da ke tattare da abinci da cututtukan da ke tattare da kiwon lafiya a cikin shekarun 1980s sun sa Cibiyoyin Kula da Cututtuka da Rigakafin Amurka su ƙara inganta tsabtace hannu a matsayin hanya mai mahimmanci don hana yaduwar cutar.
Cutar mura ta 2009 da cutar COVID-19 a cikin 2020 sun haifar da ƙarin wayewa a cikin ƙasashe da yawa game da mahimmancin wanke wanka da sabulu don kare kanku daga irin waɗannan cututtukan.
A Jamus, alal misali, an rataye alamun tallace-tallace tare da hanyoyin wanke hannu daidai a wuraren wanka na jama'a da gine-gine da kuma wuraren wanke hannu kusa da wuraren wanka a filayen jirgin sama.
Wanke hannuwanmu yana nufin cewa mun ƙi ɗaukan hakkinmu ko kuma mu yi tarayya da abin da ya faru.
Wannan furucin ya samo asali ne daga ayar Littafi Mai Tsarki a cikin Linjilar Matta inda Bilatus Ba-Penteco ya wanke hannunsa kafin ya yanke shawarar gicciye Yesu Kristi, amma ya zama sanannen magana a wasu al'ummomin Ingilishi.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta da karfi don wanke lamirinta na laifi da aka yi da launi don aikata laifukan da ta sa mijinta ya aikata.
Ya kuma gano cewa mutane suna yawan yin wanka da kuma amfani da kayan wanke hannu bayan sun tuna ko kuma sun yi tunani game da lalata.
Bugu da ƙari, ba sa iya yin wasu ayyuka na biyan kuɗi, kamar yin aikin sa kai don tsabtace jiki, wanda aka yarda su wanke hannayensu bayan irin wannan tunani.
Addinai suna buƙatar wanke hannu don tsabta da dalilai na alama. Yin wanke hannu na alama, amfani da ruwa ba tare da sabulu don wanke hannu ba, tsari ne na wanke hannu a cikin addinai da yawa, gami da Baha'i, Hindu, Tevilah da Netelai Yadaim a Yahudanci, Lavo in Kiristanci da Wudu in Musulunci. Musamman bayan wasu ayyuka, addinai suna buƙatar wanke hannu mai tsabta.
Addinin Hindu, Yahudanci da Musulunci sun umurci wanke hannu bayan amfani da bayan gida.
Haka kuma, addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci suna buƙatar wanke hannu kafin da kuma bayan kowane abinci.
Kula da haɗarin aiki don COVID-19
Kula da haɗarin wurin aiki don COVID-19 yana ba da damar kiyaye matakan tsaro na wurin aiki don hana cutar coronavirus 2019 (COVID-19).
Ingantaccen kula da haɗari a wurin aiki ya dogara da wurin aiki da nau'in aiki, da kuma kimantawa na tushen haɗari, yaduwar al'umma da yanayin haɗarin mutum na samar da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan haɗari masu ƙarancin haɗari sune ayyukan da ke da ƙarancin hulɗa da al'umma da abokan aiki, wanda ke buƙatar matakan rigakafin kamuwa da cuta na asali kamar wanke hannu, kiyaye ma'aikata a gida idan suna rashin lafiya, ci gaba da aikin numfashi da aikin tsabtace jiki da cututtukan cututtuka.
Ayyukan haɗari masu matsakaici sune mutanen da ke aiki tare da mutanen da ba a san su ba ko kuma waɗanda ake zargi da cutar COVID-19 amma waɗanda za su iya kamuwa da cutar ta hanyar ci gaba da yaduwa ko tafiya ta duniya.
Wannan ya haɗa da mutanen da ke tafiya daga cikin al'umma, kamar makarantu, wuraren da mutane ke da yawa da kuma manyan wuraren sayarwa.
Don wannan rukunin, kula da haɗari, dangane da matakan rigakafin kamuwa da cuta na asali, ya kamata ya kasance tare da kayan numfashi da kayan kariya na sirri waɗanda ke amfani da matattarar iska mai ƙarfi idan mutum yana da COVID-19.
OSHA ta ɗauki haɗarin haɗari ga waɗanda aka sani ko ake zargi da cutar COVID-19 a matsayin masu haɗari sosai, tare da ƙara haɗari sosai idan ma'aikata suna tattara samfuran daga mutanen da aka sani ko ake zargi da COVID-19 yayin aiwatar da ayyukan iska.
Gudanar da haɗari da suka dace ga waɗannan ma'aikata sun haɗa da sarrafa injiniya, kamar su iska mai guba da kayan aikin kariya na sirri.
Cutar COVID-19 na iya haifar da tasiri mai yawa a wuraren aiki.
Ma'aikata na iya barin aiki saboda rashin lafiya, kula da wasu, da tsoron haɗari.
Za a iya canja tsarin kasuwanci, har da irin kayayyakin da ake bukata da kuma yadda ake sayan su (watau a lokacin da ba a jiran mutane da yawa a layi, ta wurin mai kawo kaya, ko kuma ta wurin mai ba da sabis na wucewa).
A ƙarshe, jigilar kayayyaki a wuraren da ke da ƙarancin COVID-19 na iya zama cikin matsala. Za a iya amfani da shirye-shiryen yaduwar cutar da shirin amsawa don ɗaukar matakan kariya.
Akwai tsare -tsare da yawa da suka shafi wurare da nau'ikan ayyuka, waɗanda suka haɗa da tushen haɗari, tushen haɗari daga gida da al'umma, da kuma tushen haɗarin kowane ma'aikaci ga tsofaffi da manyan matsalolin lafiya.
Hakanan suna bayyana abubuwan da ake buƙata don hana waɗannan haɗarin da kuma shirye -shiryen da za a yi don yiwuwar barkewar cutar.
Shirye-shiryen shirye-shiryen cututtuka da shirye-shiryen amsawa na iya zama shawarwari na ƙasa ko yanki.
Manufofin mayar da martani ga annobar sun taimaka wajen rage yaduwar cutar tsakanin ma'aikata, hana mutane daga fuskantar matsalolin kiwon lafiya, kare kasuwancin da rage mummunan tasiri ga sauran ɓangarorin sarkar samarwa.
Matsayin cutar a wurin kasuwancin zai ƙayyade yadda za a amsa.
Ana amfani da tsarin tsarin kula da haɗari don ingantaccen aiki da kuma kula da haɗari ga ƙungiyoyi.
A wuraren da ba za a iya kawar da haɗarin COVID-19 ba, ingantattun hanyoyin sarrafawa sune sarrafa injiniya, waɗanda ke da taimakon kulawa ta gwamnati da kuma ƙarshe kayan kariya na mutum.
Kulawa na injiniya yana iya zama hanya mai tsada don ware ma'aikata daga haɗarin da ke tattare da aiki, ba bisa halayyar ma'aikaci ba.
Gudanarwa yana nufin canje-canje a cikin manufofin aiki ko hanyoyin aiki, wanda ke haifar da aiki daga ma'aikaci ko mai aiki.
Kayan aikin kare kai na mutum yana taimakawa rage wasu haɗari, kodayake yana da tasiri ƙasa da na injiniya da sarrafawa.
Duk nau'ikan kayan kariya na mutum dole ne a zaɓa su, kamar yadda ake buƙata, a kan ma'aikaci, a sanya su yadda ya dace (misali, filtata), a daidaita kuma a cikin yanayin da ya dace, a bincika su akai-akai, a gyara su kuma a maye gurbinsu, kuma a cire su yadda ya kamata, a tsabtace su kuma a adana su ko a taimaka wajen kawar da gurɓataccen abu.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da haɗari kaɗan suna da ƙarancin hulɗa da al'umma da sauran abokan aiki.
Matakan kariya na asali na kamuwa da cuta da aka ba da shawarar ga duk wuraren aiki sune yawan amfani da hannayen hannu, ba da shawarar mutane su zauna a gida idan suna rashin lafiya, ɗaukar matakan da suka shafi numfashi kamar tari da hancin, shirya kayan datti da datti, kasancewa a shirye don aiki ta waya da nisantar sauye-sauye, ƙarfafa ma'aikata kada su yi amfani da kayan aikin wasu mutane, da kuma tsabtace wurin aiki akai-akai.
Ganowa da sauri da kuma gano mutanen da ke iya kamuwa da cutar muhimmin mataki ne na kare ma'aikata, abokan ciniki da sauran mutane a wuraren aiki.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun ba da shawarar cewa mutanen da ke da mummunan matsalar numfashi da zazzabi, zazzabi, ko wasu alamun cutar su kasance a gida har tsawon awanni 24, amma kada su yi amfani da kowane magani don rage zazzabi ko canza wasu alamun cutar, kuma manufofin hutu na rashin lafiya ya kamata su kasance masu sassauƙa, suna ba ma'aikata damar zama a gida, kuma ma'aikata su san su.
A cewar OSHA, ayyukan haɗari masu matsakaici suna buƙatar kusanci na yau da kullun, wato, kusan ƙafa shida (1.8 m) tare da mutanen da ake zargi ko ba a san su da COVID-19, amma waɗanda ke da yiwuwar kasancewa saboda ci gaba da yaduwar al'umma na SARS-CoV-2 ko waɗanda suka yi balaguro kwanan nan zuwa ƙasashe masu yaduwar COVID-19.
Waɗannan sun haɗa da ma'aikatan da ke da alaƙa da gida, kamar makarantu, wuraren da ke da yawan jama'a, da sauran manyan kantunan sayar da kayayyaki. Don wannan da kuma ƙungiyoyin haɗari, ana buƙatar sarrafa aikin injiniya tare da ingantaccen iska, ƙara yawan numfashi, sanya shinge na zahiri kamar su filastik, da kuma kula da abokan ciniki ta hanyar taga mai wucewa. Gudanarwa don wannan da ƙungiyoyin haɗari sun haɗa da ƙarfafa ma'aikata marasa lafiya su zauna a gida, canza tarurruka na fuska da fuska a cikin taron kama-da-wane, ƙayyade canjin canji na yau da kullun, dakatar da ci gaba da yanayin da ke haifar da alamun COVID-19, amfani da hanyoyin sadarwa masu haɗari yayin da muke aiki, kamar amsawa ga masu haɗari, yin amfani da wayar hannu da wasu matakan kariya na sirri da ke nuna yadda za a iya yin aiki, da kuma ƙarfafa masu kula da lafiyar jiki da masu kula da lafiyar jiki, da kuma yin amfani da takamaiman matakan kariya da ke nuna yadda za a magance COVID-19, da kuma yin amfani da takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman takamaiman tak
Ma'aikata a cikin wannan rukunin haɗarin ba sa yawan amfani da injin numfashi.
Idan wani ya kamu da rashin lafiya a cikin jirgin sama, kulawar da ta dace don kare ma'aikatan da sauran fasinjoji ya haɗa da keɓewar mai rashin lafiya tare da nisan ƙafa 6, yi wa mai rashin lafiya hidima da kuma ba da abin rufe fuska na gaba-gaba. ko neman rufe baki da hanci da kayan shafawa lokacin da suke rashin lafiya ko hancin.
Ma'aikatan jirgin sama suna buƙatar sanya safofin hannu masu amfani da lokaci ɗaya yayin kula da matafiya marasa lafiya ko taɓa ruwa na jiki ko abubuwa masu haɗari, kuma suna buƙatar amfani da ƙarin kayan kariya na sirri idan matafiya suna da zazzabi, tari mai ɗorewa, ko wahalar numfashi.
Ya kamata a zubar da safofin hannu da sauran abubuwa da za a iya zubar da su a cikin jakar haɗarin halittu kuma a tsabtace da kuma kashe ƙwayoyin cuta. Ka'idojin kula da haɗari don jigilar kayayyaki na kasuwanci, gami da jiragen ruwa da sauran jiragen fasinja sun haɗa da jinkirta tafiya da keɓewa da sanar da lokacin rashin lafiya. sanar da cibiyar kiwon lafiya a cikin jirgin nan da nan idan zazzabi ko wasu alamomi suka bayyana a cikin jirgin.
Hanya mafi kyau ita ce a cikin ɗakunan keɓewa. Ga makarantu da cibiyoyin kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci da tsaftacewa ko kawar da kamuwa da cuta, ko da kuwa idan mutum mai cutar ya shiga ginin makaranta kuma ba tare da la'akari da yaduwar al'umma ba.
A cikin yanayin yaduwar al'umma mai sauƙi zuwa matsakaici, ana iya aiwatar da dabarun nisantar da jama'a kamar soke shirye-shiryen tafiya, warware tarurruka da sauran abubuwan da suka shafi koyo a makaranta, dakatar da manyan tarurruka a ɗakunan mawaƙa ko gidajen abinci, faɗaɗa tazara tsakanin kujeru, raba lokutan isowa da fita, hana baƙi marasa mahimmanci, da kuma gano ofisoshin keɓewa don gwajin yara masu alamun cutar.
A lokacin da akwai yaduwar jama'a, ban da dabarun nisantar jama'a, ana iya ɗaukar rufe makarantu a matsayin zaɓi. CDC ta kiyasta cewa akwai ƙananan haɗarin lafiya na gaggawa ga ma'aikatan tilasta yin doka da ke yin ayyukansu na yau da kullun.
Ana ba da shawarar cewa jami'an tilasta bin doka waɗanda ke da alaƙa da mutane da aka kama ko ake zargi da COVID-19 su bi ƙa'idodin da suka dace da na likitocin gaggawa, gami da kayan kariya na sirri masu dacewa.
Idan akwai kusanci a lokacin damuwa, ma'aikata su tsabtace bel ɗin aiki da kayan aiki da fesawa ko gogewa don hana kamuwa da cuta kafin sake amfani da kayan aiki ko kayan aiki, kuma su ajiye da zubar da PPE da kayan aiki da kayan wanki da aka yi amfani da su ta amfani da tsarin aikin da aka tsara.
OSHA ta nuna wasu ma'aikatan kiwon lafiya da ma'aikatan kula da gawawwaki a matsayin masu haɗari ko haɗari mai haɗari.
Ayyukan haɗari masu haɗari suna ba da kiwon lafiya, tallafi, dakin gwaje-gwaje da waɗanda aka sani ko ake zargi da cutar COVID-19.
Wannan babban haɗari ne idan ma'aikata suna aiki tare da ma'aikatan da ke aiki a kan hanyoyin samar da aerosol ko marasa lafiya waɗanda ke da alamun COVID-19.
Hanyoyin da ke haifar da ƙwayoyin iska, shigar da bututu a cikin numfashi, hanyoyin da ke haifar da salla, bronchoscopy wasu hanyoyin haƙori da gwaje-gwaje ko kuma tattara samfurin kariya.
Ayyukan da ke cikin ɗakunan ajiya masu haɗari sun haɗa da aikin waɗanda ke shirya gawawwakin waɗanda ake zargi da COVID-19 a lokacin mutuwarsu, wanda ke nufin cewa masu yin autopsies daga Hanoi za su kasance cikin haɗari. Ƙarin sarrafa aikin injiniya don waɗannan ayyukan shine sanya waɗanda ake zargi ko sanannun masu cutar COVID-19 a cikin ɗakin keɓewa, idan suna aiki da ke fitar da ƙananan ƙwayoyin iska.
Ana iya buƙatar na'urar numfashi ta musamman don wasu kiwon lafiya ko ajiyar gawa.
Ana buƙatar kiyaye samfurori a matakin 3 na biosafety.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa marasa lafiya masu zuwa su kasance a cikin iyakantaccen wuri saboda zargin COVID-19. Baya ga PPE, OSHA ta ba da shawarar cewa masu aiki da ke aiki a cikin iska da ke samar da ƙwayoyin cuta su yi amfani da injin numfashi tare da nesa mai nisan ƙafa 6 daga waɗanda ake zargi da cutar SARS-CoV-2.
A Amurka, NIOSH ta ba da izinin yin amfani da abin rufe fuska na N95 ko kuma a yi amfani da shi a cikin tsarin kare numfashi na duniya, wanda ya haɗa da gwaji, horo da gwajin lafiya.
Sauran nau'ikan kayan numfashi suna ba da kariya mai yawa kuma suna haɓaka jin daɗin aiki. WHO ba ta ba da shawarar rufewa gaba ɗaya ba, saboda COVID-19 cuta ce ta numfashi kuma ana watsa ta ta ruwa na jiki.
WHO ta ba da shawarar cewa ma'aikatan da ke yin gwaji a ƙofar shiga ne kawai za su sa abin rufe fuska na tiyata.
Ga mutanen da ke kula da marasa lafiya na COVID-19 ko kuma ke ɗaukar marasa lafiya ba tare da fitar da ƙwayoyin iska ba, WHO ta ba da shawarar yin amfani da abin rufe fuska, abin rufe ido ko abin rufe fuska da safar hannu.
Idan an yi aikin sarrafa iska, za a maye gurbin abin rufe fuska na tiyata da N95 ko FFP2 mai maye gurbin numfashi.
Dangane da rashin wadatar PPE a duniya, WHO ta ba da shawarar rage buƙatun PPE ta hanyar telemedicine, ƙuntatawa ta jiki, wato, kula da kai tsaye ta hanyar shigarwa kawai ga waɗanda ke buƙatar kulawa kai tsaye, amfani da kayan kariya na mutum don iyakantaccen aiki, kula da mutane da yawa ba tare da fitar da kayan numfashi ba, sarrafa sarkar samar da kayan kariya na mutum da daidaitawa don marasa alamun cutar.
Daga: Katherine Maher, Shugaba na Wikimedia Foundation
B: Duk ma'aikatan Gidauniyar Wikimedia
Maganar: [Covid-19] rage matsin lamba da shirya don gaba
Ranar da aka aika: Maris 14/2020, 00:24 UTC
Mai ba da izini: CC0: Babu haƙƙin mallaka
A wannan watan, mun sami kanmu a cikin yanayi na musamman.
Cutar COVID-19 ta bayyana alaƙarmu ta ɗan adam a duniya da kuma alhakinmu ga juna.
Duk da cewa ba mu da misali ga kalubalen, amsar da ta fi dacewa ita ce fahimtar juna, hadin kai da gina al'umma a duniya, wanda shine cibiyar wannan yarjejeniya.
Abokantaka da kulawa da muke gani a tsakanin ma'aikatanmu ta hanyar imel, tarho da hira da juna babban tabbaci ne na yadda muke ƙoƙari mu yi aiki tare da mutane masu ban mamaki.
Ina ganin kaina mai sa'a da na san ku duka a matsayin abokan aiki.
A makon da ya shige, wani ya yaba mana don aikin da muke yi.
Wannan alama ce mai mahimmanci game da yadda ma'anar duniya ta koma Wikipedia da kuma yadda wannan muhimmin abun ciki zai kasance a kan layi kuma kowa zai iya samunsa.
Aikinku zai sa hakan ya yiwu, ko kun riƙe matsayin, ko abokan aikinmu suna samun albashi, ko kuma al'ummarmu tana da aminci.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa yanzu fiye da kowane lokaci.
Wannan shine lokacin da ba kawai abin da muke yi ba amma yadda muke yi ke tasiri a duniya.
Wannan aikin da rawar da kuke takawa yana da mahimmanci, don haka za mu iya yin wasu canje-canje masu mahimmanci a yadda muke aiki tare, farawa daga mako mai zuwa.
A lokacin, muna yin wa'azi a ƙasashen waje.
Kamar yadda Robyn ya bayyana a baya, C-Team ya gana da daren jiya don tattauna tsarinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A lokacin, mun yi tunani a kan abin da ya kamata mu yi don mu ci gaba da kasancewa da ƙungiyarmu.
Mun so mu daina damuwa kuma mu ci gaba da hidimarmu.
Idan kuna son ku sake kira, ba laifi.
Ga dukan ma'aikata, masu hutu da kuma ma'aikatan wucin gadi:
Za a rage lokacin aikinmu na yau da kullum zuwa awa 4 a rana ko kuma awa 20 a mako har sai an ba da ƙarin bayani.
Ba hutu ba ne - idan za ka iya yin aiki na tsawon lokaci, aikin zai amfane ka.
Amma ba za mu iya sanin inda duniya za ta je ba, kuma ko kula da iyalinka, zuwa shagon, ko zuwa asibiti, lafiyarka ita ce abin da muke so.
Ba ma bin sa'a.
Idan ba ku da gaskiya, kada ku yi aiki.
Ba ma bukatar mu faɗi hakan, amma za mu yi.
Babu ranar rashin lafiya ko PTO da ake buƙata - kawai kuna buƙatar gaya wa ma'aikacin gudanarwa kuma ku tabbatar da cewa ƙungiyar ku ta bincika kalandarku da jadawalin don tabbatar da cewa an rufe mahimman sassan aiki.
(Idan sakamakon gwajin ku na COVID-19 ya tabbata, da fatan za a sanar da Brian don taimaka muku da tallafi da tabbatar da cewa shari'arku ta sami kulawa ta dace daga gwamnati).
Ana biyan mutane a kowane sa'a.
"Mun kasance a baya, kuma za mu ci gaba da ba da abin da muke da shi ga 'yan kwangilarmu da ma'aikatanmu na sa'o'i".
Ana biyan kowa a lokacin da yake aiki.
Wannan ya haɗa da waɗanda ba za su iya aiki ba domin rashin lafiya.
Idan kana son aiki, za mu taimaka maka.
Mutane da yawa suna amfani da aiki don su kawar da damuwarsu daga duniya.
Aikinmu zai iya kawo sakamako mai kyau, musamman a wannan lokacin.
Wannan kuma game da kula da kanka ne.
Tambayarmu ita ce muyi magana da hukumomin ku don sanin abin da za mu yi tsammani da kuma shirya.
Wasu ayyuka suna da muhimmanci.
Akwai abubuwa da muke bukatar mu ci gaba da yi.
SRE, hanyoyin HR, amintattu da tsaro da ƙungiyoyin tara kuɗi (da sauransu) suna yin aiki mai mahimmanci wanda zai buƙaci ƙarin tallafi.
A kowane sashe, muna fara aiwatar da manufa da mayar da hankali ga abin da muke bukata don cimma burinmu.
Muna da ayyuka da yawa da za mu yi, kuma muna mai da hankali ga abin da muke bukata.
A yau, ba laifi ba ne mutum ya riƙa makara.
Ba mu da shirin ninka sa'o'in aiki don kammala ayyukan da aka jinkirta bayan annobar ta wuce.
A yau, ba za ka yi aiki na tsawon lokaci ba don ka cika wasu takamaiman kwanakin da aka ba ka.
Mun yarda da cewa yanayi ya canza, kuma muna aiki don saita sabbin manufofi da jadawalin lokaci idan ya cancanta.
Menene ake ƙirƙirawa a APP (Tsarin Shekara-shekara)?
Don daidaitawa da sabon yanayinmu da lokutan aikinmu na yau da kullun, muna buƙatar daidaita lokacin nasarar shirinmu na shekara-shekara na 2020-2021.
Manufarmu ita ce mu ba da shawarar tsawaita shirinmu na 2019-2020, wanda zai ba ma'aikata damar tsara ayyukan da suka wajaba, kula da kansu, kula da danginsu, da kuma biyan bukatun waɗanda ke son yin aiki na ɗan lokaci.
Wannan ƙarin lokacin yana rage matsin lamba da matsin lamba a kan ƙungiyar gaba ɗaya.
Za mu sanar da ma'aikatanmu ga kwamitin a mako mai zuwa, kuma za mu sanar da wakilai da ƙungiyoyi matakin da za a bi nan da nan da muka sami bayanin.
Na gode da jagorancin da kuka nuna wa ƙungiyar APP a wannan lokacin.
Yanayin ofishi, haɗari, da tsabta
A makon da ya gabata, mun sami labarin cewa ɗaya daga cikin abokan aikinmu na SF na iya kamuwa da cutar COVID-19.
Amma, a matsayin mai kiyayewa, mun ɗauki ma'aikatan rigakafin cutar zuwa ofishin San Francisco.
Sun tabbatar da cewa kowane bene ba shi da kamuwa da cuta ta hanyar amfani da cakuda cututtukan da ake amfani da su a asibiti, gami da masu karɓar ƙuƙwalwa da kuma bankunan ɗagawa da ke isa ga bene.
Ginin yana da tsarin kula da kansa ta hanyar amfani da kayayyakin da ke kare lafiyar masu haya.
Mun tabbata cewa za a shirya ofishin sosai sa'ad da muka koma.
Ofishinmu na DC yana cikin WeWork kuma sun raba ayyukan COVID-19 tare da mu da ma'aikatanmu a DC.
A makon da ya gabata, ofishinmu na DC ya bi ƙa'idodin San Francisco don yin aiki daga gida.
Kamar yadda wasu ma'aikatanmu a NYC suka sani, muna kuma tattaunawa game da haya a Brooklyn.
Ana ci gaba da tattaunawar, amma za a iya jinkirta hakan.
Wasu abokan aikinmu suna aiki daga gida a karon farko.
Abokan aikinmu na dogon lokaci sun san cewa daidaitawa na iya zama, kuma suna so su ba ku wasu shawarwari:
Ka rage tsawon taron zuwa awa ɗaya ko biyu.
Idan ana bukatar zaman da ya fi haka, ka yi la'akari da yadda za ka raba zaman zuwa wasu kwanaki.
Ka bayyana abin da za ka yi a taron, ka tsara jadawalin taron, kuma ka aika da littattafan da za ka karanta a gaba.
Ka sa bidiyo ta zama tsoho, wanda ya haɗa da kayan aiki kamar Google Docs da Zoom don haɓaka haɗin kai tsaye da sadarwa.
Ka sa wani ya yi wa kowane taro jagora, ya kula da hirarraki, ya kula da jerin masu magana, kuma ya taimaka maka ka rubuta (ko kuma ka yi rubutu tare).
Idan kana son kayan ji na kunne, aika imel don tallafi na fasaha.
Ka yi amfani da kuɗin da ka biya don biyan kuɗi.
Shiga shafin #remoties don tattauna ayyukan da aka rarraba tare da abokan aikinku
Ƙungiyar Ma'aikata tana neman hanyoyin da za a yi aiki da ƙarin aiki a cikin tushe ta hanyar samar da jagorar ergonomics bisa ga yanar gizo.
A makon da ya gabata, mun nemi masu karɓar tallafi na al'umma su soke abubuwan da suka faru a Wikimedia Fund, kamar Editatons, har sai WHO ta ce annobar ta ƙare.
Mun sanar da su cewa mun fahimci cewa neman sokewa na iya sa ya zama da wahala a cika yarjejeniyar tallafi da aka amince da ita a baya, kuma ba wanda za a hukunta saboda jinkiri ko sauya waɗannan manufofin.
Za mu yi ƙarin jagororin rigakafi a Wikimania da sauran taron yanki da iyakantaccen taron al'umma a mako mai zuwa.
Halin da al'ummomin duniya ke nunawa ba kawai baƙin ciki bane amma kuma jin daɗi saboda hangen nesa mai kyau don mai da hankali kan al'ummarsu, Wikimedia da sauransu saboda rashin tsaro.
Game da nan gaba, CRT tana aiki don ƙirƙirar shafi a Meta-Wiki, tare da manufar sarrafa matsin lamba ga al'umma da ci gaba da hulɗa da su.
Kulawa da al'amuran da suka shafi COVID-19
Muna aika gayyata zuwa taron ma'aikata na musamman a ranar Alhamis mai zuwa 14:00 UTC/07:00 PT.
Muna amfani da wannan lokacin don raba ƙarin sabon bayani, amsa tambayoyinku da kuma ciyar da lokaci akan sadarwa.
Muna cikin wannan tare kuma muna taimakon juna yadda za mu iya.
A wannan lokacin, zaku iya samun bayanai daga wannan imel ɗin da kuma sauran bayanan da suka shafi COVID-19 akan Wiki na Office.
CRT yana sabunta waɗannan shafuka kuma yana sa duk bayanan su kasance a wuri ɗaya.
Bugu da ƙari, muna aiki don ci gaba da tuntuɓar ma'aikata, waɗanda ke aiki a ƙasashe masu fama da cutar.
Idan kuna buƙatar taimako game da tafiya, yanayi, babban aiki ko ƙalubalen ɗaukar hoto, ko kuma duk wani abu, don Allah kada ku yi jinkirin sanar da CRT kuma kuyi aiki tare da su.
Muna nan don bayar da tallafi da aiwatar da shi idan an buƙata.
Idan akwai wani abu da ya shafi ruwan inabi na sirri wanda ke buƙatar kulawa, aika imel zuwa Bryan Judan - Daraktan Ayyuka na Duniya na Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙungiyar Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙungiyar Ƙungiyar Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙungiyar Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ Ƙ
Babu wani cikin waɗannan canje-canjen da ya kamata ya nuna cewa mun yi watsi da aikinmu.
Amma a wannan lokacin, aikinmu da alhakinmu dole ne a daidaita su ta hanyar da ba mu taɓa gani ba.
Muna bukatar mu tallafa wa juna, mu tallafa wa ayyukanmu, kuma mu ba da hidima da duniya take bukata don mu ci gaba da aiki tare.
aikin da aka tsara zai zo a lokacin da ya dace.
A yanzu, lokaci yayi da za mu tallafawa juna da kuma samar da wuraren aiki don ayyukan da ke zuwa a cikin makonni da watanni masu zuwa.
Dukkanku kuna da mahimmanci don tabbatar da hakan, kuma muna son ku duka ku kare kanku da dangin ku don mu zama mafi kyau lokacin da ya zama dole.
Yanzu don Allah - ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine ta kasance a cikin CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da kuma ƙungiyar gudanarwa (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
b'Angiotensin -converting enzyme 2 (ACE2) wani enzyme ne da ke cikin ƙwayoyin cuta a cikin huhu, jijiyoyin jini, zuciya, koda, da hanji.
ACE2 yana hana aikin enzyme mai canza angotensin (ACE) ta hanyar rage matakin angostatin-II da haɓaka Ang (1-7), yana mai da shi mai yiwuwa maƙasudin magunguna don magance cututtukan jijiyoyin jini. ACE2 yana aiki azaman hanyar shiga cikin sel don wasu coronavirus.
Ana kiran enzyme a cikin mutane hACE2.
Angostatin-enzyme 2 wani sinadarin zinc ne mai dauke da sinadarin iron wanda ake samu a cikin endothelial da sauran kwayoyin halitta.
Ana sanya furotin ACE2 zuwa yankin N-terminal peptidase M2 da yankin C-terminal collectrin renal amino acid transporter.
ACE2 shine nau'in membrane na I wanda yake da cutarwa, kuma an samo shi a cikin huhu da sauran sassan jiki saboda enzyme yana da yanki mai aiki.
Wani enzyme mai suna Shadas ya yanke ɓangaren waje na ACE2 daga ɓangaren ƙwayoyin halitta, kuma sakamakon ya zama furotin mai narkewa wanda aka saki cikin jini kuma a ƙarshe ya fita cikin fitsari.
Ana samun ACE2 a yawancin gabobin jiki: ACE2 yana da alaƙa da enzymes na ƙwayoyin alveolar na nau'in II na huhu, ƙananan hanji, ƙwayoyin jini da jijiyoyin jini da ƙwayoyin tsoka mai laushi a yawancin gabobin jiki.
Ana bayyana mRNA na ACE2 a cikin ƙwayar kwakwalwa, stratum, hypothalamus da ƙwayoyin kwakwalwa.
Babban aikin ACE2 shine daidaitawa na ACE.
ACE yana canza hormone angiotensin I zuwa angiotensin II mai ƙuntatawar jini.
ACE2 kuma yana yanke carboxyl-terminal amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) a cikin farji kuma yana sarrafa shi zuwa hydrolyzed zuwa vasodilator angiotestin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya kawar da [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin, da sauran peptides da yawa.
ACE2 kuma yana sarrafa membrane na SLC6A19, mai jigilar amino acid mara tsaka tsaki, wanda aka sani yana da alaƙa da cutar Heartburn.
A matsayin furotin mai wucewa, ACE2 yana aiki a matsayin babban wurin shiga ga wasu kwayoyin cutar coronavirus, gami da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, sun haɗa sunadarai na S1 na SARS-CoV da SARS-CoV2 zuwa ƙwayoyin ƙwayoyin cuta na ACE2 kuma suna ba da damar kwayar cutar da enzymes zuwa cikin ƙwayoyin cuta da kuma kewayawa.
Wannan aikin shigarwa yana buƙatar samfoti na S-protein akan mai sarrafawa na TMPRSS2, wanda a halin yanzu shine magani da ake bincike. Wannan ya sa wasu suka yi tunanin cewa zai iya taimakawa wajen yaƙar kamuwa da cuta ta hanyar rage matakin ACE2 a cikin kwayar halitta.
Koyaya, ƙungiyoyi da yawa na ƙwararru da hukumomin kulawa suna ba da shawarar ci gaba da maganin ACE mai hanawa da ARB na yau da kullun.
A cikin wani bita da meta-bincike da aka buga a ranar 11 ga Yuli, 2012, FDA ta gano cewa amfani da masu hana ACE yana da raguwar ciwon huhu na 34% idan aka kwatanta da sarrafawa.
Hakanan, haɗarin kamuwa da cutar huhu ya kasance daidai da marasa lafiya da aka kula da cutar ACE tare da haɗarin kamuwa da cutar huhu, musamman a cikin kwakwalwa da rashin ƙarfi na zuciya.
An kuma yi amfani da masu hana ACE don magance mutuwar da ke da alaƙa da ciwon huhu, kuma sakamakon ya kasance ƙasa da haɗarin ciwon huhu gaba ɗaya.
Kwayar halittar mutum ta ACE2 (rhACE2) ana tsammanin sabon magani ne don cutar huhu mai saurin tashi, wanda ke inganta haɓakar jini da iskar oxygen a cikin fararen alade da ke fama da cutar ta fatar jiki ta liposaccharide.
Rabin rayuwar rhACE2 a cikin ɗan adam kusan awanni 10 ne kuma farkon aikinsa yana da mintuna 30 ban da sa'o'i 24 na aiki (lokaci).
Yawancin binciken sun nuna cewa rhACE2 na iya zama kyakkyawan magani ga cututtukan da ke da ƙwayoyin cuta na renin-angiotensin system inhibitors (RAS inhibitors) ko kuma masu cutar angiotensin II. An kimanta rhACE2 mai shiga cikin gwaji don maganin cututtukan damuwa na numfashi mai tsanani.
Aikace-aikacen COVID-19 aikace-aikacen software ne na wayar hannu waɗanda aka tsara don taimakawa wajen bin diddigin ko gano hanyoyin gano mutane (lamba) waɗanda wataƙila sun haɗu da mutumin da ke da cutar.
A wasu sassan gwamnati da yankuna, an shirya ko kuma an gabatar da aikace-aikace da yawa tare da taimakon gwamnati.
An samar da tsarin da yawa don gina aikace-aikacen bin diddigin lamba.
Musamman, damuwa game da sirrin sirri ya taso game da tsarin da ke bin diddigin wurin masu amfani da aikace-aikacen.
Zaɓuɓɓukan ƙananan tsangwama sun haɗa da amfani da siginar Bluetooth don yin rajistar kusanci da mai amfani da sauran wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su yi aiki tare don daidaita ayyukan na'urori masu amfani da Bluetooth zuwa tsarin aiki na Android da iOS.
A China, gwamnatin kasar Sin, tare da haɗin gwiwar Alipay, ta haɓaka aikace-aikacen wayar hannu wanda ke sanar da 'yan ƙasa idan sun tuntuɓi mutane da ke da COVID-19.
Ana amfani da shi a birane sama da 200 na kasar Sin. Ana amfani da wata manhaja mai suna TraceTogether a Singapore.
An samar da aikace-aikacen ta hanyar al'ummar IT ta yankin da aka saki a matsayin tushen budewa kuma an ba da shi ga gwamnati. A Arewacin Macedonia, Gwamnatin ta ƙaddamar da aikace-aikacen Bluetooth-based  StopKorona! don saka idanu kan haɗari da kuma amsawa da sauri ga waɗanda ke da cutar.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka samar da manhajar.
Tun daga ranar 14 ga Afrilu, 2020, aikace-aikacen yana jiran izini don zama a cikin Google Play Store da Apple App Store.
"A ranar 12 ga Afrilu, gwamnati ta bayyana cewa aikace-aikacen neman lamba yana cikin babban ci gaba. Hakanan ana shirin yin irin wannan aikace-aikacen a Ireland da Faransa ("StopCovid") wanda zai fara aiki a cikin makonni".
Dukansu Ostiraliya da New Zealand suna la'akari da aikace-aikace dangane da aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha na shirin gabatar da aikace-aikacen geofencing don marasa lafiya na COVID-19 da ke zaune a Moscow don hana su barin gidajensu.
Ross Anderson, Farfesa a fannin Injiniyan Tsaro a Jami'ar Cambridge, ya lissafa matsaloli da yawa, gami da yiwuwar sakamako mara kyau na karya wanda zai iya amfani da shi ga tsarin aikace-aikacen da kuma idan amfani da aikace-aikacen ya iyakance ga ƙananan ɓangarorin jama'a.
"Domin magance damuwa game da yaduwar aikace-aikacen ɓatarwa ko cutarwa na ""coronavirus"", Apple ya sanya iyaka kan waɗanne nau'ikan kamfanoni za su iya ƙara aikace-aikacen da ke da alaƙa da cutar coronavirus zuwa Shagon App, yana iyakance su ga Zyphify ko manyan kamfanoni".
Google da Amazon sun sanya irin wannan ƙuntatawa.
Masu kare hakkin sirri sun nuna damuwa game da tasirin sa ido mai yawa ta amfani da aikace-aikacen coronavirus, musamman cewa kayan aikin leken asiri da aka kirkira don magance cutar coronavirus na duniya za su rushe da zarar barazanar ta wuce.
Amnesty International da wasu kungiyoyi sama da 100 sun yi kira da a kawo karshen irin wannan leken asiri.
Kungiyoyin sun sanar da sharudda takwas kan ayyukan gwamnati:
Dole ne kulawa ta zama ta doka, dole kuma mai araha.
Dole ne tsawon lokacin kulawa da kulawa ya zama sakin layi na saiti;
Dole ne a iya amfani da bayanan don dalilai na COVID-19 kawai;
Tsaron bayanai da ɓoyewa suna buƙatar kariya da nunawa bisa ga hujja;
Dole ne kulawar dijital ta guji haɓaka nuna bambanci da rashin son kai;
Duk wani musayar bayanai ga wasu kamfanoni dole ne a bayyana ta doka;
Dole ne a sami kariya don hana cin zarafi da kuma kare hakkokin 'yan ƙasa;
"Ana buƙatar ""haɗin kai mai ma'ana"" daga ""duk masu ruwa da tsaki masu mahimmanci"", gami da masana kiwon lafiyar jama'a da ƙungiyoyi masu tsari. Kungiyar Kayan Kwamfuta ta Jamus (CCC) da kuma 'yan jarida (Reporter Oehne Grünzen) (RSF) sun ba da jerin abubuwan bincike ba tare da ƙuntatawa ba".
Idan shirin Google/Apple bai dace ba don magance matsalar sa ido na yau da kullun, za a iya cire sa ido daga dandamali.
Wasu ƙasashe sun yi amfani da sa ido kan hanyar sadarwa maimakon aikace-aikace, suna kawar da ikon saukar da aikace-aikace da hana bin sawu.
An amince da saka idanu ta hanyar sadarwa a Isra'ila.
Maganin yanar gizo don samun damar bayanai a cikin yanayin bushe yana da matsaloli masu yuwuwa.
Koyaya, ba duk tsarin da ke da sabar tsakiya bane ke buƙatar samun damar bayanan wuri na sirri, an ƙirƙiri tsarin tsare sirri da yawa waɗanda ke amfani da sabar tsakiya don sadarwa kawai (duba sashe na ƙasa).
An yi amfani da tsarin da ba na aikace-aikace ba don bincika lambobin sadarwa a Koriya ta Kudu.
Maimakon amfani da aikace-aikacen da aka tsara don wannan dalili, tsarin ya haɗu da tattara bayanan sa ido daga tushe daban-daban, gami da bin diddigin na'urar hannu da bayanan ma'amala na katin, da isar da saƙonnin rubutu ga waɗannan mutanen da ke da cutar.
Baya ga amfani da wannan bayanan, gwamnati ta ba da damar samun bayanan wurin ga kowa, saboda canje-canje masu yawa a cikin dokokin sirrin bayanai da aka yi a wannan ƙasar sakamakon barkewar cutar MERS.
Ana samun wannan bayanin ga jama'a ta hanyar aikace-aikace da shafukan yanar gizo da yawa. Kasashe ciki har da Jamus suna la'akari da amfani da tsarin tsakiya da tsarin kariya na sirri.
Har yanzu ba a fitar da cikakkun bayanai ba tun daga 6 ga Afrilu 2020.
Ra'ayin mutunta sirri da bin hanyoyin sadarwa ya kasance ra'ayi ne na farko tare da tarihin bincike na ɗan adam, aƙalla tun daga 2013. a ranar 7 ga Afrilu, 2020, sun yi amfani da mafita mai mutunta sirri, wanda ke amfani da Bluetooth low-power (BLE) wanda ke nuna kusancin su ga wasu wayoyi.
Koyaya, PPP-PT haɗin gwiwa ne wanda ya ƙunshi duka hanyoyin tsakiya da na rarrabawa kuma ya ƙunshi yarjejeniya guda ɗaya, tare da ladabi masu haɗawa waɗanda ke da alaƙa da Gundumar Kula da Sirri na Kusan Tsaro na Sirri (DP-PPT / DP-3T), Lambobin Sadarwa na Wuta, (TCN, fka Lambobin Lamarin Sadarwa, CEN), Sirrin Sirri da Tsarin Sirri don Binciken Sadarwar Wayar Hannu (PACT) da sauransu.
Bayanan sirri da aka gano a cikin waɗannan ladabi ba za su bar na'urar ba, kuma duk abubuwan da suka dace za a yi amfani da su a na'urar.
Kungiyar sirri a MIT Media Lab tana haɓaka SafePaths, dandamali wanda ke amfani da fasahohin tsare sirri yayin tattarawa da amfani da bayanan wuri ko ƙetare hanya don bin diddigin yaduwar COVID-19.
"An kafa shi ne bisa ga takaddar bincike mai taken ""Apps Gone Rogue: Kare Sirrin Keɓaɓɓun Mutane a cikin Cutar da ke yaduwa wanda aka saki a ranar 7 ga Maris, 2020. Wani ƙoƙari makamancin haka an kafa shi a MIT Media Lab tare da dandalin SafeTrace na kamfanin Enema MPC, wanda ke haɓaka fasahar tsare sirri".
SafeTrace fasaha ce ta kayan aiki mai aminci wacce ke ba masu amfani damar raba wuraren sirri da bayanan kiwon lafiya tare da sauran masu amfani da hukumomi ba tare da keta sirrin bayanan su ba.
An kafa haɗin gwiwar TCN ta duniya a ranar 5 ga Afrilu, 2020 tare da tsarin aiki iri ɗaya da kuma ƙungiyoyi da ke haɗuwa da ladabi, tare da kafa ƙungiyar don rage rata da kuma tabbatar da haɗin kai na duniya don saka idanu da faɗakar da aikace-aikace.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da buɗe yarjejeniyar BlueTrace da ake amfani da ita a cikin aikace-aikacen gwamnati na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, waɗanda ke sarrafa na'urorin hannu na Android da iOS, sun sanar da shirin sadarwa wanda suka bayyana cewa za su kiyaye sirrin sirri bisa ga haɗin fasahar Bluetooth mai ƙarancin ƙarfi da kuma bayanan sirri.
Sun kuma fitar da cikakken bayani game da manyan fasahohin da aka yi amfani da su a cikin tsarin.
A cewar Apple da Google, an tsara tsarin don sakin matakai uku:
Jerin aikace-aikacen kayan aiki don ba da damar gwamnatoci don ƙirƙirar aikace-aikacen bin diddigin cutar Corona na sirri na sirri.
Google da Apple suna shirin sauƙaƙe wannan aikin kai tsaye zuwa haɗin iOS da Android, kuma suna kawar da matsalolin sa ido na yau da kullun ta hanyar rarraba tsarin sabunta tsarin aiki da farko, kamar yadda ake yi bayan barazanar ta wuce.
Magungunan ƙwayoyi (wanda aka fi sani da sake dawo da magani, sake rarrabawa, sake dawowa ko sauyawar magani) magani ne wanda aka ba da izinin sake amfani da shi don sake amfani da magani daban da wanda aka riga aka yi.
Wannan shine layin bincike na kimiyya wanda a halin yanzu ake ci gaba don haɓaka lafiya da ingantaccen maganin COVID-19.
Sauran hanyoyin bincike sun haɗa da allurar rigakafin COVID-19 da watsa jini. SARS-CoV-2 yana da furotin 66 masu yuwuwar magani, kowannensu yana da wuraren da ke ɗaure ligand da yawa.
Binciken waɗannan wuraren dole ya haɗa da samar da ingantaccen maganin rigakafi mai inganci don sunadarai na COVID-19.
Muhimman abubuwan da SARS-CoV-2 ke niyya sune sunadarai kamar papay; RNA-dogara RNA polymer, helixis, S-protein da ADP ribophosphatase.
Hussein A A, et al sun yi nazarin wasu magungunan da aka tsara kuma daga baya suka daidaita su da magungunan da aka amince da su don haɓaka ingantaccen maganin anti-SARS-CoV-2 wanda za a ba da shawarar a cikin gwajin asibiti.
Chloroquine magani ne na rigakafin zazzabin cizon sauro da ake amfani da shi don hana wasu cututtuka na jiki.
A ranar 18 ga Maris, Hukumar Lafiya ta Duniya ta sanya chloroquine da hydrochlorotenoquine a cikin magunguna huɗu da ke cikin gwaji na gwaji na haɗin gwiwa.
Gwamnan New York Andrew Cuomo ya sanar da cewa jihar New York za ta fara gwajin chloroquine da hydrochlorothrin a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta amince da amfani da hydrochlorothrin sulfate da chloroxine phosphate a ƙarƙashin lasisin Amfani da Gaggawa (USAA).
Ba a amince da maganin ta hanyar gwajin asibiti na FDA ba kuma an ba da izinin amfani da shi azaman magani na gwaji don marasa lafiya na gaggawa a cikin Tarayyar Turai waɗanda ba za su iya samun magani a gwajin asibiti ba duk da cewa an kwantar da su a asibiti.
A cewar CDC, har yanzu ba a ƙaddara amfani da Hydroxychloroquine don proplaxis, sashi da lokacin amfani ko maganin SARS-CoV-2 ba.
"Masu magani sun ce za su yi amfani da maganin ne kawai idan ba su da wani zaɓi".
Wata ƙungiyar bincike ta Turkiyya da ke Istanbul tana gudanar da ƙananan bincike kan amfani da chlorine tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da manyan bincike a Jami'ar Duke da Jami'ar Oxford.
Makarantar Kiwon Lafiya ta NYU Langone tana gudanar da gwaji kan amfani da inganci da ingancin sabis don hana hydroxychloroquine.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun nuna favipiravir yana da tasiri sosai.
Marasa lafiya 35 a Shenzhen sun sami sakamako mara kyau a matsakaici cikin kwanaki 4, yayin da marasa lafiya 45 ba su sami tsawon lokacin cutar ba har tsawon kwanaki 11.
A cikin binciken da aka yi a Wuhan kan marasa lafiya 240 da ke fama da cutar huhu, rabin sun sami favipiravir, rabin kuma umifenovir.
Hukumar Kula da Magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ake da ita yanzu don tallafawa maganin ba ta da yawa kuma na farko.
A ranar 2 ga Afrilu, Jamus ta ce za ta sayi maganin daga Japan kuma ta yi amfani da sojojin don isar da maganin zuwa asibitocin jami'a don kula da marasa lafiya na COVID-19.
Shinzo Abe ya sayi maganin ne don tallafawa gwamnatin Trump, in ji South China Morning Post.
Ba zai zama lafiya ba ga mata masu ciki ko waɗanda suke ƙoƙarin yin ciki.
"Bincike da aka yi game da maganin cutar lopinavir da ritonavir / lopinavir / ritonavir (Kaletra) ya kammala cewa ""babu amfani"."
An tsara maganin don hana HIV ya yadu ta hanyar ɗaure shi zuwa mafitsara.
Kungiyoyin bincike a Jami'ar Colorado suna ƙoƙarin haɓaka magunguna da ƙirƙirar mahaɗin da ke da alaƙa da kwayar SARS-CoV-2. Akwai zargi da yawa a cikin al'ummar kimiyya saboda ɓarnatar da kayan aiki don maye gurbin magungunan da aka tsara don HIV / AIDS.
Hukumar Lafiya ta Duniya ta gwada Lopinvir a cikin gwajin haɗin gwiwar duniya.
Gilead Sciences ta gano cewa remdesivir yana da damar zama maganin rigakafi a cikin vitro, da yawa daga cikin kwayoyin cutar phyllo-, pneumonia-, paroxetine- da coronaviruses.
Wani batun maganin rigakafin kwayar cuta shine ci gaban juriya ta hanyar maye gurbi wanda zai iya haifar da cututtuka masu tsanani da yaduwa.
Wasu nazarin gwaji na farko sun nuna cewa remdesivir yana da iyakacin yanayin daidaitawa. Ana gudanar da bincike na asibiti da yawa, biyu a asibitocin Cleveland, ɗaya don masu ciwo mai matsakaici da ɗaya don masu ciwo mai tsanani.
Akwai gwaje-gwaje uku na gwaji na asibiti don mutane masu fama da cutar COVID-19 da ke asibiti da marasa lafiya masu tsanani: biyu tare da sarrafa wuribo (China, Kanada) da ɗaya ba tare da sarrafawa ba (Italiya).
An fara gwajin maganin azithromycin na jihar New York a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya da Kula da Lafiya ta Duniya ta Japan (NCGM) tana gudanar da gwaji na asibiti don Tegen Alvisco (Cyclosoneide), corticosteroid na asma wanda aka sanya ta hanci don kula da marasa lafiya marasa alamun cutar coronavirus.
Ana gudanar da gwajin gwaji na biyu na maganin cutar ta Angiotensin-converting enzyme 2 a asibitoci a Denmark, Jamus da Austria, tare da kulawa da marasa lafiya 200.
Masu bincike daga Cibiyar Zuciya ta Montreal, Kanada a halin yanzu suna nazarin rawar colchicine don rage kumburi da ciwon huhu a cikin marasa lafiya da ke fama da COVID-19 mai sauƙi.
Binciken COLCORONA ya kunshi manya 6000 masu shekaru 40 zuwa sama, wadanda suka tabbatar da cewa suna da COVID-19 kuma suna da alamun rashin lafiya da ba sa bukatar asibiti.
Idan mata masu ciki ko masu shayarwa ba su da maganin hana ɗaukar ciki mai kyau, ba za su cancanci ba.
Ana gwada magungunan kashe ƙwayoyin cuta da yawa a Italiya.
Ana amfani da ƙananan ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
An sanar da allurai a Italiya a ranar 14 ga Afrilu don rigakafi da magani tare da nazarin da yawa akan marasa lafiya 300 da ke amfani da enosafarin sodium.
A matsayin kwayar cutar SARS-CoV-2, an mai da hankali sosai kan ilimin kimiyya game da sake amfani da maganin rigakafin cutar da aka amince da shi don barkewar cututtuka kamar MERS, SARS da West Nile Virus.
Ribovirine: An ba da shawarar ribovirine don maganin COVID-19 a cikin fitowar 7th na jagororin China
Umifenovir: An ba da shawarar umifenovir don maganin COVID-19 bisa ga jagororin fitowar 7 na kasar Sin.
Wasu daga cikin abubuwan da ke hana cutar da aka gano cewa za a iya sake amfani da su don maganin COVID-19 sune:
Tocilizumab (mai karɓar IL-6): an amince da shi a China.
Hakanan an yi gwaji a Italiya da China. Duba Tocilizumab#COVID-19.
b'A allurar COVID-19 allurar rigakafi ce ta allurar rigakafi don cutar coronavirus ta 2019 (COVID-19).
Ko da yake babu wani allurar rigakafi da za ta kammala gwajin asibiti, akwai wasu gwaje -gwaje da yawa da ke gudana don samar da irin wannan allurar.
A ƙarshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya ta ce ba za a yi tsammanin allurar rigakafin SARS-CoV-2 ba, kwayar cutar da ke da alaƙa da cutar, ta isa watanni 18 kafin lokacin.
A watan Afrilu, an yi gwaje-gwaje na aminci na gwaji guda biyar na allurar rigakafi.
An gano COVID-19 a watan Disamba na 2019.
babbar annoba a duniya a cikin 2020 wanda ke haifar da babban saka hannun jari da ayyukan bincike don haɓaka allurar rigakafi.
Yawancin ƙungiyoyi suna amfani da kwayoyin halittar da aka buga don haɓaka alluran rigakafi na SARS-CoV-2.
Rahoton CEPI, wanda aka kammala a watan Afrilu na shekarar 2019, ya nuna himma, saurin, ƙarfin samarwa, daidaitaccen aiki da kuma isar da ci gaban sa ido a duniya.
A farkon Afrilu 2020, masana kimiyya na CEPI sun ba da rahoton cewa akwai dandamali daban-daban na fasaha 10 a cikin bincike da ci gaba don ƙirƙirar allurar rigakafin COVID-19.
Babban manufofin dandamali da aka inganta zuwa Nazarin Tsaro na Mataki na I sun haɗa da:
Nucleic acid (DNA da RNA) (mai haɓaka mataki na I da mai neman allurar rigakafi Moderna, mRNA-1273)
Kwayar cutar kwayar cuta (mataki na I na haɓaka da allurar rigakafi: Cancino Biologics, adenovirus type 5 vector)
A watan Afrilu na shekarar 2018, masana kimiyya sun ba da rahoton cewa a cikin jimlar alluran rigakafi 115, 78 suna cikin matakan farko na ci gaba (79, bisa ga bayanan Cibiyar Milken), yayin da wasu 37 aka bayyana, amma ana tsammanin akwai bayanai kaɗan ga jama'a (a cikin shirin ko matakin zane).
Gwajin Mataki na I-II yana ba da gwajin rigakafi na farko da aminci, yawanci bazuwar, sarrafawa da kuma daidaitawa a wurare da yawa, don ƙayyade mafi inganci da tasiri.
Gwaje-gwaje na Mataki na III sun haɗa da ƙarin mahalarta, waɗanda suka haɗa da ƙungiyoyin sarrafawa, ƙwarewar maganin don hana cutar, sakamakon rashin sakamako mai kyau saboda an ba da matsakaiciyar kashi.
Daga cikin alluran rigakafi 79 da ake ci gaba da su (kamar yadda aka tabbatar a watan Afrilu 2020), 74 ba a gwada su a kan mutane ba (har yanzu suna cikin gwajin farko na asibiti).
A Ostiraliya, a ranar 24 ga Janairun 2020, Jami'ar Queensland ta sanar da cewa tana binciken samar da allurar rigakafin kwayoyin halitta da ke canza kwayoyin sunadarai na kwayar cutar don bunkasa rigakafi.
A ranar 24 ga Janairun 2020, Cibiyar allurar rigakafin duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da cewa ta fara aiki kan allurar rigakafin da nufin fara gwajin mutum a 2021.
Cibiyoyin kula da cututtuka na kasar Sin da Jami'ar Hong Kong sun bude ayyukan bunkasa allurar rigakafi a ranar 26 ga Janairu, 2020.
Kamfanonin harhada magunguna na Janssen sun sanar da cewa sun fara aikin samar da allurar rigakafin da Hanneke Schuitemaker ke jagoranta a ranar 29 ga Janairu, 2020.
Janssen tare da abokin aikinsa na fasahar halittu Vaxart sun kirkiro allurar rigakafin baki.
A ranar 18 ga Maris, 2020, kamfanin Emergent BioSolutions ya sanar da kafa haɗin gwiwa tare da Vaxart don samar da allurar rigakafin.
A ranar 8 ga Fabrairu, 2020, OncoGen, wani dakin gwaje-gwaje a Romania, ya buga wani bincike kan yin aiki kan ƙirar allurar rigakafi tare da irin wannan fasaha don maganin cututtukan kansa.
A ranar 25 ga Maris, cibiyar bincike ta sanar da cewa sun kammala hada allurar rigakafin kuma a shirye suke su fara gwajin su.
A ranar 27 ga Fabrairu, 2020, kamfanin Generex na NuGenerex Immuno-Oncology ya sanar da fara aikin samar da allurar rigakafin peptide Ii-Key akan COVID-19.
Suna son samar da gwajin rigakafin da za a iya gwadawa a cikin mutane cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington da ke St. Louis ta sanar da shirye-shiryen samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, rundunar sojin Amurka da ke Fort Detrick da Walter Reed Army Institute of Research da ke Silver Spring sun sanar da cewa suna aiki kan allurar rigakafi, dukansu suna yammacin Maryland.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da fara aiki tare da Novavax Inc.
A kan ci gaba da samar da allurar rigakafi.
Abokan hulɗarsu sun sanar da ƙarin bayani game da cikakken bincike da gwajin asibiti na I zuwa Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki tare da masu keɓewa 11.
A ranar 12 ga Maris, 2020, Medigado, wani kamfanin kere kere na kere kere da ke birnin Quebec, Quebec, ya ba da rahoton ƙaddamar da wani sabon tsarin bincike na kwayar cutar coronavirus wanda aka samu tallafi daga cibiyoyin kiwon lafiya na Kanada.
Wani ɗan takarar allurar rigakafi yana cikin dakin gwaje-gwaje tare da gwajin ɗan adam da aka shirya a watan Yuli ko Agusta 2020.
A farkon makon, Jaridar Guardian ta ruwaito cewa Shugaba Donald Trump na Amurka ya ba da babbar kyauta ga Kirov don allurar rigakafin COVID-19, amma gwamnatin Jamus ta musanta hakan.
A ranar 17 ga Fabrairu, 2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
BNT162, mai neman allurar rigakafin mRNA, a halin yanzu yana cikin gwajin farko na asibiti tare da gwajin asibiti da ake tsammanin zai fara a watan Afrilu 2020.
Kamfanin fasahar halittu na Italiya, Italiya, ya sanar a ranar 17 ga Maris, 2020 cewa za a sami sakamakon gwajin farko na asibiti a watan Afrilu na 2020 kuma za su iya fara gwajin gwajin su na ƙarshe a cikin mutane.
A Faransa, a ranar 19 ga Maris, 2020, Cibiyar Innovation ta Tsaro (CEPI) ta saka hannun jari dalar Amurka miliyan 4.9 don binciken allurar rigakafin COVID-19, wanda ya hada da Institut Pasteur, Themis Biosciences (Vienna, Austria) da Jami'ar Pittsburgh. Ya kawo jimlar saka hannun jari na allurar rigakafin CEPI don COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar saka hannun jari na CEPI don haɓaka allurar COVID-19 sune Moderna, Curavac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, masu bincike sun sanar da cewa sun fara gwajin alluran rigakafi daban-daban guda shida akan dabbobi, in ji hukumomin kiwon lafiya na Rasha.
Masu bincike a Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa za su samar da allurar rigakafin RNA mai sarrafa kansa don COVID-19.
An shirya wani mai neman allurar rigakafi a cikin kwanaki 14 bayan karɓar umarni daga China.
A ƙarshen Maris, Gwamnatin Kanada ta sanar da tallafawa ayyukan bincike na C$275 miliyan don gwaje-gwaje na likita akan COVID-19, gami da yawan masu neman allurar rigakafi a kamfanonin Kanada da jami'o'i, kamar Medicago da Jami'ar Saskatchewan.
A daidai wannan lokacin, Gwamnatin Kanada ta sanar da cewa ta ba da dala miliyan 192 na C$192 don ƙarin allurar rigakafin COVID-19 kuma National Vaccine Bank zai yi aiki kan alluran rigakafi daban-daban don hana wani barkewar cutar coronavirus.
"A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh Medical School sun ba da rahoton yiwuwar gwajin rigakafin PittCoVacc a cikin beraye, suna cewa ""Akwai alamun antibodies na SARS-CoV-2 S1 a cikin beraye waɗanda suka bayyana makonni 2 bayan allurar rigakafin cutar". """
A ranar 16 ga Afrilu, 2020, Cibiyar Pharmacy ta Jami'ar Waterloo a Kanada ta sanar da ƙirar allurar rigakafin cutar ta Genotropin da za a iya yayyafa ta hanci.
Ta amfani da cututtukan ƙwayoyin cuta, an tsara DNA don yin kwafi a cikin ƙwayoyin cuta na ɗan adam don samar da ƙwayoyin cuta marasa lahani waɗanda ke motsa tsarin garkuwar jiki don samar da ƙwayoyin cuta ga kwayar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu da jami'o'i uku sun ba da gudummawar da ba su da ita don siyan manyan kwamfutoci daga IBM, wanda ya kawo kayan aikin sarrafa kwamfuta daga Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako mai iyaka, wanda ake kira sakamako mai iyaka.
Wannan yana nufin cewa suna da amfani fiye da hana cututtuka.
Australia na neman ƙarin gwaji na bazuwar don yin rajistar ma'aikatan kiwon lafiya 4,170.
Ana iya yin alluran rigakafi da ba su da lafiya ko kuma tasiri.
Bincike kan ingancin allurar rigakafin da aka yi amfani da su a cikin samfuran dabbobi da ke da alaƙa da COVID-19, kamar ƙudaje masu canzawa na ACE2, wasu dabbobin dakin gwaje-gwaje, da sauran barbashi, sun nuna cewa ana buƙatar lokaci don amfani da ƙwayoyin cuta masu aminci na matakin 3 da haɗin gwiwar duniya don amfani da ƙa'idodin aminci.
An gwada alluran rigakafin SARS da MERS a cikin samfuran dabbobi marasa ɗan adam.
Ya zuwa 2020, babu wani magani ko allurar rigakafi don SARS da aka tabbatar da aminci da tasiri a cikin mutane.
Dangane da takardun bincike da aka buga a cikin 2005 da 2006, ganowa da haɓaka sabbin alluran rigakafi da magunguna don magance SARS ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya a duniya.
A lokacin barkewar cutar MERS, an yi imanin cewa binciken SARS na yanzu zai ba da damar samar da allurar rigakafi mai amfani da magani ga MERS-CoV.
A watan Maris na 2020, akwai allurar MERS guda ɗaya (wanda ya dogara da DNA) wanda ya kammala gwajin gwaji a cikin mutane, da sauran uku da ke kan aiki, dukansu sun kamu da cutar, biyu masu daidaitawa (ChAdOx1-MERS, BVRS-GamVac) da ɗaya mai ɗaukar hoto (MVA-MERS-S).
Rubutun kafofin watsa labarun sun haifar da ka'idar makirci game da kwayar cutar da ke bayan COVID-19 da kuma ra'ayin cewa an san ta kuma an riga an sami rigakafi.
Rubutun da ke shafukan sada zumunta daban-daban sun nuna cewa masu mallakar mallaka suna da haƙƙin mallaka na kwayoyin halitta da alluran rigakafi don sauran nau'ikan coronavirus kamar SARS coronavirus.
Cutar Coronavirus ta 2019 (COVID-19) cuta ce mai saurin yaduwa wacce ke haifar da cutar sankarar barbashi mai saurin yaduwa 2 (SARS-CoV-2).
Alamun da aka saba gani sun haɗa da zazzabi, tari, da numfashi.
Sauran alamun sun haɗa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin wari, da ciwon ciki.
Daga farkon bayyanar cututtuka zuwa kwanaki biyar, lokaci zai iya zama daga kwana biyu zuwa goma sha huɗu.
Ko da yake yawancin lokuta suna haifar da alamun rashin lafiya, an sami ci gaba a cikin cutar huhu da kuma cututtukan jiki da yawa.
Tun daga ranar 17 ga Afrilu, 2020, an bayar da rahoton sama da mutane miliyan 2.24 daga kasashe da yankuna sama da 210, tare da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke daga cutar. Ana yada kwayar cutar ne daga mutum zuwa mutum yayin hulɗa, galibi ta hancin mutum, hancin mutum ko magana.
Ana yin waɗannan ɗigon sa'ad da mutum ya numfasa kuma sukan faɗi a ƙasa ko kuma a jikin mutum maimakon su yi nesa.
Hakanan mutane na iya auna ta ta hanyar taɓa ƙasa mai gurɓataccen ƙasa sannan ta taɓa idanunsu, hanci ko bakinsu.
Kwayar cutar na iya rayuwa har zuwa awanni 72 a wurare masu bushe.
Ana iya yaduwa sosai a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya watsawa kafin bayyanar cututtuka da kuma ci gaban cutar (rRT-PCR) daga nasopharyngeal bloat.
Ana ba da shawarar cewa mutanen da ake zargi da cutar da masu kula da su su sanya abin rufe fuska.
Shawarwarin amfani da abin rufe fuska ga jama'a gaba ɗaya na iya bambanta, wasu hukumomi suna ba da shawarar amfani da su, wasu suna ba da shawarar amfani da su, wasu kuma suna son amfani da su.
A halin yanzu babu allurar rigakafi ko magani na musamman na cutar COVID-19.
An samu yaduwar cutar a kusan dukkanin yankuna shida na Hukumar Lafiya ta Duniya.
Mutane da ke dauke da kwayar cutar na iya nuna alamun mura kamar zazzabi, tari, gajiya da numfashi.
Alamun gaggawa sun haɗa da numfashi mai wuya, ciwon kirji ko matsa lamba, rikicewa, rashin jin daɗi, da kuma launin shuɗi a fuska ko lebe. Idan waɗannan alamun suka bayyana, ana ba da shawarar neman magani nan da nan.
Sau da yawa, alamun na sama na numfashi kamar hancin hanci ko makogwaro.
An lura da alamun cututtukan hanji kamar tashin zuciya, amai da gudawa a cikin kashi daban -daban.
A China, wasu lokuta ana gabatar da su ne kawai don ɓoye kirji da nakasa.
A wasu, cutar na iya kaiwa ga ciwon huhu, cututtukan jiki da mutuwa.
Wannan shi ne lokacin da ake bukatar a yi jinya kafin a soma nuna alamun cutar.
Lokacin haifuwa don COVID-19 yawanci kwanaki biyar zuwa shida ne amma zai iya zuwa kwanaki biyu zuwa 14.
97.5% na mutanen da ke nuna alamun cutar suna nuna alamun cutar a cikin kwanaki 11.5 na ranar kamuwa da cutar.
Har yanzu ba a san cikakken rawar da waɗannan masu ɗaukar hoto ba ke takawa a cikin yaduwar cutar ba, amma, kamar yadda shaidu na farko suka nuna, suna iya ba da gudummawa ga yaduwar cutar.
Ba a san adadin masu kamuwa da cutar ba a halin yanzu kuma ana nazarin su, cibiyar Kula da Cututtuka da Cututtuka ta Koriya (KCDC) ta ba da rahoton cewa kashi 20 cikin ɗari na waɗanda aka tabbatar da cutar ba su bayyana ba yayin zaman su a asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta hada da shari'o'in farko, gami da na mutum, a cikin abubuwan da ke faruwa a ranar 1 ga Afrilu. Daga cikin kamuwa da cutar 166 a wannan ranar, 130 (78%) sun kasance iri ɗaya a lokacin gwaji.
Dukansu Actia da Marak na iya ɗaukar manyan nauyin ƙwayoyin cuta.
Idan ka yi magana da babbar murya, za ka iya yin magana da ƙarfi fiye da yadda kake yi.
Wani bincike da aka yi a ƙasar Singafo ya nuna cewa tari da ba a rufe shi ba yana sa ruwa ya zubo daga jikin mutum har tsawon mita 4.5.
Ko da yake kwayar cutar ba ta wucewa ta iska gaba ɗaya, Cibiyar Nazarin Kimiyya ta Kasa ta tabbatar da cewa ana iya watsawa ta hanyar bioaerosol kuma masu tattara iska suna ba da sakamako mai kyau ga RNA na kwayar cutar a cikin hanyar wucewa a waje da ɗakunan mutane.
Wasu hanyoyin magani kamar su CPR da CPR na iya sa numfashi ya shiga cikin iska kuma ya bazu cikin iska.
Ko da yake ana ganin cewa cutar za ta iya yaduwa ta hanyar kuraje, amma ba ta da haɗari sosai. Kwayar tana da saurin yaduwa idan mutane suna nuna alamun cutar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce duk da cewa ba a san yadda cutar ke yaduwa ba, mutum ɗaya yana cutar da mutane biyu zuwa uku. Kwayar cutar na iya rayuwa na awanni da kwanaki a wurare masu bushe.
Musamman, an gano kwayar cutar a cikin kwali har zuwa kwana ɗaya a cikin filastik (polyvinyl chloride) da bakin karfe (AISI 304) da kuma 99% jan ƙarfe na tsawon awanni huɗu.
Koyaya, wannan ya bambanta dangane da zafi da zafin jiki.
Sabulu da kayan wanki ma suna da tasiri idan aka yi amfani da su daidai. Samfuran sabulu suna rage, lalata, da kuma kawar da ƙwayoyin cuta daga fata da sauran abubuwa.
Sauran magungunan kamar Benzalkinum Chloride da Chlorohexidine Gluconant (mai hana aikin tiyata) ba su da tasiri.A cikin binciken Hong Kong, an ɗauki samfuran matsakaici kwanaki biyu bayan fara maganin asibiti.
Samfurin farko na biyar daga cikin marasa lafiya shida ya nuna mafi girman nauyin kwayar cutar, yayin da na shida ya nuna mafi girman nauyin kwayar cutar a rana ta biyu da aka gwada mai haƙuri.
Cutar numfashi mai saurin kamuwa da cutar coronavirus 2 (SARS-CoV-2) sabuwar cutar coronavirus ce mai saurin kamuwa da cutar coronavirus, wanda aka fara ganowa a Wuhan a cikin mutane uku da ke fama da ciwon numfashi mai saurin kamuwa da cutar huhu.
Dukkanin halaye na sabon kwayar cutar SARS-CoV-2 suna faruwa a cikin yanayin coronaviruses masu alaƙa.
A waje da jikin mutum, ana kashe kwayar cutar ta sabulu na gida, wanda ke karya murfin kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
Cutar huhu ita ce mafi cutarwa ga COVID-19, saboda kwayar cutar tana samun ƙwayoyin halitta ta hanyar enzyme agonist enzyme 2 (ACE2), wanda shine mafi yawan kwayoyin alveolar II a cikin huhu.
Kwayar cutar tana amfani da wani abu na musamman da ake kira 'stimulator' (peplomer) don haɗawa da ACE2 da shiga cikin ƙwayoyin mai masaukin.
An gano ciwon zuciya na gaggawa a cikin kashi 12 cikin dari na masu cutar da aka kwantar a asibiti a Wuhan, China, kuma cutar tana faruwa sau da yawa.
Alamun cututtukan zuciya suna da yawa saboda halayen kumburi na yau da kullun da matsalolin tsarin garkuwar jiki yayin ci gaban cutar, amma mummunan lalacewar myocardial yana da alaƙa da masu karɓar ACE2 a cikin zuciya.
Ana bayyana masu karɓar ACE2 sosai a cikin zuciya kuma suna da hannu cikin aikin zuciya.
An gano ƙwayoyin cuta masu yawa (31%) da kuma jijiyoyin jini na hormonal (25%) a cikin marasa lafiya na ECI tare da kamuwa da COVID-19 kuma ana iya danganta su da cutar prostate.
Kodayake SARS-COV-2 yana da bambanci ga ƙwayoyin cuta na numfashi waɗanda ke bayyana ACE2 don nuna numfashi, marasa lafiya da ke da mummunan COVID-19 suna da alamun cutar hawan jini.
Musamman, an nuna cewa kwayoyin halittar GM-CSF-t-cell suna da alaƙa da ɓoyewar ɓoye na In-6 a cikin marasa lafiya na COVID-19 da ke haifar da monotoni da kuma kamuwa da cutar huhu mai tsanani.
An kuma bayar da rahoton kamuwa da cutar lymphocytic a kan autopsy.
Hukumar Lafiya ta Duniya ta wallafa wasu ka'idojin gwaji don cutar.
Hanyar gwajin da aka saba amfani da ita ita ce amsawar sarkar polymerase mai kwafi na lokaci-lokaci (rRT-PCR).
Ana yin gwajin ne akan samfurori na numfashi da aka kama tare da swab na nasopharyngeal. Koyaya, ana iya amfani da samfurin hanci ko acta.
Sakamakon zai kasance a cikin 'yan sa'o'i kaɗan zuwa kwanaki biyu.
Ana iya amfani da gwaje-gwajen jini, amma waɗannan suna buƙatar samfuran jini biyu a cikin mako biyu kuma sakamakon ba shi da mahimmanci.
Masana kimiyya na kasar Sin sun gano cutar coronavirus kuma sun buga jerin kwayoyin halitta don taimakawa dakunan gwaje-gwaje a duniya su samar da gwaje-gwaje na PCR don gano cututtukan da suka kamu da cutar.
An fara gwajin rigakafin cutar (wanda zai iya gano cututtukan da ke aiki kuma idan mutum ya riga ya kamu da cutar) tun daga 4 ga Afrilu, 2020, amma har yanzu ba a yi amfani da shi sosai ba.
Kwarewar Sinawa a cikin aikin gwaji ya nuna cewa daidai ne kawai daga 60 zuwa 70%.
FDA ta Amurka ta amince da gwajin don fara-kulawa a ranar 21 ga Maris, 2020. Jagororin gwaji da Asibitin Zhongnan na Jami'ar Wuhan ya fitar sun ba da shawarar hanyoyin gano cututtuka dangane da halayen asibiti da haɗarin mura.
Rarraba filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen filayen fila
Ana iya ganin ƙananan rinjaye, ƙumburi mai ƙarancin ƙarfi (don kaurin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Akwai ɗan bayani game da ƙananan raunuka da canje -canje a cikin tsarin cutar COVID-19.
Abubuwan da aka gano a binciken da aka yi a kan gawawwaki:
Macrococopia-pleurisy, pericarditis, ciwon huhu da kuma kumburi na huhu
Ana iya gane nau'ikan cutar sankarar bargo guda huɗu:
Ƙaramin ciwon huhu: ciwon huhu, hyperplasia na huhu, cututtuka na tsutsotsi, ciwon kansa na ƙwayoyin lymphatic da kuma ciwon ƙwayoyin cuta
Cutar huhu mai tsanani: lalacewar alveolar (DAD) tare da yaduwar cutar alveolar oxidase.
DAD shine sanadin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Maganin ciwon huhu: yana nuna fibrosis na tsakiya tsakanin alveolar rami da huhu
jini: yaduwar jini na intravascular (DIC); amsawar leukoerythroblastic
Matakan kariya don rage haɗarin kamuwa da cutar sun haɗa da kasancewa a gida, guje wa wuraren da mutane ke taruwa, wanke hannuwanku da sabulu da ruwa na aƙalla dakika 20, da kiyaye tsabtace numfashi da kuma guje wa taɓa idanu, hanci ko baki da hannaye marasa wankewa.
CDC ta ba da shawarar rufe baki da hanci da kayan shafa yayin hancin ko hancin kuma amfani da cikin kunne idan babu kayan shafa.
Ana ba da shawarar tsabtace hannu bayan kowane tari ko hancin.
CDC ta ba da shawarar amfani da abin rufe fuska na masana'anta a wuraren taron jama'a don iyakance yaduwar cutar idan mutum mai dauke da cutar. Dabarun nisantar zamantakewa da aka tsara don rage hulɗa da mutane masu cutar a cikin manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, ƙuntata balaguro da soke manyan taron jama'a.
Dokokin nisantawa sun haɗa da kiyaye nesa da mutane aƙalla ƙafa 6 (1.8).
"Babu wani magani da aka sani da zai yi tasiri wajen hana COVID-19 ba. Tun da ba a tsammanin allurar rigakafi har zuwa 2021, wani muhimmin ɓangare na gudanar da COVID-19 yana ƙoƙarin rage yaduwar cutar da aka sani da ""jinkirin yaduwar kwayar cutar""".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na aƙalla dakika 20, musamman bayan sun je bayan gida ko idan hannayensu sun kasance da datti, kafin su taɓa hanci da hancin su, ko kafin su yi tari ko kuma kafin su ci abinci.
WHO ta ba da shawarar yin amfani da wanke hannu da ke da giya da ke da aƙalla kashi 60% na giya kawai idan sabulu da ruwa ba su da sauƙi. A wuraren da ba za a iya samun tsabtace hannu a kasuwa ba, WHO ta ba da shawarwari biyu don samar da muhalli.
A cikin waɗannan ƙirar, aikin maganin ƙwayoyin cuta yana fitowa daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don kawar da ƙwayoyin cuta a cikin barasa; ba shine sinadarin aiki ba don maganin kashe ƙwayoyin cuta.
An ƙara glycerol a matsayin mai sanyaya ruwa.
Mutane suna amfani da taimakon kuɗi wanda zai iya haɗawa da maganin ruwa, tallafin oxygen, da sauran sassan jiki da tallafi masu mahimmanci.
CDC ta ba da shawarar cewa mutanen da ke da tabbacin cewa suna da kwayar cutar su sa abin rufe fuska mai sauƙi.
An yi amfani da maganin oxygenation na ECMO don magance matsalar numfashi, amma har yanzu ana ganin fa'idodi.
Ana ba da shawarar tsabtace mutum da salon rayuwa mai kyau da abinci don inganta rigakafin cutar.
Jiyya mai tallafi na iya zama da amfani ga mutanen da ke da alamun rashin lafiya a farkon matakin cutar. Hukumar Lafiya ta Duniya da Hukumar Lafiya ta Kasa ta China sun ba da shawarwari don kula da mutanen da ke asibiti a cikin COVID-19.
Likitocin marasa lafiya da masu aikin numfashi a Amurka sun bi shawarar likitoci daga hukumomi daban-daban don amfani da tushen bayanai na IBCC.
Babu wani magani na musamman don COVID-19 har zuwa Afrilu 2020.
Don bincike, wasu likitoci suna ba da shawarar amfani da papamol (acumulonid) tare da ibuprofen don amfani da layin farko.
Ya kamata a yi hankali don rage haɗarin yaduwar kwayar cutar yayin aiwatar da hanyoyin numfashi, kamar inhalation ko numfashi na hannu.
Kwararrun likitocin kiwon lafiya da ke kula da mutane tare da COVID-19, CDC ta ba da shawarar cewa mutum ya sanya mutum a cikin ɗakin tserewa na kamuwa da cutar ta iska (IIR), ban da amfani da matakan kariya na yau da kullun, kariya da kuma kulawar iska.
Ana ba da shawarar kayan aiki: tufafin PPE, kayan numfashi ko fuska, kariya ta ido da safofin hannu na likita. Idan akwai, ana son masu numfashi (maimakon abin rufe fuska).
An amince da kayan numfashi na N95 don saitunan masana'antu amma FDA ta ba da izinin su a matsayin abin rufe fuska don amfani da izinin Amfani da Gaggawa (EUA).
An tsara su don karewa daga ƙwayoyin iska kamar ƙura amma inganci akan takamaiman wakili na halitta ba ya ba da tabbacin amfani da shi a waje da bayanin samfurin.
CDC ta ba da shawarar yin amfani da abin rufe fuska lokacin da babu abin rufe fuska ko amfani da abin rufe fuska na gida a matsayin makoma ta ƙarshe.
Yawancin lalacewar COVID-19 ba su da tsanani kamar yadda ake buƙatar motsawar iska ta inji ko wasu zaɓuɓɓuka, amma ƙananan lalacewar suna da tsanani.
Ana nazarin nau'ikan numfashi na mutane da ke fama da matsalar numfashi da ke da alaƙa da COVID-19 don waɗanda ke asibiti, ana iya kawar da ciwo ta hanyar hawan hanci mai ƙarfi ko matsin iska mai kyau na matsin lamba biyu.
Ba a san ko waɗannan abubuwan biyu suna da amfani iri ɗaya ba ga ciwo mai tsanani.
Wasu likitoci suna zaɓar kayan aikin numfashi na inji a gaban wasu likitoci saboda yana iyakance yaduwar ƙwayoyin iska idan aka kwatanta da tsananin ɓarkewar hanci. Ana samun su sosai a cikin tsofaffi (mafi girma fiye da shekaru 60, musamman ma fiye da shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isasshen gadajen asibiti na mutum, wanda ke haifar da karuwar marasa lafiya masu cutar COVID-19 da ke buƙatar asibiti da ke rage ikon tsarin kiwon lafiya.
Wani bincike a China ya nuna cewa kashi 5% na masu jinya a dakunan kulawa mai tsanani, kashi 2.3% na bukatar taimakon numfashi, kuma kashi 1.4% sun mutu.
Kashi 30% na mutanen da ke asibiti da ke fama da COVID-19 a China suna cikin ICU.
Matsanancin damuwa na numfashi (ARDS) yana da rikitarwa yayin da COVID-19 ke ci gaba da wahalar samun iskar oxygen.
Ana buƙatar ƙarin isar da iskar oxygen yayin da ake ƙara yanayin sarrafa iska da kuma PEEP mai ƙarfi don rage haɗarin lalacewar huhu da ciwon huhu da ke tattare da numfashi.
Ba za a iya samun PEEP mai yawa a kan tsofaffin masu numfashi ba.
An fara binciken don gano magunguna masu tasiri a cikin Janairu 2020, kuma yawancin magungunan rigakafi suna cikin gwaji na asibiti.
Remdesivir yana da alama mai ban sha'awa.
Kodayake zai iya ɗaukar har zuwa 2021 don haɓaka sabbin magunguna, yawancin magungunan da ake gwadawa an riga an amince da su don wasu amfani ko kuma suna cikin gwaji mai zurfi.
Ana iya gwada maganin rigakafi a kan mutanen da ke da ciwo mai tsanani.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa masu sa kai su shiga cikin gwaji na inganci da amincin hanyoyin magani waɗanda ke da tasiri. FDA ta ba da izinin FDA na ɗan lokaci lokacin da rayuwar mutum ke cikin haɗari ko cikin haɗari.
Ba a bincika nazarin asibiti da ake buƙata don tabbatar da cewa yana da aminci da tasiri ga cutar ba.
A watan Fabrairun 2020, China ta ƙaddamar da aikace-aikacen wayar hannu don magance cutar.
Ana buƙatar masu amfani su shigar da sunayensu da lambar ID.
Aikace-aikacen na iya amfani da bayanan hankali don gano 'kusanci na kusa', don haka gano yiwuwar kamuwa da cutar.
Kowane mai amfani zai iya bincika halin wasu masu amfani uku.
Idan an gano haɗari, aikace-aikacen ba kawai yana faɗakar da keɓe kai ba amma har da hukumomin kiwon lafiya na gida. Ana amfani da nazarin bayanan fuska akan bayanan wayar hannu, fasahar gano fuska, bin diddigin wayar hannu da hankali na wucin gadi don bin mutanen da ke fama da cutar da kuma bin su.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba hukumomin tsaro damar bin diddigin bayanan wayar salula na mutanen da ake zargi da kamuwa da cutar coronavirus.
An dauki matakan ganowa da kare wadanda zasu iya saduwa da 'yan kasar da ke dauke da cutar.
Bugu da ƙari, a cikin Maris 2020, Deutsche Telekom ta raba bayanan yanayin wayar da aka inganta tare da Cibiyar Robert Koch, wata hukumar gwamnatin tarayya ta Jamus don bincika da hana yaduwar cutar.
Rasha ta yi amfani da fasahar gano fuska don gano waɗanda ke tserewa daga tsare su.
Kwamishinan kiwon lafiya na yankin Italiya Giulio Gallera ya ce masu amfani da wayoyin salula sun sanar da cewa kashi 40% na mutane sun ci gaba da motsa jiki ta kowace hanya.
Gwamnatin Jamus ta gudanar da bincike na tsawon sa'o'i 48 a karshen mako tare da mahalarta sama da 42,000.
Shugaba Kersti Kaljulaid na Estonia ya kuma yi kira ga duniya da ta samar da hanyoyin samar da hanyoyin magance yaduwar cutar coronavirus.
Mutane suna iya fuskantar rashin haɗin kai, hana tafiya, sakamako masu illa na magani, ko kuma kamuwa da cuta.
BBC ta nakalto Rory O'Connor yana cewa: "Keɓewa ta zamantakewa, kadaici, damuwa da lafiya, damuwa da koma bayan tattalin arziki sune cikakkiyar guguwa da ke lalata lafiyar mutane da lafiyarsu".
Alamun da ke kama da cututtukan numfashi na yau da kullum, kamar mura, suna iya zama masu sauƙi ko kuma babu alamun.
Yawancin lokuta masu sauƙi suna murmurewa cikin makonni biyu, yayin da waɗanda ke da ciwo mai tsanani ko mai tsanani na iya ɗaukar makonni uku zuwa shida don murmurewa.
Mata masu ciki na iya zama masu saurin kamuwa da cutar COVID-19 bisa ga wasu ƙwayoyin cuta irin su SARS da MERS, amma babu bayanai game da COVID-19. A cikin wasu mutane, COVID-19 na iya haifar da cutar huhu ta hanyar cutar huhu.
A cikin mutanen da cutar ta fi shafawa, COVID-19 yana haifar da saurin kamuwa da cutar numfashi, tashin hankali ko lalacewar jiki zuwa cututtukan cututtukan numfashi (ARDS).
Matsalolin da ke tattare da COVID-19 sun haɗa da cutar sepsis, rashin lafiyar hanji da lalacewar zuciya, koda da hanta.
Rashin lafiya, musamman ƙara yawan lokacin prostate, ya bayyana a cikin kashi 6% na waɗanda aka kwantar a asibiti don COVID-19, kuma aikin koda mara kyau ya bayyana a cikin kashi 4% na wannan rukunin.
Kimanin kashi 20 zuwa 30% na mutanen da ke da cutar COVID-19 suna nuna ƙwayoyin enzymes na hanta (transaminases).
A cewar wannan rahoton, matsakaicin lokacin tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki goma, biyar daga cikinsu a asibiti.
Koyaya, marasa lafiya da aka sauya zuwa ICU suna da matsakaicin lokaci na kwanaki bakwai tsakanin asibiti da mutuwa.
Nazarin a kan shari'o'in da suka gabata ya kasance kwanaki 14 a cikin yanayin daga kwanaki shida zuwa 41 tare da farkon bayyanar cututtuka zuwa mutuwa.
A wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin (NHC) ta yi, mace-macen maza sun karu da kashi 2.8 cikin dari, yayin da mata suka karu da kashi 1.7 cikin dari.
Binciken binciken tarihi na samfurori na huhu bayan mutuwa ya nuna lalacewar alveolar da ke nuna fibroxide na wayar hannu a cikin huhu biyu.
An nuna canjin kwayar cutar a cikin kwayoyin cuta.
Hoton na huhu yana kama da ciwon damuwa na numfashi (ARDS).
A cikin kashi 11.8 cikin dari na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito, an gano cewa cutar zuciya ta haifar da mummunan rauni na zuciya.
A cewar bayanan watan Maris na Amurka, kashi 89 cikin dari na wadanda aka kwantar a asibiti suna da yanayin da ya gabata. Samun kayan aikin likita na iya shafar tattalin arzikin zamantakewar yankin da kuma mutuwa.
Mutuwar ta bambanta saboda waɗannan bambance-bambance na yanki, amma yana iya zama saboda matsalolin dabaru.
Ƙari ga haka, idan mutum ya yi rashin adalci, zai iya kashe mutane da yawa.
Amma, saboda mutuwar ta kasance ne daga abubuwan da aka riga aka kama, an kiyasta cewa adadin mutuwar yanzu ya ragu.
Masu shan sigari suna da yuwuwar sau 1.4 su sami mummunan bayyanar cututtuka na COVID-19 kuma suna buƙatar kulawa mai tsanani ko kusan sau 2.4 idan aka kwatanta da masu shan sigari.
Jami'an asibitin Hong Kong sun tabbatar da cewa wasu mutane da suka warke daga cutar sun sami raguwar numfashi da kashi 20 zuwa 30 cikin dari, kuma an gano lalacewar sassan jiki a cikin binciken scan.
Wannan na iya haifar da alamun rashin lafiya bayan dawowa.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar da ta gabata tana ba da damar ingantacciyar juriya ta dogon lokaci ga mutanen da suka warke daga cutar ba.
Ana ganin yanayin cutar ta fara ne bisa la'akari da yanayin sauran coronavirus, amma daga baya an ba da rahoton cewa an gwada tabbatacce ga coronavirus bayan an dawo da su daga COVID-19.
Ana ganin cewa waɗannan cututtukan suna sa ciwo ya yi muni maimakon warkarwa.
Ana tsammanin kwayar cutar ta asali ne ta halitta kuma ta dabbobi ta hanyar kamuwa da cuta ta halitta da kuma ci gaba.
Ba a san ainihin asalin cutar ba, amma a watan Disamba na 2019, za a iya samun kamuwa da cutar daga mutum zuwa mutum.
Nazarin farko na 41 na COVID-19 da aka tabbatar da shi da aka buga a Lanet a watan Janairun 2020 ya nuna ranar farko ta bayyanar cututtuka a ranar 1 ga Disamba, 2019.
Hukumar Lafiya ta Duniya ta ba da rahoton bayyanar cututtukan farko tun daga 8 ga Disamba, 2019.
An yi amfani da matakai daban-daban don auna yawan mutuwar.
Waɗannan lambobin sun bambanta ta yanki da lokaci kuma suna shafar girman gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tun farkon barkewar cutar, da halayen al'umma kamar shekaru, jinsi, da lafiyar gaba ɗaya.
A ƙarshen 2019, an ba da lambar ICD-10 ta gaggawa U07.1 don mutuwar gaggawa ta hanyar tabbatar da cutar SARS-CoV-2 a cikin dakin gwaje-gwaje da lambar U07.2 don gwajin COVID-19 don nazarin asibiti ko cututtuka masu alaƙa da cutar SARS-CoV-2 da aka tabbatar a cikin dakin gwaje-gwaje.
A cewar kididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya ya kai kashi 6.9% (153,822/ 2,240,191) tun daga ranar 17 ga Afrilu, 2020.
Sauran matakan sun haɗa da ƙimar mutuwar mutum (CFR), wanda ke nuna yawan mutanen da suka mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da ke fama da cutar (masu magani da marasa magani) waɗanda ke mutuwa daga cutar.
Kuma ba a riƙe waɗannan ƙididdigar a cikin wani lokaci ba har sai an ware wasu mutane daga allurar rigakafi.
Ko da yake duk mutanen da ke da cutar ba su samar da rigakafi ba, kasancewar rigakafi na iya ba da bayani game da yawan mutanen da ke da cutar.
A cikin ƙaramin ƙauyen Castiglione d'Adda, wanda ke da mazauna 4,600, 80 (1.7%) sun mutu a tsakiyar cutar a Italiya.
A Gangelt, cutar ta bazu a lokacin bikin Carnival, kuma ta bazu ga matasa, tare da ƙananan mutuwar, wanda hakan na iya haifar da duk mutuwar COVID-19 ba a rarraba su a matsayin irin wannan ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai wuce ƙarfinsa ba.
An kiyasta cewa kashi 3% na masu bayar da jini a Netherlands na iya samun ƙwayoyin rigakafi.
An tabbatar da mutuwar mutane 69 (kashi 0.004% na yawan jama'a) daga COVID-19.
Tasirin cutar da yawan mace-mace sun bambanta tsakanin maza da mata.
A cikin binciken da aka yi a China da Italiya, an sami ƙarin mutuwar.
Babban haɗarin ga maza yana cikin shekaru 50, inda rata tsakanin maza da mata ke kusan 90.
A kasar Sin, mace-macen maza sun kai kashi 2.8 cikin dari, mata kuma kashi 1.7 cikin dari.
Ba a san ainihin dalilin wannan bambancin jinsi ba, amma ƙwayoyin halitta da halayen mutum na iya zama sanadi.
Bambancin cututtukan da ke tattare da jima'i, kamar rashin karfin jini, da shan taba sigari na iya haifar da yawan mace-mace fiye da mata.
A Turai, maza ne ke da kashi 57% na masu kamuwa da cutar, kuma kashi 72% na waɗanda suka mutu daga COVID-19 maza ne.
A watan Afrilu 2020, Gwamnatin Amurka ba ta lura da bayanan batsa da ke da alaƙa da kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtuka kamar Ebola, HIV, mura da SARS sun bambanta a cikin maza da mata.
Yawancin ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya mata ne, kuma suna da haɗarin kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar zai zama COVID-19.
A cewar Darakta Janar na Hukumar Lafiya ta Duniya, Theodoros Adhanom Ghebreyesus, cutar Corona, cutar da ta fara ganowa, cuta da cutar ta shafi mutane 19, a ranar 31 ga Disamba, 2019.
Don hana nuna bambanci, a cikin layi tare da shawarwarin duniya, an zaɓi sunan don kauce wa masu cutar daga takamaiman yanki (misali China), nau'in dabba, ko rukuni na mutane. Ana kiran kwayar cutar da ke haifar da COVID-19 mai saurin kamuwa da cutar numfashi mai saurin kamuwa da cuta 2 (SARS-CoV-2).
Hukumar Lafiya ta Duniya ta kuma yi amfani da kalmar "Covid-19 virus" da "virus" wanda ke haifar da COVID-19 a cikin kafofin watsa labarai.
"Ana kiran cutar da kwayar cutar da ""coronavirus""".
An san cutar da cutar da sunan coronavirus da Wuhan coronavirus lokacin da aka fara gano shi a Wuhan, China.
A watan Janairun 2020, Hukumar Lafiya ta Duniya ta ba da shawarar cewa cutar mai saurin kamuwa da cuta ta 2020-nCov da 2019-nCoV za a yi amfani da su a matsayin sunaye na wucin gadi don cutar da cutar, bisa ga jagororin 2015 game da amfani da sarari a cikin sunayen ƙwayoyin cuta da sunayen ƙwayoyin cuta.
An sanya sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iya aiki a cikin sarƙoƙin samar da kayayyaki na yau da kullun, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su hanci da kayan iska.
A cikin misali guda, asibiti na Italiya yana buƙatar bawul ɗin iska na gaggawa kuma mai ba da sabis na iya samar da shi a cikin adadin lokacin da ake buƙata, yayin da farawa na gida mai ɗaukar hoto ya buga bawul 100 a rana ɗaya da ake buƙata a dare.
Tun bayan barkewar COVID-19, asalin cutar, ma'auni, rigakafi, magani da sauran fannoni da bayanai game da cutar sun bazu cikin sauri akan Intanet.
Da alama mutane suna da ikon yada kwayar cutar ga wasu dabbobi.
Binciken bai sami wata hujja ba game da yaduwar kwayar cutar a aladu, agwagwa da kaji.
Babu magani ko allurar rigakafin cutar.
Ana gudanar da bincike na duniya kan alluran rigakafi da magunguna kan COVID-19 ta hanyar hukumomin gwamnati, ƙungiyoyin ilimi da masu bincike na masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta kafa gwajin Solidarity don kimanta tasirin maganin kwayoyin cuta huɗu da ke akwai, tare da alƙawarin tasiri sosai.
Babu riga-kafi, amma hukumomi daban-daban suna haɓaka takarar allurar rigakafi.
SARS-CoV da SARS-CoV-2 duka suna amfani da mai karɓar mai karɓar ACE2 don shiga cikin sel saboda an riga an yi amfani da su a cikin SARS-CoV.
Akwai hanyoyin allurar rigakafi guda uku da ake gwadawa.
Da farko, masu bincike suna da niyyar ƙirƙirar allurar rigakafin cutar gaba ɗaya.
Amfani da wannan nau'in kwayar cutar, ko yana aiki ko ya mutu, shine don taimakawa jikin mutum ya sami ƙarfin rigakafi mai tsanani don amsa sabon kamuwa da COVID-19.
Dabara ta biyu ita ce allurar rigakafi, wanda ke nufin ƙirƙirar allurar rigakafi da ke bin tsarin garkuwar jiki na wasu ƙananan ƙwayoyin cuta.
Dangane da SARS-CoV-2, irin wannan binciken ya mai da hankali ne kan furotin S-spike wanda ke taimaka wa kwayar cutar ta kama mai karɓar enzyme ACE2.
Hanya ta uku ita ce rigakafin nucleic acid (wani sabon tsari don ƙirƙirar allurar rigakafin DNA ko RNA).
A cikin waɗannan hanyoyin, alluran rigakafin gwaji dole ne a gwada su don aminci da inganci. A ranar 16 ga Maris, 2020, an fara gwajin asibiti na farko na allurar rigakafin a Seattle akan masu sa kai huɗu.
Allurar rigakafin ta ƙunshi lambar halittar halitta mara lahani da aka kwafe daga kwayar cutar da ke haifar da cutar. An gabatar da shi azaman haɓaka mai dogaro da ƙwayoyin cuta don samar da allurar rigakafi don SARS-COV-2, amma wannan yana da rikice-rikice.
Tun daga watan Afrilu na 2020, an gudanar da gwaji sama da 300 na asibiti.
An sake nazarin magungunan da aka amince da su a baya don zazzabin cizon sauro, gami da bincike huɗu da aka amince da su, gami da bakwai na hydrochloroquine ko chloroquine.
Yawancin binciken da ake yi na maganin rigakafin cutar yana cikin binciken kasar Sin, wanda aka ruwaito a ƙarshen Afrilu a cikin gwaji tara na babi na III a ƙasashe da yawa.
An gudanar da nazarin ci gaba na asibiti na allurar rigakafi da magungunan COVID-19 har zuwa Afrilu 2020. Ana kimanta yawancin magungunan rigakafin cutar da ke akwai don maganin COVID-19 tare da maganin Reflovir, Chloroquine da Hydrochlorothiazines, Lopevia / Rutanvir da Lopeanavir / Rudonavir a hade tare da interferon beta.
Akwai tabbataccen shaida game da tasirin ragin farashin har zuwa Maris 2020.
An nuna ci gaban asibiti a cikin marasa lafiya da aka bi da su ta hanyar amfani da tausayi.
Ana gudanar da gwaji na asibiti na Mataki na III a Amurka, China da Italiya. An fara nazarin chloroquine a China a watan Fabrairun 2020, wanda aka yi amfani da shi a baya don magance zazzabin cizon sauro.
Duk da haka, an yi kira ga nazarin bincike don nazarin takwarorinsu.
Hukumomin kiwon lafiya na Koriya da China sun ba da shawarar amfani da chloroquine.
Duk da haka, Cibiyar Nazarin Kwayoyin Cutar Wuhan ta nuna cewa, yayin da ake ba da shawarar shan gram ɗaya a kowace rana, sau biyu na adadin yana da haɗari kuma yana iya zama mai kisa.
A ranar 28 ga Maris, 2020, zaɓin likitocin da ke kula da mutane da COVID-19 ya ba da izinin amfani da gaggawa na hydroxychloroquine da chloroquine.
Bayanai na farko sun nuna cewa ana buƙatar manyan matakan ribavirin don hana SARS-CoV-2 a cikin in vitro.
Bayan nuna ƙananan ƙwayar ƙwayar cuta don SARS-CoV-2, an ba da shawarar amfani da Nitazoxanide a matsayin ƙari a cikin binciken vivo. Bincike ya nuna cewa, babban amfani da furotin na trans-protein cell protease serine 2 (TMPRSS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Chloroquine da hydrochlorocurine tare da ko ba tare da arthromycin ba suna da manyan iyakoki waɗanda ƙungiyar likitoci za su iya ganowa don hana su magance waɗannan magungunan ba tare da ƙarin bincike ba. Oseltamivir ba ya gado SARS-CoV-2 a cikin vitro kuma ba shi da wani sanannen aiki a cikin maganin COVID-19.
Guguwar cytokine na iya zama mai rikitarwa a ƙarshen matakan COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine na iya samun kaddarorin anti-cytokine wave. Bayan kammala karamin bincike, Hukumar Kiwon Lafiyar Kasa ta kasar Sin ta sanya Tocilizumab a cikin jagororin magani.
Ana gudanar da gwaji na kasa na biyu a Italiya bayan an sami sakamako mai kyau a kan marasa lafiya masu tsanani.
An haɗa shi da gwajin jini na Sem Fritzstein don gano tasirin iodine, wanda aka yi niyyar hana irin waɗannan ci gaban da ake tsammanin suna haifar da mutuwa a cikin waɗanda ke fama da cutar.
An yarda da mai karɓar interleukin-6 ta hanyar FDA bisa ga nazarin da aka yi dangane da maganin maganin cutar ta CAR T cell, wanda aka buga a cikin 2017 wanda ya dogara da maganin maganin cutar ta hanyar fitowar cutar ta steroidal.
Har zuwa yau, babu wani tabbataccen, bayanan da aka sarrafa wanda ya tabbatar da cewa Toxilisezim magani ne mai tasiri don CRS.
Ana nazarin ko kwayoyin rigakafi da aka kirkira daga mutanen da suka warke daga COVID-19 za su iya zama hanyar da aka ba da shawarar don yin allurar rigakafi ga mutanen da ke buƙatar ƙwayoyin cuta da aka tace da kuma adana su.
Wannan dabarar ta haifar da sakamako mara kyau ga kwarewar SARS.
Matsayin tsaka tsaki na kwayar cuta / iko shine aikin da aka tsara wanda zai iya zama matsakaiciyar kariya ga SARS-CoV-2.
Koyaya, akwai wasu dabaru masu yuwuwa kamar anti-dependent cellular cytotoxicity da / ko fungicotosis.
Sauran hanyoyin maganin rigakafin rigakafin rigakafin rigakafi, alal misali, amfani da ƙwayoyin rigakafin monoclonal na wucin gadi, ba su da yawa.
Za a iya ƙara samar da ƙwayoyin cuta daga marasa lafiya da suka dawo daga cutar, wanda shine ɓangaren jini na marasa lafiya kuma yana ɗauke da ƙwayoyin cuta na musamman don cutar don saurin turawa.
Cutar Coronavirus, cuta da ke da nasaba da juna
Likita Li Wenliang ya mutu bayan kamuwa da COVID-19 bayan ya wayar da kan mutane game da yaduwar cutar a asibitin Wuhan.
